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Summary
A collection of over 300 streptomycetes, comprising both natural isolates 
and type strains, were assessed for the distribution of fatty acids, antibiotic 
resistances, compounds in solvent extracts, and sequences that hybridized to 
antibiotic resistance gene probes. These data were clustered using numerical 
methods and groups of similar strains were delimited. The production of selected 
antibiotics by all strains was also determined and the data examined for any 
correlations with the defined clusters.
Production of bioactive compounds was observed in twenty percent of the 
natural isolates studied; nigericin and geldanamycin production was common. 
Geldanamycin was only biosynthesized by strains which also produced nigericin and 
most strains which were thought to produce a novel antibiotic were also capable of 
nigericin production. When the sources and concentrations o f nutrients in the 
cultures of antibiotic producers were altered, differentiation responses and the 
expression of antibiotic production were found to be strain specific. In addition to 
this, nigericin production could be repressed by oxygen limitation.
In a production medium, fluctuations in fatty acid profiles occurred 
concomitantly with antibiotic biosynthesis, although this could not be correlated. 
However, fatty acid profiles did not allow the delimitation of groups of 
taxonomically related strains, which were cultured in a growth medium. Thin layer 
chromatography patterns obtained from the solvent extracts of streptomycete 
cultures showed much variation and were not suitable for use as systematic data.
Antibiotic resistance patterns allowed the delimitation o f bioactive strains 
from certain non-bioactive groups of strains; antibiotic producers showed multiple 
antibiotic resistance phenotypes, whereas a single selected resistance and a multiple 
sensitive phenotype was characteristic of non-bioactive strains. Most strains were 
resistant to penicillin and a large proportion were resistant to nigericin, but strains 
with resistance to aminoglycosides were rare.
Preliminary evidence showed that DNA from strains with multiple 
resistance patterns hybridized more often to gene probes (these were internal 
fragments of aphD, aph, vph, bar, tsr Nbr) than did DNA from strains with 
multiple sensitive phenotypes. Similarités were observed between strains grouped by 
their hybridization patterns and those grouped by the chemical class of their 
product. This work also allowed the selection of phenotypically resistant strains 
with different resistance genes and possible resistance mechanisms.
X X II
Chapter 1.
Introduction
1.1. The Lifecycle and Ecology pf the Streptomycctca.
Streptomycetes are commonly found in a variety of terrestrial and aquatic 
environments, including compost, river mud, sea water (Williams and Wellington, 
1982; Williams et al., 1989b) and the intestines of insects (Bignell et al., 1991). 
They are particularly abundant in the soil (Williams and Wellington, 1982) and are 
present in both the surface layers and the lower horizons. Soils which are present in 
countries with warm climates are more conducive to extensive colonisation than are 
those in cooler areas and streptomycete populations proliferate in grassland and 
pasture soils rather than those which are waterlogged or acidic ( Alexander, 1977; 
Reed Rodrigues Coelho and Drozdowicz, 1978).
The number and diversity of streptomycetes depends on seasonal variations 
(Williams, 1978, Huck et al., 1991); although their abundance can vary markedly 
in different microsites within the same soil sample. For example, Wellington et al. 
(1990) obtained electron micrographs of streptomycete mycelia in the soil showing 
large uncolonised areas, but with hyphae present in distinct regions within crevices 
between the soil particles. The size of a streptomycete community also depends on 
physical characteristics, such as pH and the presence of organic matter.
Streptomycetes play an important role in degrading complex recalcitrant 
polymers from plant and animal tissue (Williams, 1978). When nutrients have been 
depleted streptomycetes undergo a series of morphological changes, which begin 
with the lysis of vegetative mycelia. This provides nutrients for the production of 
aerial mycelia, which coil and divide from the tip downwards. The walls of the 
individual compartments formed by this process thicken and round off to give 
chains of immature, asexual spores which become more spherical and contain 
pigments when fully mature.
Organisms which sporulate may be well suited to survival in an environment 
where there are large fluctuations in nutrient availability. Streptomycetes are likely
1
to exist in the soil predominantly as spores, only becoming active mycelial 
organisms for brief periods of time when conditions are favourable (Wellington et 
a l., 1990). Germination of spores and the development of mycelium is a rapid 
process (Wellington et al., 1990) and so shows good adaptation to feast and famine 
conditions. In addition, the ability to grow in filaments facilitates the search for 
nutrients over a larger area than would be permitted by unicellular growth.
1.2. The Taxonomy of Streptomvcetes.
1.2.1. The Definition of the Genus Streptomvces.
Waksman and Henrici proposed the genus Streptomyces in 1943, and its 
taxonomy was developed over the next forty years, by workers such as Silvestri et 
al. (1962) and Williams et al. (1983a). Streptomyces became well known as a rich 
source of antibiotics with many new species being described for patent purposes. 
This was often a subjective procedure, since early attempts at species classification 
were based on differences in morphology and cultural characteristics. Conditions 
used in these studies were not standardised and so the overall result was a 
proliferation in the total number of Streptomyces species. The International 
Streptomyces Project was initiated in 1964 to help improve the situation and it 
resulted in the redescription of over 450 species (Shirling and Gottlieb, 1976).
In 1983, Williams et al. (1983a) published a study, which became the 
foundation of the current Streptomyces classification. Correct identification of 
streptomycetes was viewed as polythetic (Williams et a l., 1983a) and was obtained 
by probabilistic methods (Williams et al., 1983b). The resulting phena contained 
strains with high overall similarities, but no single character could cause or prevent 
group membership. The work (Williams et al., 1983a and b) clarified relationships 
within the genus and led to an extensive revision of the number of genera assigned 
to the family Streptomycetaceae. It also provided information which was useful for 
formulating selective isolation procedures (Williams and Wellington, 1982).
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Several probabilistic identification matrices have been constructed from the 
Williams et al (1983a) data. The first used forty one distinguishing characters to 
identify 23 major phena and was a valuable framework for the identification of 
Streptomyces isolates (Williams et al., 1983a). Two further matrices were 
constructed by Langham et al. (1989), one comprised all major clusters from the 
original classification and the other contained minor and single member clusters. 
This extended the number of streptomycetes which could be identified 
probabilistically, whilst utilizing the minimum number of characters required for 
discriminating taxa.
The great diversity of the genus made it difficult to devise a single workable 
identification matrix and large numbers of time-consuming tests were therefore 
required to identify unknown isolates. Several rapid tests have emerged over the last 
five years, culminating in the introduction of miniaturized numerical identification 
tests (Kampfer and Kroppenstedt, 1991a). The system was based on physiological 
characters from which a single probabilistic identification matrix was constructed 
for all major and minor clusters (Kampfer et a l., 1991b). Morphological criteria 
were not included in this study because they were thought to be too difficult to 
determine. Many of the groups found by Williams et al. (1983a) were confirmed, 
although some were not detected and the authors concluded that the genus was still 
overspeciated and suggested the amalgamation of certain species groups and the 
inclusion of streptoverticillia within the genus Streptomyces. Streptoverticillium has 
been formally reduced to synonomy with Streptomyces by Witt and Stackebrandt 
(1990) and the genus now also includes Kitasatosporia (Wellington et al., 1992) 
and the genera Actinopycnidium, Chainia, Elytrosporangium and Microellobisporia 
(Goodfellow et al., 1986; Williams eta l., 1989b).
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1.2.2. Chemotaxonomic Tests used for Classifying Streptomycetes
Carbon source oxidation tests have been used in several numerical taxonomic 
studies (Williams et at.; 1983a, Kampfer et at., 1991a) and the more traditional 
methods relying on detecting pH changes were often biased towards sugar 
utilization tests. Recently, Bochner (1989) devised an automated microtitre system, 
which used up to 93 carbon sources for differentiating between Gram-positive 
organisms. A redox dye indicated increased respiration and the results were 
automatically stored on a computer database which was equipped with systematic 
techniques. Other recently developed methods, which have proved useful for 
detecting enzymatic activity, have used chromogenic and fluorogenic substrates. For 
example, Goodfellow et at. (1987) found that groups, which were defined by 
Williams et at. (1983a), had individual patterns of enzyme activity, whilst Kampfer 
et at. (1991a), who incorporated similar tests in their numerical study, obtained 
different results from the work of Williams et at (1983a).
Pyrolysis mass spectrometry has been used to give whole cell fingerprints of 
a variety of organisms including streptomycetes (Gutteridge, 1983). Protein 
profiling has also proved to be a useful taxonomic tool (Kersters, 1983). The latter 
technique, involves submitting soluble cellular proteins to electrophoresis and 
extracting the banding pattern obtained on the gel, which can then be compared with 
the profiles of other strains. For example, Ochi (1989) made ribosomal protein 
patterns using two-dimensional gels, which showed specific profiles within 
Streptomyces species, whilst Vesselinova and Tsvetkov (personal communication) 
have shown discrimination between variants of the same strain. Serology has also 
been applied to Streptomyces taxonomy and although it previously relied upon 
Ouchterlony double diffusion assays, it has now been improved by the use of 
Enzyme Linked Immunosorbant Assays (Kirby and Rybicld, 1986).
Isoprenoid quinones are present in most bacterial membranes and the 
menaquinones of streptomycetes, which vary in length and saturation, have proved 
valuable in Streptomyces taxonomy (Alderson et at., 1983). The composition of
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isoprenoid quinones changes as the culture ages and so harvesting must talm place at 
specific stages in the growth cycle (Saddler et a l, 1986). Fatty acids are also 
present in bacterial membranes (Kaneda, 1991) and Saddler et al. (1986) showed 
that the fatty acid profiles of Streptomyces cyaneus remained relatively constant 
during both the stationary phase and logarithmic growth. Fatty acid methyl esters 
(FAMEs) have most frequently been used to differentiate organisms above the genus 
level (Goodfellow, 1989), although Saddler et al. (1987) partially recovered a group 
of S. cyaneus strains from a heterogeneous mixture of related taxa by using FAME 
profiles.
DNA hybridization studies on streptomycetes have been carried out by 
various workers, who have then compared their results with species groups which 
were defined using other methods. Mordarslri et al. (1985) carried out 
hybridizations using DNA from members of the Streptomyces albidoflavus, 
Streptomyces halstedii and Streptomyces griseus clusters, which were previously 
defined by Williams et al. (1983a) and found partial congruence between the two 
studies. In a similar study, Labeda and Lyons (1991) carried out extensive DNA- 
DNA hybridizations on the S. cyaneus cluster, but found that hybridization values 
spanned a wide range (40%-60ft) and were not consistent with strains belonging to 
the same species. Another molecular approach has been to obtain fingerprints of 
bacterial DNA using restriction analysis with pulse field electrophoresis; the 
patterns produced appear to be highly strain specific and reproducible (K J. Forbes, 
personal communication).
Information from RNA sequencing studies has been used to design species 
specific oligonucleotide probes (Stackebrandt and Charfreitag, 1990; Kemmerling et 
al., 1989; Witt et al., 1990). Studies to date have concentrated on 16S rRNA 
sequences in three regions of hypervariability, however Stackebrandt et al. (1991) 
reported that only one third of strains tested could be distinguished. Probes from the 
gamma region of 16S rRNA, 23S rRNA and the intercistronic spacer remain under
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investigation, although the variation in SS rRNA was considered unlikely to be 
sufficient for the construction of species-specific probes (Stackebrandt et al., 1991).
1.2.3. Systematic Methods Used in Taxonomic Studies.
Various aspects of the history and development of taxonomic methods have 
been reviewed by Cain (1962), Cowan (1962) and Sneath (1962), whilst thorough 
descriptions of techniques that are used are given by Alderson (1985), Sneath and 
Sokal (1973) and Austin and Priest (1986).
Classifications can be constructed to serve a variety of purposes and 
phylogenic, genealogical or cladistic classifications (often based on sequence data) 
attempt to trace evolutionary pathways, whilst taxonomic classifications aim to 
make generalisations (with respect to a wide range of tests) about their members 
(Sneath, 1962). Both are equivalent to phenetic classifications, provided there has 
been no parallel or convergent evolution (Sneath and Sokal, 1973) and they aim to 
arrange organisms into groups based on high overall similarities and which contain 
polythetic taxa (Sneath, 1962).
Special purpose classifications are designed for particular disciplines, where 
traditional taxonomy is inadequate because of its general nature (eg. a classification 
system for the food industry might only contain spoilage organisms, Heslop- 
Harrison, 1962). Such methods of grouping strains are artificial and are based on 
restricted information; they are largely monothetic and a single feature can be 
sufficient for group membership (Sneath, 1962).
For a good taxonomic classification the number of strains or operational 
taxonomic units (OTU's) should be greater than sixty to take account of strain 
variation and sampling error (Sneath and Sokal, 1973). Larger numbers of strains 
are required for studies which aim to define taxa than for those which examine 
relationships within species groups (Austin and Priest, 1986). Sokal (1985) stated 
that stable classifications can result from as few as 60 characters, although the 
optimum number of tests for a taxonomic study was given as 100 to 150 by Austin
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and Priest (1986). The tests, chosen for a numerical study, should be reproducible, 
standardized, easy to assess and appropriate for all strains (Goodfellow and 
Dickenson, 1983), whilst the strains should not be biased towards a particular group 
and should include reference organisms. Suitable statistics can be employed to 
detect test error (Sneath and Johnson, 1972).
After the tests have been scored the data must be coded; qualitative data is 
represented in binary form (1 or 0). Quantitative data can also be represented by 
binary numbers if one arbitrarily divides the scale up into one or more two state 
characters (Sneath and Sokal, 1973) or alternatively it can be computed in its raw 
form. Certain forms of qualitative data can be multi-state; for example colours and 
these can be divided into several two state characters.
The next stage is to calculate similarity and this is achieved using various 
coefficients, such as those formulated by Jaccard (Sneath, 1957) Sj (a/a+b+c), 
Dice (1943), S<jice (2a/2a+ b+c) and Sokal and Michener (1958) Ssm (a+d/ 
a+ b + c+ d ). The symbols refer to the number of positive and negative matches (a 
and d respectively) and dissimilar results (c and b). Distance coefficients, such as 
Euclidian distance (Sokal, 1961) measure geometrical distances between OTUs; this 
particular coefficient satisfies the Pythagoras theorem by measuring the distance 
between OTUs in terms of co-ordinates of a right angle. The choice of coefficient 
can be determined by the nature of the original data matrix and an association 
coefficient is preferred for binary data, whereas a distance coefficient is suitable for 
multi-state data (Sokal, 1983). Most taxonomic studies have used Ssm or Sj 
(Goodfellow and Dickenson, 1983).
Taxonomic structure is found by ordering OTUs into groups of high overall 
similarity; hierarchical clustering uses an algorithm to search the data matrix for the 
best matched pairs of OTUs. The couple with the highest similarity value is treated 
as a single OTU and the computer retrieves the next most similar OTU to form a 
group. Algorithms differ by their criterion for group admission; single linkage 
(nearest neighbour clustering, Sneath, 1957) joins an OTU to an established group
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at the highest similarity level of any member of that group and complete linkage 
(furthest neighbour clustering, Sorensen, 1948) clustering joins the OTU at the 
lowest similarity, whilst average linkage (the unweighted pair group method of 
arithmetic averages or UPGMA, Sokal and Michener, 1958) joins a new OTU at 
the average similarity for all group members. The output from these processes is 
usually represented as a hierarchical taxonomic tree, which summarises the salient 
points and can be related to taxonomic rank (Sneath 1962). However such trees can 
distort the distances between major groups (Alderson, 1985). UPGMA is reportedly 
the algorithm of choice, because it gives high within-group similarity (Sokal, 1985), 
although single linkage is often used for comparison against UPGMA (Goodfellow 
and Dickenson, 1985).
All taxonomic relationships are multi-dimensional and ordination methods 
allow up to three dimensions to be observed and give a more realistic measure of 
the distances between groups than a dendrogram. They are most useful if the 
relationship between entities is continuous, but they may distort distances between 
close neighbours (Alderson, 1985). OTUs are viewed in phenetic or taxonomic 
space and their arrangement depends to some extent on the position from which they 
are observed. Examples include principle co-ordinates analysis, which use distance 
matrices (PCD) and principle components analysis (PCA), which use distance and 
similarity matrices. Computing the principle components of the resulting matrix 
involves calculating its eigenvalues and eigenvectors. The eigenvalues are 
orthogonal and a framework of low dimensionality accounts for a large proportion 
of the variation in the original data (Sneath and Sokal, 1973, Alderson, 1985); both 
methods can give similar results, but PCD is less disturbed by missing data than 
PC A.
Sackin (1985) pointed out that differences between classifications can be due 
to addition or removal of characters or OTUs and changes in character coding, 
coefficient and algorithm. Good classifications should remain invariant when 
different methods are used for measuring similarity and for the clustering data.
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They should also remain stable when new tests and strains are added (Sokal, 1985). 
Strain similarity can be distorted by test error, reproducibility and the statistics used 
and it has therefore been recommended that duplicate strains amounting to 5% of 
the total should be included as an internal check (Goodfellow and Dickenson, 
1985).
In addition, the taxonomic map should adequately represent the original data 
matrix (known as goodness of fit) and this can be assessed by calculating cophenetic 
values. A good classification shows little overlap between phena (Goodfellow and 
Dickenson, 1985) and Alderson (1985) pointed out that care should be taken when 
trying to interpret ordination diagrams, since clusters which are distinct in the full 
hyperspace may overlap in low dimensional plots. However, there may be a 
tendency to overlook the fact that many organisms from natural habitats do not form 
tight clusters (Goodfellow and Dickenson, 1985) and hierarchical methods may 
impose a hierarchy on data which is not warranted.
Identification is the culmination of a taxonomic procedure and has been 
reviewed by Holmes and Hill (1985). The difference between the frequency of a test 
in one taxon and that in another can be used to choose good distinguishing 
characters (Sneath, 1962). Not all members of a taxon give uniform results, but 
values of 80-85% of organisms is considered positive and 15-20% negative for the 
overall phenotype of the group (Austin and Priest, 1986). Computer-based 
identification systems use diagnostic tables and compare results from unknowns with 
stored data. The likelihood of an isolate belonging to a given taxon is the 
probability of obtaining the observed test result with a strain of this taxon and is 
derived by multiplying together the probabilities o f individual test results.
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1.3. The Biosynthesis. Evolution and Natural Role o f Antibiotics in Streptomycetes.
1.3.1. Interactions Between Primary and Secondary Metabolism in Streptomycetes.
Primary metabolism is an interrelated series of enzyme-catalysed reactions, 
which are ubiquitous to all microorganisms and which function under a very wide 
range of growth conditions; the physiological processes involved serve known roles 
and are important for cellular growth. In this type of metabolism, biosynthetic 
precursors are converted into essential macromolecules (ie. DNA, RNA, protein, 
lipids and polysaccharides) which are formed as single definite products. Primary 
metabolites usually have relatively simple constitutions and intermediate products 
rarely accumulate, because the relevant processes are finely regulated.
Secondary metabolites are produced by certain taxonomically defined groups 
of organisms, such as the actinomytcetes, and, although they can reflect common 
molecules present in particular groups (Lechevalier, 1977), they are usually the 
distinctive products of individual strains (Arai et al., 1976). Well-defined 
physiological conditions are required for secondary metabolism and it often occurs 
after growth-associated cellular processes have declined. Secondary metabolites are 
structurally diverse compounds with intricate molecular frameworks and, although 
they have no known role in the internal economy of the producer, they often exibit 
biological activity. In addition, they have low molecular weights and are usually 
formed by multi-enzyme complexes as mixtures of closely related substances.
Secondary metabolites belong to a large number of different chemical classes 
(Figure 1.1.), but are formed by a few basic biosynthetic pathways (Turner, 1973) 
which are related to and use the intermediates of primary metabolism (Figure 1.2.). 
In primary metabolism, the catabolism of glucose occurs via pyruvate and acetate 
and then joins the tricarboxylic acid cycle (TCA). Alternatively hexose 
monophosphate is shunted through the pentose phosphate pathway and returned to 
glycolysis in the form of trióse phosphate. Glucose is eventually converted to 
carbon dioxide, water and energy (ATP), although
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Fig. 1.1. The chemical classification o f antibiotics.
The diagram summarizes a method for classifying antibiotics into families and 
subfamilies, which is based on their chemical structures. It follows the same 
classification as that used in the Berdy database (1988), where antibiotics are further 
sub-divided into groups and then individual antibiotics.
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Fig. 1.2. The interactions of primary and secondary metabolic pathways.
The diagram gives a brief summary which shows how the pathways of 
secondary metabolism seen in streptomycetes are derived from the catabolic and 
anabolic pathways of primary metabolism.
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intermediates of the glycolytic pathway are used in the anabolism of various 
primary metabolites, such as amino acids, fatty acids and nucleosides.
The entire carbon skeleton of glucose is incorporated into aminoglycosides 
(eg. kanamycin, neomycin and streptomycin (Grisebach, 1978), whilst other 
antibiotics, such as erythromycin and novobiocin contain only a portion in the form 
of a glycoside moiety (Kominek, 1972; Weber et a l., 1985; Stanzak et al., 1986). 
Ribose from the pentose phosphate pathway can be used to form nucleosides or 
structurally related antibiotics, such as 5-azacytidine, tubercidin and blasticidin S. 
The biosynthesis of the sugar components in antibiotics has been reviewed in detail 
by Grisebach (1978).
The shildmic acid pathway of aromatic amino acid synthesis originates from 
erythrose 4 phosphate in the pentose phosphate pathway and phosphoenolpyruvate 
from glycolysis. Antibiotics such as lincomycin, actinomycin, thiostrepton and 
novobiocin are produced directly from aromatic amino acid precursors, whilst 
ansamycins, such as geldanamycin and herbimycin (Ghisalba et al., 1984) arise 
from intermediates which lead to shildmate formation. Pathways for the formation 
of other amino acids, which are involved in antibiotic formation, branch off from 
triose phosphate (eg. Beta-lactams; Pratt, 1989), pyruvate (eg. bialaphos; Murakami 
et al., 1986), acetate and the TCA cycle (eg. blasticidin S; Prabhakaran and Gould, 
1990). In addition to the standard 18 L-amino acids of primary metabolism 
microorganisms can use D-amino acids and methyl, dihydro and hydroxy amino 
acid derivatives to form bioactive cyclic peptides (eg. virgineomycin and 
cyclosporin A; Monaghan and Teaks, 1990). Peptide antibiotic formation has been 
described extensively by Kleinhauf and von Dohren (1987).
Carboxylation of acetate produces malonate, the basic building block of fatty 
acid biosynthesis, whilst further condensations of these two molecules can lead to 
the coenzyme-A derivatives of propionate, butyrate, 2-methyl malonate and 2-ethyl 
malonate, which are involved in polyketide biosynthesis (Floss et al., 1986; Nisbet 
and Porter, 1989). The substrate specificity of enzyme complexes involved in
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polyketide biosynthesis is much lower than that required by enzymes involved in 
fatty acid anabolism (Kaneda, 1991). Biosynthesis begins with a starter unit (acetate 
or some other compound) and a highly variable number of malonate, acetate, 
propionate, butyrate, 2-methyl malonate or 2-ethyl malonate units which become 
attached together by successive condensation steps. Chain elongation is not 
dependent on whether the beta-keto group is modified prior to the next condensation 
step and some of the keto groups are maintained in the final structure, although 
most are simply reduced to hydroxyl groups. Products of this pathway include 
actinorhodin, oxytetracycline (Binnie et al., 1989; McDowell et al., 1991) and 
polyene macrolides, such as erythromycin and polyethers, such as nigericin (Martin, 
1977). The isoprenoids, steroids and terpenes are formed via mevalonate from 
acetate, and geosmin, which gives acdnomycetes their characteristic odour, is also 
formed via this route (Bendy and Megan than, 1981).
1.3.2. The Diversity o f Secondary Metabolites from Streptomvcetes.
Table 1.1 illustrates the diversity of secondary metabolites with respect to 
their mode of action, chemical class and spectrum of activity and Fig. 1.1. shows 
the chemical classification of antibiotic groups and sub-families by their chemical 
structure and biosynthetic origins. Each sub-family contains a number of groups, for 
example aminoglycoside antibiotics comprise streptamine, 2-deoxystreptamine and 
inositol-inoseamine derivatives (eg streptomycin, neomycin and validomycin 
respectively), other aminocyclitols (fortimycin) and aminohexitols (sorbistin) 
(Lechevalier et a l., 1988). There are over one hundred chemical groups to which 
the six thousand or more different antibiotics discovered so far (Berdy, 1988) can 
belong and this constitutes an enormous structural diversity.
The activity spectra shown by antibiotics can differ substantially between 
compounds belonging to the same group. For example, although the ansamycins 
geldanamycin and herbimycin are both antifungal compounds, this property is much 
weaker in herbimycin, whose main activities are against plants and viruses.
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Table 1.1. The chemical groups, inodes of action and activity spectra of selected 
antibiotics.
This table shows the diversity of secondary metabolites from streptomycetes (and 
fungi) and also includes information on antibiotics which were of interest with 
respect to the research presented later in this thesis; these were bialaphos, 
herbimycin, geldanamycin, nigericin, erythromycin, neomycin, novobiocin, 
streptomycin, thiostrepton, viomycin, blasticidin S, kanamycin, Oxytetracycline and 
penicillin G.
Key to activity spectra;
F — fungicidal 
G +  = anti-Gram-positive 
G- ”  anti-Gram-negative 
H = herbicidal 
I =  insecticidal 
M ”  anti-mycoplasmal 
P “  anti-protozoal 
T -  anti-tumour activity 
V *  anti-viral
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Geldanamycin has a broader spectrum of activity including antagonism 
against tumours, protozoa, Gram-negative and Gram-positive bacteria. Other 
macrolide antibiotics are antiparasitic, antibacterial, antifungal, antiviral and 
antitumour agents, enzyme inhibitors, immunomodulators and coccidiostats, 
showing that this family exhibits a wide range of biological activities (Monaghan 
and Teaks, 1990).
The modes of action of bioactive secondary metabolites can be categorised 
into a series of broad groups based on the physiological processes with which they 
interact and targets include proteases, glucosidases, chitinases and membrane 
transport; they can also interfere with the biosynthesis of DNA, RNA, proteins and 
cell wall components. The specific activity of antibiotics can depend on their 
molecular shape and the distribution o f specific functional groups, although 
compounds with very different structures can act on the same metabolic process 
(Vining, 1990).
1.3.3. The Evolution of Antibiotics and its Relationship to Antibiotic Function.
ZShner's theory of "elbow room in biochemical evolution" (1982) suggests 
that secondary metabolic pathways arise in a games room, where a reasonable level 
of low cost inventive evolution is tolerated. ZShner et al. (1982) hypothesized that 
random combinations of catalytic sequences which gave no advantage to an 
organism would eventually be eliminated, whilst advantageous combinations would 
be selected for and maintained. This view o f secondary metabolism as evolution in 
progress was shared by Hotter (1982), who believed that it increased the ability of 
organisms to cope with a changing environment and Vining (1990), who postulated 
that new secondary metabolic pathways were acquired when the precursors of 
primary metabolism became modified by a mutated enzyme. The resulting abnormal 
product was then modified by random permutations of existing enzymes and 
advantageous pathways were then be improved by further mutation and selection. 
Zfthner's model also accommodates horizontal gene transfer by "division of labour
in biochemical evolution.” Here novel compounds can find a function in an 
organism other than the one in which they originated. Recent sequence comparisons 
were consistent with Zahner's gene transfer theory (L.C. Vining, personal 
communication); for instance, amino acid sequence similarity between fatty acid 
synthases in animals and polyketide synthases in Penicillium was greater than when 
both enzymes from Pemcillium were compared. This indicated to Vining that 
secondary metabolism evolved due to a  high rate of gene transfer, rather than 
coevolution.
Williams et al. (1989a) rejected the idea that natural products could have 
originated from initially neutral mutations, arguing that this was an unlikely route 
for the formation of the highly ordered gene clusters which give rise to antibiotic 
production. Instead they reasoned that whilst essential structures and mechanisms 
evolved early in the evolution of living organisms and are highly conserved, the 
increased diversification of individual microbial niches led to a later development in 
genotypic and phenotypic variation. Williams et al. (1989a) believed that natural 
product diversity co-evolved alongside species variety and gave examples of specific 
compounds, which may have evolved to act in an antagonistic capacity with 
neighbouring organisms. The sophisticated receptor-antibiotic complementarity of 
these molecules was seen as evidence for their evolution under the pressures of 
natural selection specifically as a strategy for survival. Piepersberg et al. (1991) 
took a similar view, believing that secondary metabolism has undergone a long term 
of evolution, but thought that this may have been in parallel with the metabolism of 
proteins or RNA with the complete pathways being diversified, degenerated or 
individualized at a later stage. These workers also suggested that the main period 
where antibiotics had general and essential functions could have been in precellular 
times. This is in agreement with recent studies by Julian Davies (personal 
communication), who has been studying the interactions of certain aminoglycoside 
and peptide antibiotics with group I introns (which are related to rRNA with respect
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to catalytic function). This work has led to the hypothesis that the original function 
o f  these molecules could have been to interact with an early form of catalytic RNA.
The gathering of production genes to form clusters could be viewed as a 
means for conservation under strong selective pressures (the nature of which 
remains unknown), but this may also allow the transfer of whole biosynthetic 
pathways (Piepersberg et a l., 1991). Piepersberg et al. (1991) believe that evolution 
continued as production genes were acquired, lost and exchanged and that enzyme 
families involved in secondary metabolism were derived from a few ancient protein 
groups (not necessarily in producer organisms), whose substrate specificities then 
evolved divergently and convergently to form various catalytic functions observed 
today. It is known that genes involved in secondary metabolism are frequently in 
unstable genomic segments (Altenbuchner and Cullum, 1985; Flett and Cullum, 
1987; Birch et a l., 1989; Hausler et al., 1989; Leblond et al., 1989) and gene 
duplication could also be a means of evolution. Genetic instability is often 
associated with amplification and deletion events in genomic "hotspots* (Demuyter 
et al., 1991; Schrempf, 1991), which can involve up to 10% of the streptomycete 
genome (Cullum et al., 1991). Variable streptomycete phenotypes may also be 
explained by the loss of plasmids (Schrempf, 1982). Hopwood et al. (1992) views 
gene duplication events as a means by which the different forms of polyketide 
synthase may have evolved.
1.3.4. Theories Proposed for the Function of Secondary Metabolites
One of the leading questions in the study of secondary metabolism is "why 
are antibiotics biosynthesized?" Even though antibiotics are a highly diverse group 
o f  compounds, many of the early hypotheses suggested that they had a universal 
function. This concept is no longer supported (Vining, 1990) and the present view 
is that it probably serves a selection of different purposes. There is a great deal of 
evidence for the functionality of secondary metabolism; firstly the molecules are 
structurally complex and often show a high degree of complementarity to receptors
18
at their sites of action. This may suggest a highly sophisticated structure, function 
relationship (Williams et al., 1989a). Secondly antibiotic biosynthesis is an energy- 
requiring process and involves a series of complicated reactions, which are are 
frequently catalysed by unique enzymes and which can respond to environmental 
factors. Large tracts of DNA are consigned to antibiotic production (Binnie et al., 
1989; Stanzack et al., 1990) and the relevant biosynthesis genes are organised into 
clusters along with regulatory elements and resistance determinants (Chater and 
Bruton, 1985; Malpartida et al,. 1986; Murakami et al., 1988; Binnie et al., 1989; 
Stanzak et al., 1990).
It may be possible that antibiotics have no function and are an artefact of 
laboratory cultivation or else they may be produced at such low levels in the natural 
environment that they remain intracellular. Demain (1981, 1984) has stated several 
times that antibiotic production in non-autoc laved non-amended soil has been 
detected and although Williams and Vickers (1986) maintained that convincing 
evidence was lacking, they believed that production could be possible at low levels 
within micro-habitats. More recent evidence for antibiotic production in the soil has 
been provided by Weller and Thomashow (1990), who believe that secondary 
metabolites are responsible for the success of certain biological control agents.
Some early theories on the function of secondary metabolites considered that 
they were vehicles for unwanted primary metabolites, which had formed from the 
metabolism of reactive intermediates and had deleteriously accumulated within the 
cell (Bu'Lock et al, 196S). The fact that many antibiotics are highly toxic 
themselves was used as evidence against the cellular waste or detoxification theories 
and Tempest and Neijssel (197S) put forward a modified theory of overflow 
metabolism. Secondary metabolites were now thought to be adventitious shunt 
products, which were formed by the action of normal non-specific enzymes on 
abnormal accumulations of primary intermediates and the biological activity of 
secondary metabolites was therefore presumed to be accidental. Demain (1984) 
pointed out that there was an array of regulatory mechanisms to maintain
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endogenous products at low levels and that such a system would require the loss of 
these resulting in competitive disadvantages. The above theories are now discarded 
by many scientists (Demain 1984; Williams et al. 1989a; Vinning 1990), who argue 
against antibiotic-producing organisms expending large amounts of energy, DNA 
and enzymes in creating compounds, which at the outset have no use. It has been 
suggested that the non-specific enzymes involved in the overflow theory may belong 
to vestigial remnants of a formerly useful pathways. However the existence of 
dormant pathways is questionable when loss due to mutations and lack of selective 
pressure is considered.
There are certain cases where shunt products may be a bona fide  solution to 
an organism's problem. Hood et al. (1992) have shown that proline transport and 
catabolism are constitutive in a  wild type strain of Streptomyces coelicolor. Mutant 
cells, which cannot utilise proline dispose of it in the form o f undecylprodigiosin 
excreted into the medium. These workers suggest that the capacity to produce an 
antibiotic from an amino acid, creates a sink for excessive amounts of this precursor 
and that the need to tightly regulate its metabolism is negated; they expect 
regulation to be tighter in cases where there is no relevant sink compound. Vanek 
and Mikulik (1978) commented that identical sugar precursors are used in cell wall 
and aminoglycoside biosynthesis and both processes use the same initial enzymes; 
consequently cell wall inhibitors can lead to increased aminoglycoside production.
Another early theory o f  antibiotic function was that they were nutrient 
reserves and although this theory has been dismissed because antibiotics are usually 
excreted, it may be true for specific cases. The streptomycin biosynthesis pathway 
may have developed under positive selection because guanido inositol derivatives 
served a function as nutrient reserves (Walker 1990). Another hypothesis given by 
Bu'LocK (1961) was that secondary metabolism maintained enzymes from primary 
metabolism at a standby level during deleterious growth conditions so that 
producing organisms could resume normal activity more quickly than dormant 
species.
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Some believe that all secondary metabolites have a biological function and 
more recently specific functions have been proposed for individual antibiotics and 
groups of compounds (Drautz and Z3hner, 1985). Ionophores are produced by 
Nocardia, Streptomyces and Micromonospora and can transport specific ions across 
cell membranes and there is evidence that this plays a useful role in the producer 
organisms. For example the siderophores and sideramines are involved in the uptake 
of ferrous and ferric ions (Hutter, 1982) and producers of these compounds have 
specific membrane proteins for their uptake. Such strains probably have a survival 
advantage in low iron environments because they are not detrimentally affected by 
iron depletion. A similar case has recently been cited by Vinning (1990), where a 
macrotetralide-producing S. griseus was able to survive in a high sodium low 
potassium environment; this was in direct contrast to a non-producing strain. 
Williams et al. (1989a) were convinced that the ionophore lasalocid must have a 
function because out of all the alternative structural configurations this compound 
had the best barium-binding capabilities.
Antibiotics have also been proposed as weapons against competitive species. 
The bleomycins, produced by Streptomyces verticulus have been reported to act by 
binding to guanine containing nucleic acids, especially at sites with alternate 
purine/pyrimidine bases and sequences with C and T 's are cleaved preferentially. 
Mitomycin C, from Streptomyces caespitonis, alkylates DNA and causes cross- 
linkages to form in helical DNA; it also inhibits DNA polymerase and might inhibit 
DNA repair. This antibiotic remains inactive until the quinone is enzymatically 
reduced by the victim, causing activation of the carbamate and azidine moieties. A 
similar example is given by calichemycin a compound which remains latent until 
activated by nucleophilic attack, when it develops the ability to cleave double- 
stranded DNA (specifically after TCCT). Williams et al. (1989a) suggested that the 
function in all of the above cases was cleavage of non-self DNA.
Functions have also been proposed for certain aminoglycosides and Barabas 
et al. (1976) suggested that streptomycin might be involved in building the cell wall
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network in S. griseus because streptidine (a component of the streptomycin 
molecule) was a cell wall constituent. Szabo et al. (1985) found streptomycin was 
bound to the cell walls of hyphae and the spores of S. griseus. The antibiotic was 
liberated mainly in germinating spores and was implicated in the protection of 
young hyphae. Aminoglycoside antibiotics have also been implicated as regulators 
of cell wall lysis, since streptomycin has been shown to accelerate the action of 
autolytic enzymes (Szabo et al., 1990).
Some antibiotics may be agents of metabolic change and may modify gene 
activity in response to the environment or they could link various activities, which 
are involved in cytodifferentiation; A-factor, which positively controls sporulation 
and streptomycin production in S.griseus is an example of this (Horinouchi and 
Beppu, 1986). Intraspecific pheromones which coordinate sporulation within a 
colony have also been observed in several streptomycetes, namely Streptomyces 
viridochromogenes, Streptomyces bikiniensis and Streptomyces cyaneofusculus 
(Professor T. Beppu, personal communication). Antibiotics which affect 
differentiation include pamamycin, which induced the formation of aerial mycelium 
and inhibited the uptake of inorganic phosphorus and nucleosides in its producer, 
Streptomyces albidoniger (Pogell, 1984) and methylenomycin A and lincomycin 
(high concentrations), which inhibited aerial mycelium formation in S.coelicolot 
(Pogell, 1984). However, low concentrations of lincomycin enhance the production 
of aerial mycelium.
Some antibiotics may confer activity against the activities o f organisms from 
other species and the term ecomone can be used to describe an antibiotic activity 
which is specifically directed at these organisms in the natural environment. Such an 
activity could confer a selective advantage on producing organisms and the 
acceptance that microbial secondary metabolites might be formed in soil 
microenvironments has helped this idea. For example Rothrock and Gottlieb (1984) 
described the production of geldanamycin and two other antibiotics by a strain of 
Streptomyces hygroscoplcus in sterile soil containing diseased plants.
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Martin and Demain (1980) suggested that secondary metabolites could be 
produced in microenvironments and might confer antimicrobial activities or even 
reducing predation by protozoa , but to follow the theory through, substances which 
act on the physiology of higher animals and their immune system must be 
adequately accounted for; for example B-factor is produced by yeast cells and 
functions in nocardia by stimulating rifamycin production and it also has a structural 
similarity to cAMP. Beppu (198S) suggested that some effectors in actinomycetes 
could be universal signals or messengers for cellular functions in both prokaryotes 
and eukaryotes. Williams et at. (1989a) expanded this idea by suggesting that the 
molecules which permit specialized glands, neurones and immune blood and tumour 
cells to communicate (eg. hormones and receptors) were present in unicellular 
organisms before these larger organs evolved. Some fungi produce sex hormones 
similar to testosterone, oestradiol, antherdiol and oogoniol and there are also fungal 
peptide hormones which lead to animal cell proliferation and other compounds (eg. 
FK506), which can activate T-cells. It has been accepted for a long time that 
chemical defenses play an important role in the survival of plants and Williams et 
al. (1989a), who pointed out that natural products are most common in organisms 
which lack an immune system, believe that this is also true for microorganisms.
On the whole the different reputable concepts neither exclude nor contradict 
one another and each probably plays a part in the true explanation of secondary 
metabolism, which must encompass mechanisms of evolution, the development of 
individual functions and nutritional and regulatory aspects.
1.4. The Regulation and Control of Secondary Metabolism.
The course of events associated with the production of antibiotics in the 
laboratory include a phase of biomass formation (the trophophase) followed by a 
decline in growth rate and a period of natural product synthesis (the idiophase). 
Demain (1984, 1983) has suggested that a similar growth and production profile
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might be advantageous in the natural environment if the product is either an effector 
of differentiation or a potent antibiotic which can inhibit the growth of the producer.
Microbial growth is limited in soil ecosystems because nutrients are scarce 
and so appropriate control systems are required (Mateju, et al. , 1985). The various 
control mechanisms which regulate secondary metabolism in streptomycetes include 
environmental factors such as carbon, nitrogen, phosphorus, salts, trace metals, 
oxygen and light and regulation can be through intermediary metabolism or by 
feedback regulation in secondary metabolic pathways. The negligible expression of 
antibiotic biosynthesis genes at high growth rates could be due to the repression of 
inducible catabolic enzymes (Hutter, 1982) or the inhibition o f enzyme activity 
(Iwai and Omura, 1981).
14.1. Carbon Source Regulation.
Glucose exerts carbon catabolite regulation in many fermentations (Iwai and 
Omura, 1981) and its catabolism accompanies growth. If another substrate is 
present in the same medium then antibiotic production usually accompanies the 
utilization of this second compound. The glucose effect interferes with the synthesis 
of many antibiotics including oleandomycin (Belousova et al., 1985), tylosin 
(Behai, 1985) and granaticin (James and Edwards, 1988) and is also important for 
the interconversions of members of an idiolite family. Carbon source regulation can 
be diminished and antibiotic production stimulated by adding the carbon source 
periodically as has been shown for the biosynthesis of both candicidin and polyenes 
(Iwai and Omura, 1981).
When glycerol, sucrose and D-mannose as were used as carbon sources in 
cultures of Streptomyces erythraea they delayed erythromycin production, but 
increased growth (Sanchez et at., 1984). Erythromycin biosynthesis was only 
transiently repressed by D-glucose, whilst citrate, propanol and propionate 
stimulated production of this antibiotic and the effect was thought to be due to 
induction of propionyl-Co-A carboxylase, one of the first enzymes involved in
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erythromycin biosynthesis (Sanchez et a l., 1984). Glucose and glycerol are known 
to completely repress the formation of several enzymes, including tryptophan 
pyrrolase, kynurenine formamidase II, hydroxykynureninase and phenoxazinone 
synthase, which are involved in actinomycin D biosynthesis by Streptomyces 
parvulus (Katz et al., 1984, Jones, 1985). Other carbon sources exert a suppressive 
effect, such as citrate on the production o f novobiocin, arabinose on heliomycin 
biosynthesis (Vinogradova et al., 1985), glycerol on cephalosporin synthesis 
(Demain, 1985) and mannitol and starch on granaticin production (James and 
Edwards, 1988).
1.4.2. Nitrogen Source Regulation.
Repression of antibiotic biosynthesis by nitrogen sources such as ammonium 
ions and certain amino acids is common in streptomycetes (Demain, 1985). 
Microbial nitrogen metabolism has been reviewed by Grife (1982), who concluded 
that the control of antibiotic formation by nitrogen sources can take three forms. 
These are (i) positive control, where production is enhanced, (ii) negative control, 
where antibiotics accumulate after the nitrogen source has been consumed and (iii) 
control o f the product spectrum. Positive nitrogen regulation was thought to be 
important in rifamycin SV biosynthesis because nitrate induced nitrate and nitrite 
reductases and enhanced the activity of various dehydrogenases. It also caused a 
decline in cellular lipid content, suggesting that the presence of nitrate had increased 
rifamycin biosynthesis at their expense (Chiao et al. , 1988).
Nitrogen metabolites can regulate primary metabolism by repressing 
enzymes that act on nitrogen-containing substrates and changes to both the type and 
concentration of nitrogen sources can influence antibiotic production (Iwai and 
Omura, 1981). For example, Sanchez et al (1984) found that ammonium strongly 
repressed erythromycin biosynthesis in S. erythraea and that the extent of 
suppression was proportional to the type of ammonium salt used and its 
concentration. Differences in erythromycin production were also observed in the
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presence of various amino acids and alanine was preferable for both growth and 
antibiotic formation. Katz et al. (1984) reported that other amino acids, namely L- 
glutamate, aspartate, alanine and D-valine, repressed the synthesis o f enzymes 
which was involved in actinomycin D production.
Rapidly utilised nitrogen sources such as ammonium ion, nitrate and amino 
acids are good growth substrates, but they sometimes inhibit antibiotic production; 
examples include oleandomycin biosynthesis by Streptomyces antibioticus, and the 
production of novobiocin by Streptomyces niveus. Ammonium ion also exerts a 
negative effect on the production of streptomycin, cephalosporins, chloramphenicol, 
leucomycin, tylosin and some rifamycins (Demain, 1985).
1.4.3. Regulation bv Inorganic Phosphorus (Pit.
Many idiolites are produced at concentrations of inorganic phosphate (Pi), 
which are sub-optimal for growth (Demain, 1985) and there are at least two 
mechanisms responsible for this effect. Pi can repress or inhibit the phosphatases 
which are involved in antibiotic synthesis, but it can also repress intracellular 
effectors or possibly other synthetases. Antibiotics with phosphorylated 
intermediates, such as streptomycin, neomycin, viomycin, turimycin and 
nourseothricin are subject to the first type of control mechanism (Iwai and Omura, 
1981; Muller and Ozegowslri, 1985). For example high levels of Pi in the 
streptomycin fermentation lead to poor antibiotic production and a high 
concentration of streptomycin phosphate (the last intermediate in the pathway). For 
antibiotics, which do not have phosphorylated intermediates, but are subject to Pi 
control, ATP levels decline as Pi decreases and secondary metabolism increases 
because the metabolic conversions required for antibiotic production are 
derepressed. As Pi increases, ATP levels increase and so does primary metabolism 
(Iwai and Omura, 1981).
Candicidin production in S. griseus requires the depletion of Pi and 
extracellular Pi remains low during the entire candicidin idiophase, although
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addition of Pi (lOmM) at the onset of production, returns the culture to 
trophophase. During this period ATP levels rise, but protein and RNA synthesis 
remain constant. This implicates ATP in the control of biosynthesis (Martin and 
Demain, 1980). High Pi levels repress the synthesis of candicidin synthase (Hutter, 
1982) and rifamycin SV production (Chaio et aJ., 1988). In the latter case growth 
and ATP levels were enhanced and mycelial lipid levels increased (at 2.5 mM Pi), 
whilst the enzyme activities involved in rifamycin SV production (methylmalonyl- 
CoA carboxytransferase and methylmalonyl-CoA mutase) were suppressed. 
Variations in the adenylate pool were thought to be responsible for these effects. Pi 
also exerts control over the production of Chlortetracycline in Streptomyces 
aureofaciens and an increase in potassium dihydrogen orthophosphate (0.2-0.4mM) 
accelerates glucose and ammonium consumption, whilst Pi depletion is required 
before antibiotic production can occur (Martin and Demain 1980). Jechova and 
coworkers (1985) made similar observations and noted that the intracellular level of 
adenylates was inversely proportional to the activity of the penultimate enzyme in 
the Chlortetracycline biosynthesis pathway. In Streptomyces clavuligerus, another 
Chlortetracycline producer, production increases with increased levels o f  Pi up to 
25mM then declined at higher concentrations (Iwai and Omura, 1981).
1.4.4. Other Bioregulators.
In the cases described above enzyme induction has been caused by the 
catabolites themselves, but there are also more unusual molecules, which can elicit 
these effects (reviewed by Beppu, 1985). The best known example of this is the 
induction of streptomycin biosynthesis by A-factor, which is encoded by the 
structural gene qfsA and stimulates transcription of the streptomycin 
phosphotransferase gene (Horinouch and Beppu, 1986). Demain (1985) stressed that 
A-factor was most effective when added before growth. The compound is produced 
by 15% of non-streptomycin-producing streptomycetes and is strain specific. AfcA
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has an extrachromosomal location in S. griseus and this is in contast to the 
regulatory gene (tfsB, which is located on the S.coelicolor chromosome. The latter 
gene positively regulates the biosynthesis o f  A-factor in S. coelicolor and also plays 
a role in regulating the production of actinorhodin, undecylprodigiosin and possibly 
methylenomycin and a calcium-dependent antibiotic. Horinouchoi and Beppu (1986) 
put forward the hypothesis that the product of this gene, which contains two DNA- 
protein binding domains, might bind to a regulatory region of a key gene involved 
in secondary metabolism and either stimulate or decrease its activity. Alternatively 
the qfsB protein could bind directly to biosynthetic genes (eg the act genes) and 
stimulate their expression.
Other regulatory substances of actinomycètes include inducing material (IM) 
in Streptomyces virginiae, which effects staphylomycin production and B-factor, 
which is essential for rifamycin production in Nocardia species (Beppu, 198S). The 
whiG gene of S.coelicolor encodes an RNA polymerase sigma factor and mutations 
in this gene block the formation of spores in the aerial mycelium. An increased gene 
dose of whiG gives rise to greater sporulation in S.coelicolor and its product is 
thought to be a positive effector (Mendez and Chater, 1987). Chater et al. (1989) 
sequenced the gene and found it was related to a minor motility sigma factor of 
Bacillus subtiUs. Multiple copies of a sigma-dependent promoter from this strain 
were introduced into S.coelicolor, where they caused reduced sporulation. This 
suggested that the S.coelicolor sigma factor recognised and bound to the Bacillus 
promoter and reduced transcription of its normal targets. A range of diverse 
streptomycetes were found to harbour a  whiG homologue and this is in direct 
contrast to the bldB gene needed for normal aerial mycelium, which appears to be 
absent from species other than S.coelicolor (Piret et a l., 1988).
1.4.5. Genetic Control and Organisation in Secondary Metabolism.
A large number of studies have shown that the genes for the biosynthesis of, 
resistance to and control of many antibiotics are organised into co-ordinately
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regulated clusters (Malpartida and Hopwood, 1984; Murakami et a l., 1986; Distler 
et a l., 1987b; Malpartida et al 1987, Binnie et al., 1989, Webber et al., 1990). 
Most appear to be located on the streptomycete chromosome, however the 
methylenomycin cluster is plasmid-borne (Kirby et al., 1975, Wright and 
Hopwood, 1976). There is evidence for other production (Kinashi et a l., 1987) and 
resistance (Woodman, personal communication) genes being associated with 
extrachromosomal elements. The most extensively studied streptomycete genome is 
that of S.coelicolor, a strain which produces several antibiotics including 
actinorhodin (Rudd and Hopwood, 1979; Malpartida and Hopwood, 1984 and 1986; 
Malpartida et al., 1987), but much is also known about the genetics of many other 
antibiotic pathways (Seno and Baltz, 1989).
The streptomycin biosynthesis pathway is fairly well understood (Walker and 
Walker, 1982) and S.griseus has provided a good model to study gene organization 
and regulation (Distler et a l., 1987b) Blocked mutants from this strain have been 
isolated and analysed for accumulated intermediates (Ohnuki et a l., 1985; Distler et 
al., 1985) and cloned segments of its DNA have been used in complementation 
studies (Ohnuki et al., 1985). A genetic map of some streptomycin genes is given in 
Fig. 1.3., although currently sequence analysis of the streptomycin gene cluster has 
revealed at least 14 genes (Piepersberg et al., 1991). The strB gene, which encodes 
an aminidotransferase is linked to strC (a dihydrostreptosyl-transferase gene), strR, 
a regulatory gene, which is thought to be a trans-acting positive effector and the 
resistance gene, which encodes a streptomycin-6-phosphotransferase (strA, aphD, 
SPH). A different resistance gene has also been cloned from the biosynthesis gene 
cluster (Heinzel et a l., 1988) and this encodes a streptomycin-3- 
phosphotransferase. Not all genes involved in streptomycin biosynthesis have been 
cloned, so evidence for a single gene cluster is incomplete. More is known about 
the actinorhodin cluster, whose genes are organised into four transcription units, 
consisting of two polycistronic mRNA's encoding actl, VII, IV  and act V and V7 
respectively and single small transcripts encoding actll (thought to be a positive
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Fig. 1.3. Summary of genes, which have been cloned and which are involved in the 
biosynthesis of streptomycin.
The diagram has been adapted from Seno and Baltz, 1989 and shows the structural 
organization o f the streptomycin gene cluster. DNA segments A to E refer to genes 
cloned by the following researchers:
A =  Ohnuld et al., 1985 (cloned from S.griseus ATCC10137).
B =  Distler et al., 1985, 1987a and 1987b (cloned from S.griseus N2-3-11).
C =  Tohyama et al., 1987 (cloned from S.griseus ISP 5236).
D =  Vallins and Baumberg, 1985 (cloned from S.griseus ATCC1247S).
E =  Kumada et al., 1986 (cloned from S.bikiniensis ATCC11062).
30
regulator) and actll (Malpartida and Hopwood, 1986). In the case of streptomycin 
biosynthesis at least 5 partially overlapping transcripts have been detected (Distler et 
al., 1987b). This type of arrangement might facilitate the co-ordinate or prior 
activation o f resistance genes similar to that demonstrated in Streptomyces rimosus, 
where the otrA resistance gene is linked to the early oxytetracycline biosynthesis 
genes and otrB to the late genes (Butler et al., 1989.).
Antibiotic producers may encounter endogenous or foreign antibiotics and 
might have more than one genetic mechanism specifying resistance to them. 
Additionally the same resistance mechanism could be under more than one form of 
regulation (Seno and Baltz, 1989). The streptomycin-6-phosphotransferase gene 
(Onhuld et al., 1985), which is clustered with streptomycin biosynthesis genes in 
S.griseus, is under both negative regulation by a region downstream o f strA and 
positive control by strR, which also activates at least one biosynthesis gene. Seno 
and Baltz (1989) postulated that the negative control responds to exogenous 
antibiotic, whilst the positive control activates a  higher level of resistance prior to 
antibiotic production.
The promoter regions of several streptomycin biosynthesis and resistance 
genes have been analysed (aphD, strB and orfl). The two promoters in aphD (PI 
and P2) and in orfl (PI and P2), the hydroxystreptomycin phosphotransferase gene 
of Streptomyces glaucescens (Vogtli and Hutter, 1987) have two or more 
transcription start points. This might relate to the need to express the genes in 
different phases of growth, when different promoter binding specificities are 
expressed by the predominant forms of RNA polymerase (Seno and Baltz, 1989). 
One of the aphD promoters, located inside the strR gene is constitutive, whilst the 
other is switched on later in the growth phase (Distler et a l., 1987b).
There is thought to be no difference between promoters used in primary and 
secondary metabolism and base similarities have been observed between different 
streptomycete promoters. For example, there is a highly conserved 8-10 bp 
sequence centred around -13 in aphDPl, aphDPl and strBP, although its
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significance is not known. Sequence homology observed within the -10 and -35 
regions of promoters does not seem sufficient to explain promoter activity and it is 
also thought that the high GC content of streptomycete DNA might make the 
formation of open complexes difficult, necessitating the involvement of 
transcriptional activators (Seno and Baltz, 1989).
The translational start codon in some streptomycete promoters (eg. aphPl), 
is located at the extreme S' end of the mRNA. This allows no room for ribosome 
binding, and so translation might require a "back-tracking” mechanism (Seno and 
Baltz, 1989).
1.4.6. Antibiotic Resistance Mechanisms in Streptomycetes.
Over the last twenty years the molecular and physiological basis for 
antibiotic resistance in streptomycetes has received considerable attention and the 
resistance mechanisms elucidated so far can be classified into three main categories 
(illustrated by Tables 1.2., 1.3. and 1.4). Many antibiotic producers make enzymes 
that specifically inactivate secondary metabolites, including the beta-lactamases, 
which work by opening up covalent bonds in chemical structures. The majority of 
streptomycetes have been shown to produce these enzymes constitutively (Ogawara, 
1981), although the major form of resistance to beta-lactams is the modification of 
penicillin-binding proteins (Ogawara, 1991). Antibiotics can also be disrupted via 
the chemical substitution of key residues (Table 1.2.). The position of the 
substitution is given as a prefix to the enzyme responsible.
Popular forms of self-defence for aminoglycoside producers are acetylation, 
where acetyl-Co A provides the acetyl group, and phosphorylation, where ATP is 
the source of phosphate (Cundliffe 1984, 1986); these chemical reactions have also 
been observed in the producers of peptide antibiotics, but less commonly in the 
producers of nucleosides and macrolides (Table 1.2). Other enzymes which can 
confer resistance include hydrolases, such as chloramphenicol hydrolase, which
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Tables 1.2., 1.3. and 1.4. give examples of antibiotic resistance mechanisms, which 
have been classified into three groups; modification by enzyme detoxification, target 
site modification and exclusion mechanisms.
Key to Tables 1.2. to 1.4.
NP = non-producer of these compounds 
M = methylase
AAC = aminoglycosides acetyltransferase
AC = acetyltransferase
APH =  aminoglycosides phosphotransferase
PH = phosphotransferase
VPH = viomycin phosphotransferase
GS = glutamine synthetase
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Table 1.2. The modification of antibiotics bv detoxifying enzymes.
Organism Antibiotic Modifying Enzyme Reference
S.capreolus capreomycin PH, AC Skinner and 
Cundliffe, 1980, 
Cundliffe, 1984.
S.coelicolor macrolide 2' PH’s Marshall e ra /., 1989
S.fradiae neomycin APH(3') Thompson et a l., 
1980
AAC(3)
S.griseus
S.griseus
streptomycin
kanamycin
(NP)
APH(6)
APH(3')
AAC(3)
Distier étal., 1987a. 
Heinzel et a l., 1988 
Hotta et al., 1988
S.glaucescens hydroxystrep
-tomycin
APH Hintermann et al. , 
1984.
S.hygroscop-
-icus
S.hygroscop-
icus
bialaphos 
hygromycin B
AC
APH
Murakami et a l., 1986 
Sezonov et a l., 1990, 
Zalacain et al., 1986
S.kanamycet-
icus
kanamycin AAC(6')
AAC
Cundliffe, 1986 
Murakami et a l., 
1983.
S.rimosus paramycin APH; AAC Zalacain étal., 1986
S.vendar-
-gensis
macrolide 2' glycosylase Eady étal., 1990
S. Venezuela* chloramphen
-icol
hydrolase Mosher et a l., 1990
S. vinaccia viomycin VPH Thompson et al., 
1982b
S.virido
-chromogenes
bialaphos AC Strauch et al., 1988 
Wohlleben et a l., 
1991
Srv.eurocidicus 2 APH's Zalacain étal., 1986
Stv.spp. Blasticidin S AC Perez-Gonzalez et al., 
1990
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Table 1.3. Target site modifications, which confer antibiotic resistance.
Organism Antibiotic Target Modification Reference
S.azureus thiostrepton rRNA Methylase Thompson and Cundliffe, 1980
S.fradicie tylosin rRNAM Zalacain and Cundliffe 1991
S.hyçros-
-copicus
bialaphos 2 x GS isoforms Kumada et al., 1990
S.kanam-
-yceticus
kanamycin RNA methylase 
23S
Nakano and Ogawara, 1986
S.hygros-
-copicus
geldanamycin resistant RNA 
polymerase
Blanco et al., 1986
S. U vidons macrolide
lincosamide
23S rRNA 
methylase
Jenkins et al., 1989
S.mycofa-
-ciens
midecamycin rRNA methylase Hara and Hutchinson 1990
S. ni ve us novobiocin DNA gyrase 
+2 unknown 
mechanisms
Mitchell et al., 1990
S.noursei nosiheptide rRNAM Woodman, 1991 
(personal communication)
S.rimosus oxytetrac
-ycline
ribosomal
resistance
Ohnuld et al., 1983.
S.spheroides novobiocin DNA gyrase Thiara and Cundliffe, 1989
S.tene-
-braius
kanamycin
(np)
RNA methylase Skeggs et a l., 1987.
S.thermo-
-tolerans
carbomycin RNA methylase Epp et a l., 1987
S.tenji-
-mariensis
S.virido-
-chromogenes
apramycin
kanamycin
(np)
rRNA methylase 
16S
resistant glutamine 
synthetase
Skeggs et al., 1986 and 1987 
Wohlleben et al., 1991
S.virido-
chromogenes
rRNAM Kami may a and Weisblum, 
1986
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Table 1.4. Resistance to antibiotics conferred bv drug exclusion or excretion.
Organism Antibiotic Exclusion Mechanism Reference
S.fradiae tylosin multi-component ATP- 
dependant transport system 
for active secretion
Rosteck et a l., 1991
S.griseus strepto­
mycin
transport and permeability 
mechanisms
Sugiyama et a l., 1990.
S.rimosus ox y tetra 
cycline
drug export Ohnuki et a l., 1985, 
McDowell et al., 1991
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catalyses the removal of a dichloroacetyl moiety from the antibiotic and 
glycosylases, which introduce a glycoside residue to the relevant compound.
Enzymes, which modify antibiotics may also be involved in antibiotic 
biosynthesis; for instance the bar gene encodes an acetytransferase, which catalyses 
the acetylation of dimethylphosphinothricin, step 10 in bialaphos production 
(Murakami et al., 1986). Cundliffe (1984) pointed out that some antibiotic­
inactivating enzymes might normally act at an earlier step in the biosynthetic 
pathway and might not contribute to the mechanism of resistance, which is actually 
used by the antibiotic-producing organism. Thus the physiological roles o f  
antibiotic-inactivating enzymes should not be assumed, especially when the 
permeability properties of the cell surface are not known. In addition , certain 
antibiotics might not have vital groups which are sensitive to modification and it 
might not be possible to prevent all drugs from binding to their targets by 
performing chemical modifications (Cundliffe, 1984). This may explain the 
existence of other resistance mechanisms.
The modification of drug targets in antibiotic-producing streptomycetes is 
well documented (Table 1.3.). Specific méthylation of ribosomal RNA has been 
frequently cited (Cundliffe, 1986) and is a common means of resistance to 
macrolide antibiotics. The macrolide-lincosamide-streptogramin type B (MLS) 
phenotype was first described by Fujisawa and Wiesblum (1981), who found that 
resistance to subsets of MLS antibiotics, could be induced by a range of these 
compounds in strains with a variety of diverse phenotypes. Other examples include 
erythromycin resistance in S.erythraea (Skinner et al., 1983), tylosin resistance in 
Streptomyces fradiae (Zalacain and Cundliffe, 1989) and an inducible rRNA 
méthylation in the non-producer Streptomyces lividans (Jenkins et al., 1989). 
Resistance is due to either mono- or di-methylation of adenine residue 2038 
(Graham and Weisblum, 1979) and it operates by a mechanism known as 
translational attenuation (Weisblum 1984). The inducer binds to prokaryotic 
ribosomes during translation of the erm leader region and this H*»«tahiii»« the
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mRNA structure. Then the ribosome binding site for erm methylase is free and 
methylase synthesis begins; thus MLS drugs are prevented from binding to 
ribosomes. The potency of individual inducers in a given system may be determined 
by their ability to inhibit the incorporation of different amino acids (Kadam, 1989). 
Not all producers of MLS antibiotics employ this resistance mechanism, although 
hybridization analysis has revealed homology between ermE and resistance genes in 
many of these organisms (Stanzack et al., 1990; Epp et al., 1987). Ribosomal RNA 
methylation has also been reported to confer resistance to the aminoglycoside 
kanamycin and its derivatives (Skeggs et al., 1986; Skaggs et al., 1987; Nakano 
and Ogawara, 1986) and to certain peptide antibiotics (Cundliffe et a l., 1984).
Target site modification includes enzymatic alterations, such as that found in 
the RNA polymerase of ansamycin producers (Blanco e t a l., 1986) and in the DNA 
gyrase of novobiocin producers (Thiara and Cundliffe, 1989; Mitchell et al., 1990). 
In the latter case the enzyme is duplicated, one form being resistant and the other 
sensitive. Similarly protection against bialaphos is conferred by resistant forms of 
glutamine synthetase (Kumada et al., 1990; Wohlleben et a l., 1991) and 
S.hygroscopicus harbours two resistant isoforms of this enzyme. Reduction in the 
physiological importance of the target is also included in the category of target site 
modification and the inate bialaphos resistance of streptomycetes with an alternative 
pathway for ammonium utilization is an example of this. Target site modification 
confers higher levels of resistance than does antibiotic modification, however if an 
antibiotic confers a regulatory role during cell growth or differentiation then 
producers may need to be sensitive to their products at certain times (Cundliffe, 
1984).
Resistance by prevention of access to the target can be via a total or partial 
permeability barrier (ie. is combined with other forms o f  resistance) or by confining 
products to discrete sub-cellular compartments. For example, it is thought that in 
the biosynthesis o f aminoglycosides' inert precursors are activated during export 
from the cell by dephosphorylation (Miller and Walker, 1969). Many antibiotic
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producers have been shown to harbour more than one resistance mechanism; for 
example they might contain more than one substituting enzyme working in 
conjunction (Table 1.2.)> sometimes synergistically (Thompson et al., 1982b). 
Alternatively, they might contain additional types of resistance mechanisms and 
effective permeability barriers are thought to exist in many antibiotic producers 
(Cundliffe, 1984; Sugiyama et al., 1990). Similarly bialaphos and kanamycin 
resistance are conferred by both enzymic modification and resistant target molecules 
(Tables 1.2., 1.3. and 1.4.).
1.4.7. The Relationship o f Antibiotic Resistance and Biosynthetis to Phenotype and 
Genotype.
Information on how far phenotypic and genotypic similarities correlate 
between producers or with one another is still fragmentary. However there has been 
a remarkable congruence in the resistance phenotype between some producers of 
similar or identical compounds. For example the rRNA methylases of Streptomyces 
sioyaensis, Streptomyces lauremii, Streptomyces azureus and Planomonospora 
paronyospora are almost indistinguishable (Thompson and Cundliffe, 1980). These 
strains produce the highly related peptide antibiotics siomycin, thiostrepton, 
thiostrepton and sporangiomycin respectively. In addition, the methylases of 
Streptomyces actuosus and Streptomyces bemenisl partially resemble that of 
S. azureus. Nosiheptide, the S.actuosus product, is similar to thiostrepton, but 
beminamycin is not structurally related, although it does have a similar mode of 
action (Thompson et a l., 1982b). There is often great symmetry in the organisation 
and regulation of biosynthetic pathways between different producers of identical 
compounds (Fig. 1.3.) and this may be shown to extend to the pathways of related 
products, such as streptomycin and blueniomycin (Walker, 1990).
In some cases gene homologies correlate with taxonomy, whilst in others 
they do not; for example erythromycin biosynthesis and resistance genes from 
Saccharopolyspora erythraea hybridize strongly to macrolide producing
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Saccharopolysporas, but only weakly with the DNA of macrolide-producers from 
other genera (Stanzak et al., 1990). In a different case, rRNA methylases from 
different genera and from the producers of widely different antibiotics appear 
related at the DNA level (Skeggs et al., 1987). Reports where genes of secondary 
metabolism do not correlate in producers of the same compound are rarer, however 
Mosher et al., (1990) have shown that the chloramphenicol resistance gene of 
Streptomyces venezuelae does not hybridize to the DNA of Streptomyces 
phaeochromogenes, another chloramphenicol producer.
There has been much evidence of genetic homology between families of 
genes, probably due to their common ancestry. Beta-lactamases may be descendants 
of or parallel developments to the peptidoglycan-metabolizing peptidases from 
eubacteria or to the penicillin binding proteins, which are related to a very ancient 
family of molecules including many esterases and serine proteases (Brenner, 1988). 
Forseman et al (1991) have found significant homology between the beta-lactamase 
genes from Streptomyces badius, Streptomyces cacaoi, Streptomyces fradiae and 
Streptomyces lavendulae and suggest that the Gram-negative class A beta-lactamases 
evolved from these. Piepersberg et al. (1988 and 1991) illustrated a similar example 
for the 23S rRNA methylases, stating that they were related to 16S rRNA 
methyltransferases, whose targets are often very similar. Lim et al. (1989) revealed 
a striking homology between the aphD gene o f Streptomyces griseus with other 
antibiotic phosphotransferases and protein kinases, suggesting similar structures and 
a common ancestry; this relationship was also suggested by Distler et a l., 1987b, 
Heinzel et al., 1988 and Piepersberg et al., 1991. Kiiby (1990) presented evidence 
that aminoglycoside phosphotransferase genes originated in an ancestor closely 
related to actinomycetes and he illustrated this with rooted phylogenetic trees based 
on protein sequence data. It was also implied that aminoglycoside acetyltransferases, 
phosphotransferases and nucleotidyltransferases shared a common origin with other 
kinases and nucleotide-binding proteins because they shared conserved motifs.
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Our knowledge on the interplay between antibiotic action, its regulation and 
the development o f resistance is very poor (Piepersberg, 1991). Antibiotic 
resistance can be acquired by the mutation of resident genes in a given sensitive cell 
or by taking up additional preformed determinants, as with the resistance genes of 
clinical bacteria. Piepersberg (1991) regards the hypothesis that most resistance 
determinants could have originated in producing organisms as proven for many 
wide-spread mechanisms and DNA sequencing studies between Streptomyces and 
clinical isolates have been used to support the notion of horizontal gene transfer 
(Trieu-Cout et al., 1987). Kirby (1990) have given further support to this notion by 
demonstrating (via phytogeny) that aminoglycoside phosphotransferases probably 
originated in an actinomycète and were transferred to clinical bacteria through 
transposition. This event was believed to have occurred after the split between 
Gram-negative and Gram-positive organisms and it was thought likely that several 
horizontal gene transfer events occurred at different times in the evolutionary past. 
Evidence against horizontal gene transfer has been given by data base studies at the 
John Innés Institute (Bibb 1986), where the level of resemblance between 
Streptomyces resistance determinants and those of clinical isolates has been shown to 
be identical to sequence similarity of Streptomyces resistance determinants and those 
of other proteins. There are barriers to DNA transfer and gene expression, but in 
view of its diverse nature, soil could provide the relevant conditions for transfer of 
antibiotic resistance and production genes (Kirby, 1990). The acquisition of genes 
within the genus Streptomyces is a complicated issue, for example O- 
acetlytransferases, involved in chloramphenicol acetylation, are not found in 
producers but have been observed in other streptomycetes (Murray et al., 1989). 
Therefore clinical resistances may originate from a variety of sources, which 
includes bioactive and non-bioactive actinomycètes, but does not necessarily 
comprise them.
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1.5. The Exploitation of Antibiotics from Streptomycctes.
1.5.1. The History of Natural Product Screening.
The beginning of the antibiotic era was marked by the discovery of penicillin 
by Alexander Fleming and its extraction twelve years later by Florey, Heady and 
Chain. The search for other antibiotic-producing microorganisms accelerated due to 
the medicinal needs of World War II resulting, in the discover o f streptomycin and 
more broad spectrum compounds such as chloramphenicol and the tetracyclines. To 
begin with researchers focused on the fungi for sources o f new medicinal 
compounds, but few leads were discovered and major emphasis shifted to the 
Streptomyces. This genus has become the most prolific source of commercially 
important antibiotics in the history of natural product screening.
The soil is a reservoir of numerous diverse microorganisms and so in the 
archetypal days of antibiotic discovery little effort was required to isolate novel 
strains and isolation was designed to match the scale-up procedures of a particular 
company. Early methods of screening were based on the random screening of high 
numbers of isolates and included a variety of simple procedures. In one method, 
plates were inoculated to a density of 300-400 colonies and microbes which were 
surrounded by a ring of inhibition were selected for further investigation; the 
drawback of this method was that zones of clearing could form due to pH effects or 
nutrient depletion. These tests were superceded by screens which overlayed plates 
(30-200 colonies per plate) with a series of test organisms; antibiosis profiles could 
also be obtained by overlaying streak plates or plugs of streptomycete growth. 
Another development was the use of replica plating which provided an easy way to 
increase the numbers of test organisms (Rhodes et a!., 1961;Lechevalier and Corlce, 
1953).
Secondary screening further tested the capabilities of the organisms under 
study and often taxonomic classification was used to predict pathogenicity and to 
give an indication of growth characteristics. The scientific and patent literature was 
examined to find related organisms which could give an indication of the type of
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product being formed and to avoid rediscovering known antibiotics. Other 
techniques were to scrutinize UV absorption spectra, chromatographs, extraction 
patterns and bioautographs o f the crude extracts. It was during this stage that the 
feasibility of pharmacological or agrochemical use of a compound was determined. 
For example some good attributes for the agrochemical products were stability of 
homogenates in plant tissue, stability to heat, exceptionally high biological activity 
with a desired spectrum of activity and the ability to move through discs of plant 
tissue. Following selection the ability to protect plants against target pathogens and 
the phytotoxicity of the crude extract were determined in small greenhouse tests. If 
these were successful then large scale trials both in the greenhouse and small plots 
of land would be undertaken.
1.5.2. Modem Antibiotic Discovery.
Due to the ease of antibiotic discovery described above more sophisticated 
methodologies were not required until the mid-1960's onwards, when qualitative 
improvements were brought about at every step of the screening programme. Data 
feedback systems were initiated and these contained microbiological, biochemical 
and chemical information about the producing organisms and about the biosynthesis, 
mode of action and biochemical properties of the antibiotic. A description o f new 
screening methods is presented in the sections below, but the reasons for their 
development are given in this section.
The probability of finding new antibiotics steadily declined as the number of 
discovered antibiotics increased and many promising activities were found to be due 
to known antibiotics (Okami, and Hotta 1987; Ayer et al, 1989). Random screening 
wasted time and resources on the examination of thousands of strains, which lacked 
desired activities and the use o f easily isolatable strains probably meant that highly 
common strains were screened repeatedly. It is generally accepted that many strains 
capable of producing useful compounds have been screened under conditions which 
did not allow expression; for example the tetracenomycins were discovered by
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screening the hydroxystreptomycin-producer Streptomyces glaucescens under a 
different set of conditions (Zahner et al., 1982). Another problem is that more than 
one compound can be present in a culture extract and the activity of many useful 
highly specific compounds could have been masked by the presence of known 
antibiotics, which were identified by their spectrum of activity.
1.5.3. The Selection of Organisms for Industrial Screens
At first antibiotics of actinomycete origin were exclusively provided by the 
Streptomyces, but more recently companies have begun to target rarer genera 
(Williams and Wellington, 1982), consisting of actinomycetes with relatively low 
isolation frequencies (Okami and Hotta, 1988). Rare genera include actinoplanetes 
and maduromycetes, Kitasatosporia (Omura 1986), Nocardia, streptoverticillium 
and rare forms of streptomycetes. By 1982 one quarter of actinomycete products 
were provided by non-streptomycetes (Nisbet 1982) and 400 o f the 6,000 known 
antibiotics are produced by actinoplanetes and maduromycetes (Berdy, 1988). The 
streptomycetes continue to provide larger numbers of diverse antibiotic products 
than other actinomycete genera (Okami and Hotta, 1988) and there may still be 
large numbers of Streptomyces species or strains with novel antibiotic productivity 
in nature. Nevertheless, the shift towards rare genera reflects a search for increased 
variety and aims to reduce the re-isolation of known strains and the rediscovery of 
known products. A related approach taken by some companies has been to isolate 
the organisms which they screen from extreme (Williams and Wellington, 1982) or 
unusual, previously unexplored, environments (N. Porter, personal 
communication).
The extent to which antibiotic production correlates with taxonomic 
identification is extremely important when deciding which organisms should be 
targeted. There is some evidence that selected Streptomyces species do have 
distinctive antibiosis patterns (Wellington and Cross, 1983) and there are also 
specific taxonomic groups such as S. hygroscopicus (Arai et a l., 1976) which show
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a high incidence of antibiotic production. Generally, however, antibiotic production 
in actinomycetes is strain specific (Okami and Hotta 1988) and conventional 
taxonomy cannot be used to predict the type of antibiotic produced, although Okami 
and Hotta (1988) postulated that there might be some specific genotypes which do 
correlate with antibiotic production. Classification is still an important part of the 
drug discovery process because it helps avoid screening duplicate strains and also 
patents often require a thorough description of the producing organism (O'Donnell, 
1988). This type of data is also important because physiological characters which 
correlate with bioactivity may be discovered and isolation methods can be developed 
for those species which are useful targets for antibiotic production; for example the 
actinoplanetes are mainly novobiocin resistant so this compound can be used as a 
positive selection pressure for their isolation.
1.5.4. The Design of Media for Antibiotic Screening Programs.
In 1981, Iwai and Omura reviewed the culture conditions necessary for 
secondary metabolite screening. They concluded that different carbon and nitrogen 
substrates were favoured by different cultures and that generally readily utilized 
carbon and nitrogen sources were unfavourable for antibiotic production. There are 
exceptions to this including anticapsin production, which is favoured at 10% 
glucose (Boeck et al, 1971). The use of slowly utilizable sugars and nitrogen 
compounds, as the sole sources of carbon and nitrogen were advised by Hu and 
Demain (1979) and Martin and Demain (1980); although the more rapidly utilized 
nitrogen source, ammonium can be used if ion depressors are also added (Omura 
and Tanaka, 1984, Omura, 1986).
Large amounts of Pi accelerate carbon and nitrogen utilisation, but tend to 
reduce antibiotic production. However Imanaka and coworkers (Arima et al., 1965; 
Miyairi et a l., 1970; Miyoshi et al., 1972) discovered three new antibiotics by 
screening on high (>  180mM) phosphate media. The production of some antibiotics 
takes place between two threshold concentrations of Pi; for example Hall and
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Hassall (1970) described the differential production of two antibiotics by 
Streptomyces jamaciensis. At O.lmM, monamycin was produced but a different 
antibiotic was produced at 0.4mM.
Inorganic salts are added to media to increase production and different ones 
affect different antibiotics; for instance very large amounts o f sodium chloride can 
inhibit antibiotic biosynthesis, or in rarer cases, stimulate production (Okami et al., 
1976). Trace elements are needed for enzymes and cofactors and zinc and iron are 
reported as being the most important for actinomycetes (Weinberg, 1970), with 
larger amounts being needed for production rather than growth. S.clavuligerus 
required 130 /tg/ml ferrous iron for maximum cephamycin C biosynthesis (Rollins 
et al., 1989). However, there are often thresholds beyond which antibiotic 
production is negatively or positively affected (Iwai and Omura 1981).
The dilemma of media design is that although specific growth requirements 
are important for the expression of certain types of secondary metabolites general 
use media are needed. Researchers have used complex media containing a variety of 
carbon and nitrogen sources to vary growth rates and physiological states hoping to 
alter internal metabolite pools and to diversify secondary metabolite production. 
Nisbet (1982) put forward some guide-lines for the design o f media which allow 
good product formation and he stated that different media should be prepared using 
a variety of growth-limiting nutrients because secondary metabolite patterns can 
often vary when same strain is grown on different media (Grabley et al., 1990). For 
each type of nutrient depletion different forms of the growth sufficient nutrient 
should be used and readily assimilated forms of carbon and nitrogen ought to be 
avoided; the recommended C:N ratio was 10 for antibiotic production (Hutter, 
1982). Finally use of a polymeric or complexed form of the growth-limiting 
substrate was thought advisable and an attempt should be made at buffering the 
medium, which should also include known cofactors.
Increased screening of rare actinomycetes and extremophiles has lead to the 
development of special ranges of media suitable for their growth (Okami and Hotta,
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1988) and selective isolation (Wellington et al., 1987); specific media have also 
been used to select for growth forms which were more likely to result in antibiotic 
production (M. Bushell, personal communication). Some companies screen on solid 
media on the premise that antibiotics decompose more slowly and may diffuse away 
from destructive enzymes (Iwai and Omura, 1981). Screening for enzyme producers 
also tends to involve zone clearing assays on solid media, although an advantage of 
liquid media is that there is a  better correlation with scale up procedures. Economic 
aspects are also of importance and simple growth media form the basis of cheaper 
commercial processes, although this must be balanced with the fact that this could 
limit what is discovered.
1.5.5. Extraction Procedures and Chemical Identification Systems.
For the initial stages o f screening general use solvents are required. These 
are usually chosen for the ability to extract a wide range of chemicals, which can 
then be formulated as required prior to being applied to screens, but they are also 
selected for safety because large volumes are handled. The solvents which are used 
include butanol, methanol, ethyl acetate, isopropanol, dichloromethane, diethyl 
ether and various mixtures.
One of the earliest methods for assessing the probability that an interesting 
antibiotic was already known was by chromatographic analysis. Aszalos et al (1968) 
presented a rapid TLC method for assessing antibiotics from crude extracts, where 
eighty four known antibiotics and fourteen solvent systems were used in a two tier 
system, which assigned mqjor and then sub-group classifications to the antibiotics. 
The antibiotics could not be identified but the choice was narrowed to a small 
number, which were then eliminated.
Hamill (1982) described the use of specific chemical reactions on semi- 
purified preparations to identify various chemical groups. Another innovative 
method was described by Z&hner et al. (1982) who selected unique spots from strain 
extracts run on TLC plates and out of five compounds tested three were novel.
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Aszalos (1980) hinted that combinations of many of the new and old techniques (eg. 
TLC, preparative chromatography, gas chromatography, high performance liquid 
chromatography, mass spectrometry and infra-red spectroscopy) might increase the 
number of antibiotics that could be included in a particular identification system.
Techniques, such as high performance liquid chromatography (HPLC), 
nuclear magnetic resonance (NMR) spectrometry and diode array detectors meant 
that the tiniest amounts o f active substances could also be isolated and analysed and 
unstable compounds and minor products could be extracted and purified (Omura, 
1986). Many companies now have computer libraries (H.P. Fielder, personal 
communication), which contain the HPLC and ultraviolet and visible light spectra 
spectra of hundreds of microbial secondary metabolites, but one of the most useful 
tools, which many natural product screening companies still use, is the Berdy 
database (Berdy database, 1988).
1.5.6. Target Directed Screening.
As the rate of discovery of new antibiotics declined screening programmes 
consisting of differential assays for targeting specific groups of antibiotics were 
established. For example Zihner et al. (1982) explained a novel approach to the 
detection of narrow spectrum antibiotics, where an unusual bacterium was added to 
established test organisms (ie. Staphylococcus aureus and B.subtilis) and then in 
order to increase the chance of discovering a novel compound, only antibiotics 
which affected the unusual organism were selected. Many other screens have been 
developed to detect activity against a variety of human, plant and animal pathogens 
and target-directed screening may focus on searching for inhibitors of the target 
sites of known antibiotics or of rationally selected receptor sites. They may also use 
unusual biological or chemical test procedures to detect rare types of activity or 
specific structural moieties (Fleming et al., 1982).
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1.5.7. Screens used in the Agrochemical Industry.
Highly specific, biodegradable compounds are needed for the control of crop 
pests because treatment involves the release o f large amounts of chemicals into the 
environment. This often involves choosing a target, which is specific to a certain 
weed or insect or the selection of a specific bacterial, fungal or viral plant pathogen. 
For example the conversion of lanosterol to ergosterol (Nisbet and Porter, 1989) has 
a lethal effect on fungi but is harmless to plants.
Prevention of fungal protoplast regeneration has been used to find chitin and 
glucan inhibitors because it is difficult to find antifungals with low mammalian 
toxicity. The fungal membrane is a good target because differential binding to 
ergosterol rather than cholesterol can ensure the selection of highly specific 
compounds. Nisbet and Porter (1989) predicted that by cloning genes from Candida 
albicans into defective mutants of Saccharomyces cerevisiae, preferential inhibition 
o f recombinants could provide an innovative means of discriminating the most 
selective compounds.
Some herbicides are inhibitors of glutamine synthetase and cause death by 
ammonium accumulation. Phosalacine was discovered by use of an assay in which 
B.subtilis was inhibited on minimal medium but not in the presence of glutamine. 
Other screens for herbicides can involve detecting inhibition of germination and 
radicle growth from surface-sterilised seeds and foliar or root elongation assays 
(Heisey et al. , 1988).
Some of the early screens detected antifungal activity by the abnormal 
growth of test organisms or by inhibition of their growth. The nikkomycini were 
discovered as inhibitors of zygospore formation in Mucor hiemalis (Z&hner 1986) 
and were of interest for the development of insecticides because they attack chitin 
synthesis. A simple assay to detect insecticidal activity is the photoactivity response 
of insect larvae; healthy mosquito larvae swim away from light and compounds with 
insecticidal activity prevent this reaction (Heisey et al., 1988).
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Highly specific assays were designed for the discovery of avermectins and 
were based on the fact that these compounds bind to membrane receptors. 
Avermectins enhance the affinity of these receptors for benzodiazepines and this 
provides a new incentive to design screens, which may discover second generation 
avermectins, (Monaghan and Tkacs, 1990)
1.5.8. Screens Used in the Pharmacological Industry.
A range of enzyme inhibitor screens have been used in the pharmaceutical 
industry and these have been aimed at discovering compounds which inhibit 
enzymes involved in the synthesis of compounds important in human physiological 
disorders such as obesity, diabetes, migraines, Parkinsons disease and Senile 
Dementia. Inhibitors of enzymes involved in adrenalin and lipid synthesis have 
provided drugs for the treatment of hypertension (eg oudenone, fusaric acid) and 
cholesterol reduction (monacolin K) and inhibitors of glycosidases are o f potential 
use in the treatment of obesity and diabetes, and protease inhibitors may prove 
useful for inflammatory, thrombotic and haemorrhagic conditions (Hamill, 1982).
Screens have also been designed to detect inhibitors of essential enzymes 
involved in bacterial, viral and fungal diseases and such assays must be highly 
specific for the organism under study. Monaghan and Tkacs (1991) described a 
screen for inhibitors of HIV reverse transcriptase in their review on bioactive 
microbial products. The enzyme can now be produced in large quantities in 
Escherichia coli, purified by affinity chromatography and used to test natural 
products.
Other pharmacological screens have involved the search for beta-lactamase 
inhibitors, which could be used with beta lactamase sensitive antibiotics such as 
penicillin; for example novel compounds could be detected by the increased 
beta-lactamase production of resistant strains in their presence. Mechanism-based 
screens for beta-lactam antibiotics are reviewed by Okami and Hotta (1988) and 
Nisbet and Porter (1989), but included a mode of action assay based on peptidase
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inhibition, the use of hypersensitive mutants and antimycoplasma activity (Omura, 
1986).
Many glycopeptide antibiotics have also been discovered using mechanism 
based assays, which have exploited their binding with peptides that end in acyl-D- 
ala-D- ala. Radio-immuno-assay (RIA), enzyme-linked immunosorbant assay 
(ELISA) and fluorimmunoassay have also been used for glycopeptide detection and 
have shown little cross reactivity with other antibiotics.
In vitro screens have been developed for the initial stages of antitumour drug 
discovery (White, 1982), although these drugs must be tested later on the more 
expensive in vivo screens. Initially the drugs were discovered using antimicrobial 
and cell toxicity assays, but more recently mechanistic approaches have been taken; 
protozoa have similar multiplication behaviour to tumour cells, and can be affected 
by the same drugs. For example hitachimycin was discovered on an antiprotozoal 
screen simultaneously to its discovery as an anticancer compound (Omura, 1986). 
Recent assays are reviewed by Okami and Hotta (1988) and Nisbet and Porter 
(1989), who describe the use of mutant cell lines which respond to oncogene 
expression, antibiotics which intercalate with DNA molecules and the use of human 
and animal tissue cultures.
L 5 A  Beneficial Products Derived from the Pharmaceutical and Agrochemical 
Industries.
Demain (1983) listed about 40 different pharmacological activities of 
microbial secondary metabolites, including anti-inflammatory drugs (eg pyrothrine 
from Streptomyces verticillium), antitumour drugs (eg bleomycins from 
S.verticullus), vasodilators (eg WS1228 A and B from S.aureofaciens), inhibitors of 
the complement cascade (eg complestatin, from S.lavendulae) and
immunosupressors (eg FK506 from Streptomyces tsukubaensis). Drugs which are 
known to bind to specific receptors include L-156,373, which binds to the oxytocin
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receptor and might have a use in delaying premature labour and MY336a from 
Streptomyces gabonae, which is an agonist of the beta-adrenergenic receptor.
The farming industry have benefited from veterinary drugs, produced by 
Streptomyces such as the coccidiostatic agent, lasalocid, and other antibiotics, 
including monensin and virginiamycin which are marketed as animal growth 
promoters. The mode of action of virginiamycin is probably as an appetite modifier 
because it is acts as an antagonist of the brains' gastrin and cholestoldnin satiety 
controlling receptors.
Chitin synthase inhibitors have proved useful as agricultural fungicides and 
insecticides. For example allosamidin is an insect chitinase inhibitor, which 
interferes with insect moulting, nikkomycins have been used as acaricides and their 
relatives, the polyoxins as antifungal compounds. Highly specific insecticides 
include the avermectins, which work by blocking neuromuscular transmission in 
arthropods and helminths; their mode of action is to bind to synaptic gamma 
aminobutyrate receptors and paralyse the victim.
Microbially-produced herbicides include antimetabolites such as the 
herbicidins, active against dicotyledonous plants, homoalanosine which has a 
functional resemblance to aspartate and glutamate and the herbimycins, which block 
angiogenesis and are also active against plant viruses (eg TMV). Enzyme inhibitors 
also have a place in the herbicide market. For instance, bialaphos is a competitive 
inhibitor of chloroplast glutamine synthase, causing the accumulation of ammonium 
and death of plant pests.
1.5.10. Target Directed Isolation and Selection.
If screens are exclusively dependent on target-directed assays the hit rate can 
still be as low as 1 in 1,000, but this can be improved by including target-directed 
isolation and selection of organisms. For example Okami and Hotta (1988) isolated 
aminoglycoside-resistant actinomycètes and obtained aminoglycoside resistance 
profiles for them. They then preselected strains with many resistances because they
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had a higher probability of antibiotic production. In this work novel antibiotic 
resistance patterns were regarded as markers for new antibiotic producers. The hit 
rate using this protocol was 1 in 10 and aminoglycosides were not the only type of 
antibiotic discovered. A similar example is the glycopeptide-directed screening of 
Rake et al. (1986) who isolated actinomycètes on vancomycin-containing media and 
then cultivated them under conditions suitable for glycopeptide production; the hit 
rate of these workers was improved from 0.3% to 2.2%. Directed isolation 
protocols can also involve choosing an environment which is likely to harbour 
organisms with desired activities and Lievens et al (1989) selected plant-associated 
organisms as a source of anti fungal s for phytopathogenic diseases. Similarly Verces 
et al. (1990) successfully chose the grapevine carposhere as a source of organisms 
producing anti-yeast compounds. Biological control agents have also been targetted, 
because their activity may be due to the production of compounds with biocidal 
activity (Weller and Thomashow, 1990). The isolation of organisms from dead 
insect pests is another common approach.
1.3.11. Other Approaches to Antibiotic Discovery.
Actions such as regrowing previously tested organisms on different media or 
testing them on new screens can lead to novel discoveries about their ability to 
produce natural products. Previous sections of this introduction contain several 
examples of compounds which were discovered on a particular screen and were then 
found to exhibit another useful activity. There have also been examples of strains 
which produced different compounds under altered conditions of growth.
Modem technology has permitted a more directed manipulation of known 
antibiotic producers. Okami and Hotta (1988) showed how a biosynthetic pathway 
could be directed in a different direction by supplying various precursors to the 
producer organism. Mutasynthesis also uses this approach but with blocked mutants, 
which require special media for antibiotic production (ie. analogues are incorporated 
into the biosynthetic pathway of the compound which they cannot synthesize to
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produce new antibiotics). Blocked mutants or those with altered biosynthetic 
pathways are another source of novel antibiotics because they accumulate 
intermediates which do not build up in the parent strain. There are also reports of 
foreign antibiotics being converted to new products by the biosynthetic enzymes of 
other antibiotic producers (Okami and Hotta, 1988).
Protoplast fusion and protoplast regeneration are powerful tools for 
generating or activating the expression of silent genes in actinomycètes, as in the 
discovery of indolizamycin (Yamashita et al., 1985a,c). Kurzatowsld et al., (1985) 
have also observed diversification of antibiotic production in cultures from 
regenerated protoplasts; however protoplast regeneration can result in the loss of 
antibiotic production as with carriomycin production in S. hygroscopicus (Ogura et 
al 1986.,); when this same strain was treated with ethidium bromide and a new 
antibiotic curromycin was produced.
In a few cases both inter- and intra-specific in vivo and in vitro genetic 
recombination have resulted in the formation of new antibiotics. For example the 
recombination of an auxotrophic non-producing mutant of the turimycin-producing 
S. hygroscopicus with a blocked mutant of a violamycin-producing S.violaceus 
resulted in the discovery of the anthracycline antibiotic, iremycin (Okami and 
Hotta, 1988).
The development of molecular cloning in Streptomyces made the isolation of 
many biosynthetic gene clusters possible (Chater and Bruton, 1985; Malpartida and 
Hop wood, 1986; Murakami et al., 1986). Hopwood et al., (1985) and Malpartida 
et al., (1987) discovered novel antibiotics by carrying out gene transfer experiments 
between strains which produce different isochromanequinone antibiotics. For 
example dihydrogranatirhodin was produced when the act genes were introduced 
into the granaticin-producer Streptomyces violaceoruber.
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1.6. Rationale and Aims for this Research
Over recent years, much has been learnt about antibiotic biosynthesis, 
antibiotic resistance and the physiology of antibiotic producers. Many relevant genes 
have been cloned and thousands of antibiotic producers are deposited in culture 
collections. This provided the means for the research presented in this thesis, which 
took a broad approach for studying secondary metabolism. The aims of the work 
were to investigate the distribution of antibiotic production and antibiotic resistance 
phenotypes in natural populations of streptomycetes. It was of additional interest to 
investigate the genetic basis of the observed antibiotic resistances and to examine 
factors which influenced the expression of antibiotic production in relevant bioactive 
strains. Another aim was to use any discoveries about the physiological and genetic 
characters, which are necessary for activity to develop techniques which could 
predict bioactive and non-bioactive groups o f streptomycetes and which would 
encourage antibiotic gene expression.
A further objective was to search for phenetic and chemotaxonomic 
characters, which correlated with bioactivity and the characters studied included 
antibiotic resistance patterns, fatty acid profiles and patterns obtained by thin layer 
chromatography of solvent extracts from streptomycete cultures. An overall 
objective was to use the information gathered from the population studies to try to 
understand the ecological role of secondary metabolism.
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Chapter 2
Materials and Methods.
2.1 M aterials
Strains, which were used in this research comprised both type strains and 
natural isolates. Table 2.1. shows the natural isolates which were taken from the 
E.M.H. Wellington culture collection and Table 2.2. lists the type strains. Certain 
other strains were used as a source of plasmid DNA and a list of these is presented 
in Table 2 .3.; the genes which were isolated from the plasmids are given in Table 
2.4.
The compositions of media are shown in Table 2.3. and these were 
autoclaved at 121°C for 20 mins., unless otherwise indicated. Constituents are 
given in g/1 and exceptions to this are also given on the table. Table 2.6. shows the 
formulations of the buffers and reagents which were used and quantities of 
components are given in mM, unless otherwise indicated.
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Table 2.1 Summary o f natural isolates used for this research
Strain Source Isolation Medium No. of
Series Method Strains
A Italy Chemostat Starch 13
B Warwick Chemostat C32 2
C Warwick Pour Plate AGS 98
D Warwick Pour Plate C32 36
E Italy Chemostat C32 11
F Warwick Pour Plate C32 7
MM Martin
Mere
Pour Plate C32 I«
W Warwick Pour Plate C32 4
RB Italy Pour Plate AGS 3
MEL Brazil Spread Plate AGS 4
CAG Greece Various Various 25
JHCC Various Various Various 8
TOTAL 225
Series A to E were isolated by T.N. Whitmore; MM and W by N. Cresswell; RB 
by R. Bandoni; Mel by M. Walker; CAG by A. Karagouni and JHCC by various 
workers. Starch and C32 media were developed by T.N. Whitmore.
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Kev to superscripts on Table 2.2
^Strain was used in Chapter 4 for Fatty Acid Work.
^Strain was used in Chapter 5 for Chemical Profiles.
^Strain was used in Chapter 6 for Resistance Profiles.
^"Strain was used in Chapter 6 for Resistance Profiles, but were not used for cluster 
analysis.
NB. Superscripts with several numerals (eg. 456) indicate that the strain was present
in more than one study (eg. 4 and S and 6) and can therefore be taken to mean 4>
6.
Key to abbreviations used in Table 2.2. 
S. refers to .Streptomyces.
Stv. refers to Streptoverticillium.
The taxonomic identities, which are given on the table were assigned by 
Williams et al. (1983a). All strains apart from ATCC 442, ISP 5233, DSM 40069 
and KCC S-0783 were used in Chapter 7. for probing work. In addition to the 
strains shown in the table, M180 S.violaceoniger (C32) was used in Chapter 4 for 
Catty acid work and Chapter 5 for TLC profiles.
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Table 2.2. Summary o f type species and reference strains used in this research.
Culture
Collection
Tax.
Reference Name ID. Product
ATCC 274166" S. annulatus Cl Antibacterial
Antifungal
KCC S-04466" S. albidoflavus Cl
DSM 40260 S. albofaciens C42 Oxytetracycline
DSM 401066 S. azureus C18 Thiostrepton
DSM 40232 S. baamensis Cl
DSM 405986' S. bacillans Cl
ATCC 110626" S. bUdniensis C64 Streptomycin
KCC S-04595 S. bottropensis C19 Bottromycin
DSM 40419456 S. caesius C21
KCC S-0731456 S. caesius C21
DSM 403135 S. coralus C19
ISP 54A26- S.coeliatus Cl
A3(2)456 S. coelicolor C21 Methylenomycin
Undecyl-
prodigiosin
Actinorhodin
Polyamines
ISP 52334 S. coelicolor C21 As Above A3(2)
JCM 422045 S.cyaneus C18
ISP 4213456 S. endus C32 Endomycins
ISP 5060 S. exfoliatus C5
ISP 5022 S. filamentosus C5 Caryomycin
DSM 4112 S. filipensis C30 Filipin
DSM 403236" S. flavogriseus C l
ATCC 239076- S. flourescens Cl Actinomycin-X
KCC S-01336 S. fradiae C68 Neomycin
ISP 5064 S. gardened C5 Proactinomycins
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Culture
Collection
Reference Name
Tax.
ID. Product
DSM 4023646 S. griseus C l Streptomycin
DSM400684 S. halstedii C l
ATCC 21705456 S. hygroscopicus C32 Bialaphos
ATCC 146076" S. hygroscopicus C32 Bluensomycin
NRRL3602456 S. hygroscopicus C32 Geldanamycin
Nigericin
ATCC 3672456 S. hygroscopicus C32 Herbimycins
Nigericin
KCC S-077246 S. hygroscopicus C32 Hygromycins
NRRL 5739450 S. hygroscopicus C32 Milbemycin
NRRL366446 S. hygroscopicus C32 Scopofungin
ATCC 319554 S. hygroscopicus C32 L-155-175
ATCC 394470 S. hygroscopicus C32 MA 5000
ATCC 12760^ S. humidus C19 Dihydro-
Streptomycin
ISP 55505- S. katraie C61 Streptothricin
Polyenes
DSM4006946 S. lavendulae C61 Strq>tothricin
Polyenes
DSM 402166 
ATCC 33316“
S. lavendulocolor 
S. lipmanii
C61
KCC S-078346 S. lividans C21
J.I. 132645 S.lividans C21
KCC S-0495456 S. melanosporo- 
faciens
C32 Melanosporium
Elaiophylin
DSM 40091s S.murinus C17 Actinomycin-X
KCC S-0785456 S. lusitanus C44 Tetracycline
Chlor­
tetracycline
DSM 405086* S. naraeruis C l Naramycins
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Culture
Collection
Tax.
Reference Ñame ID. Product
ISP 5016 S. narbonensis C5 Narbomycin
DSM 40023®' S. nitrosporeus C1 Nitrosporin
NCIMB 9219 S. ni ve us C1 Novobiocin
ISP 5552 S. omiyaensis C5 Chloramphenicol
ATCC 25481®- S. omatus C1 Omamycin
DSM 40268 S. rimosus C42 Oxytetracycline
ISP 5174 S. roséolas C5 Antibacterial
ISP 5122 S. roseosporus C5 Antibacterial
ISP 54134 S. roseus C7
DSM 40077®" S. rutgersensis C1 Camphomycin
DSM 40445®* S. subrutilus C61 Hydroxy-
streptomycin
ISP 5329 S. termitum C5
KCC S-051946 S. thermotolerans C19 Carbomycin
ISP 5278 S. umbrinus C5 Antibacterial
NCIMB 8852® S. vinaceus C6 Viomycin
DSM 404384® S. violaceolatus C21
KCC S-0850456 S. violaceoniger C32
ISP 5196 S. zaomyceticus C5 Zaomycin
JHCC 131956 S. *pp. Actin
JHCC 123345® S. spp. Bialaphos
JHCC 139056 S. spp. Blasticidin
JHCC 123456 S. spp. Cyclohexamide
DSM 40049®" S. spp. C1
Lív. 463®- S. spp. C1
KCC S-0331® Stv. hachijoensis C55 Trichomycin
6 1
Culture
Collection
Reference Name
Tax.
ID. Product
KCC S-03316 Srv. hachijoensis C55 Trichomycin
ATCC 274416" Stv. ladakanum SMC 5-Azacytidine
ATCC 239346" Stv. mashuensis C55 Streptomycin
TOTAL 73 STRAINS
Key to Abbreviations used to denote culture collections
ATCC refers to the American Type Culture Collection.
KCC S refers to strains from the Kaken Chemical Company.
DSM refers to the Deutsche Sammlung von Mikroorganismen.
ISP refers to the International Streptomyces Project.
NRRL refers to strains from the Northern Regional Research Laboratory.
NCIMB refers to the National Culture Collection of Industrial and Marine Bacteria. 
J.I. refers to strains from the John Innes Institute.
JHCC refers to strains from the ICI culture collection at Jealotts Hill.
Liv. refers to strains obtained from Liverpool University.
M refers to a type strain, whose origin was unknown.
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Table 2.3. shows the strains which provided plasmids for use during this work.
Table 2 .3 . The nlasmid hearing strains nsad in thi« research
Plasmid Host Selection
PCKL7191 E.coU DH1 Ampicillin
pU41042 E.coli Rec A 
Delta M15
Ampicillin
pSACJ3 E.coli
(unknown strain)
Ampicillin
pU6734 S. lividans TK24 Viomycin
PU6804 S. lividans TK24 Thiostrepton
Neomycin
pGL1035 S. lividans TK24 Thiostrepton
Key:
The superscripts on the plasmids refer to the suppliers, who were:
1. S. Baumberg, Department of Genetics, University of Leeds.
2. M.J. Bibb, Department of Genetics, John Innes Institute.
3. P. Leadley, Department of Biochemistry, University of Cambridge.
4. John Innes Institute.
5. D. Ritchie, Department of Microbiology, University of Liverpool.
E. refers to Escherichia.
S. refers to Streptomyces.
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Table 2.4. Genes used for preparation of the DNA probes used in this resftarrh
Plasmid Gene Source Enzyme Restriction 
Fragment 
Size (Kb)
pCKL719 aph S.griseus Pstl 0.671
DSM 40236 Stul
pU4104 bar S. hygroscopicus 
ATCC 21705
EcoRl 
HindHI
0.605
pU673 vph S. vinaceus 
NCIMB8852
Sphl 0.950
pU680 aphD S. fradiae 
KCC 013
SstU 0.953
tsr S. azure us 
DSM 40106
Ben 1.087
pGL103 NbR S. ni ve us
NCIB 9219
Bglil 1.100
Explanation of genes qouted in Table 2.4.
aph «  streptomycin phosphotransferase gene (Vallins and Baumberg, 1985).
bar = modified bialaphos resistance determinant, dimethyl phosphinothricin
acetyltransferase gene (Murakami et a l., 1983).
vph -  viomycin phosphotransferase gene (Thompson et a l., 1982a).
aphD -  neomycin phosphotransferase gene (Thompson et al., 1982a).
tsr -  thiostrepton rRNA methylase (Thompson et al., 1982a).
Nbr  -  undetermined novobiocin resistance determinant (Mitchell et al., 1990). S.
S. refers to Streptomyces.
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Table 2.5. Media used in this research,
Key to Superscripts in Table 2.5..
The amount of constituents in the medium is given as g/1 unless otherwise 
indicated
Added after autoclaving from filter sterilized stocks.
'i
. Amounts are given as grams per 800ml.
All media were autoclaved at 121°C for 20 mins. 
pH was adjusted to the values shown prior to autoclaving.
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Table 2 5 Media used in this research
Medium Ingredients * Amount g/1
A37 Broth Glucose 5.0
Starch 15.0
pH 7.0 NaCl 5.0
Com Steep Liquor 10.0
Soya Bean Meal 10.0
CaCC>3 32.0
Arginine Glycerol 12.5
Glycerol Arginine 1.0
Salts KH2P04 1.0
(AGS) k2s o 4 0.5
NaCl 1.0
pH 8.0 Agar 15.0
^Trace Elements MgS04 .7H20  (10g/l) 1ml
Solution for ZnS04 .7H20  (lg/1) 1ml
AGS. FeS04 .7H20  (10g/l) 1ml
CuS04 .5H20  (lg/1) 1ml
MnS04 .4H20  (lg/1) 1ml
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Medium Ingredients * Amount g/1
Glucose k h 2p o 4 7.0
Mineral K2HP0 4 3.0
Salts KNC>3 4.0
MgS04 .7H20 1.0
NaCl
^Add 133ml filter sterilised 
glucose (30%) after autoclaving.
1.0
GYM Yeast Extract 4.0
Malt Extract 10.0
Agar 13.0
ISP7 Glycerol 15.0
Tyrosine 0.5
pH 7.3. Asparagine 1.0
k 2h p o 4 0.5
TES 1.0ml
^ ra c e MgSO4 .7H20 0.5
Element FeSO4 .7H20 1.0
Solution (TES) MnCl2.4H20 1.0
for ISP7 ZnSO4 .7H20 1.0
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Medium Ingredients 1 Amount g/1
L Broth Bacto Tryptone 10.0
Yeast Extract 3.0
NaCl 3.0
Glucose 1.0
Malt Extract Broth 20.0
Agar (Oxoid) Agar 15.0
Nutrient Agar 28.0
(Oxoid)
Nutrient Broth 13.0
(Difco)
Oatmeal Agar Oatmeal 20.0
Yeast Extract 5.0
Agar
pH 7.2
Steamed before autoclaving.
15.0
R5 Sucrose 103.0
K2S04 0.25
MgCl2.7H20 10.12
Glucose 10.0
68
Medium Ingredients * Amount g/1
R5-Continued Casaminoacids 0.1
Yeast Extract 5.0
TES Buffer 5.73
^Trace Element Solution 2 .0ml
Agar 22.0
^Trace ZnCl 20.04
Element FeCl2.7H20 0.2
Solution CUCI2 .2H2O 0.01
for R5 and R2. MnCl2.4H20 0.01
Na2B4O7 . 10H2O 0.01
(NH4)gMo7024.4H20 0.01
2After autoclaving and 0.5% KH2PO4 10.0ml
immediately prior to use 5M CaCl2.2H20 4.0ml
these ingredients (opposite) 20% L-proline 15.0ml
were added per litre. IN  NaOH 7.0ml
3R2 Sucrose 103.0
K2SO4 0.25
MgCl2.7H20 10.12
Glucose 10.0
Casamino acids 0.1
Distilled Water 800ml
Agar 22.0
69
Medium Ingredients 1 Amount g/1
R2 (continued) 0.5% KH2PO4 10.0ml
After autoclaving and 3.68% CaCl2 .2H20 80.0 ml
immediately prior to use 20% L-proline 15.0 ml
the opposite ingredients 5.73% TES Buffer 100.0 ml
were added per 800 ml. (pH7.2)
2Trace Element Solution 2 .0ml
IN  NaOH 5.0ml
Sautons Medium Glucose 15.0
(Modified) Asparagine 5.0
pH 7.2 Casein Hydrolysate 2.0
Sodium Citrate 1.5
k h 2po 4 5.0
MgS04 .7H20 0.5
Ferric Ammonium Citrate
^Glucose is filter sterilized 
and added after autoclaving.
0.1
Yeast Extract Yeast Extract 3.0
Malt Extract Bacto-Peptone 5.0
(YEME) Malt Extract 3.0
Glucose 10.0
Sucrose
2.5M Magnesium Chloride 
(hexahydrate) 2.0  ml/1 added 
after autoclaving.
340.0
Media constituents were supplied by Oxoid, Difco, BDH or the Sigma chemical 
company.
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Table 2.6. Buffers and reagents used in probing work.
Table 2.6. gives the buffers and reagents, which were used during this research. 
They were made up using double distilled water and were sterilized by autoclaving 
at 121°C, when appropriate.
Key to superscripts used in this research:
1 The quantity of constituents is given as mM unless otherwise stated.
y
The DNA was dissolved to give 10 mg/ml in sterile distilled water. Following 
this it was syringed through a narrow bore needle, boiled for 10 minutes, chilled 
rapidly on ice and stored at -20°C.
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Table 2.6. Buffers and reagents used in probing work.
Reagent Ingredients ^Quantity (mM)
Acid Phenol Phenol (analar) 5.00(g)
Chloroform Chloroform 5.00 (ml)
Water 1.00 (ml)
8-hydroxyquinoline 5.00 (mg)
Alkaline SDS NaOH 300.00
Solution Sodium Dodecyl 
Sulphate
2%
Denaturing NaOH 1000.00
Solution NaCl 1500.00
Denhards Ficoll 2 %(w/v)
Solution (MW400.000 Sigma)
Bovine Serum Albumin 
(Fraction 5 Sigma)
2 %(w/v)
Polyvinyl Pynolidone 
(MW360,0d0, Sigma) 2 %(w/v)
^Non-homologous
DNA
Salmon sperm DNA 10.00 (mg/ml)
GTE Glucose 50.00
Sodium-EDTA (pH 8) 10.00
Tris-HCl 25.00
TBE Tris-HCl 89.00
Buffer Boric acid 89.00
Sodium-EDTA (pH 8) 2.00
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Reagent Ingredients * Quantity (mM)
TE Tris-HCl (pH8) 10.00
Buffer Sodium-EDTA (pH8) 1.00
Lysozyme Lysozyme 2.00 (mg/ml)
Solution Heat Treated RNAse 50.00 (mg/ml)
Tris-HCl (pH8) 0.30
Sodium-EDTA (pH8) 25.00
5 x Loading Sucrose 6.00 (g/1)
Buffer Sodium-EDTA (pH 8) 0.37 (g/1)
pH 8.00 Sterile Distilled 
Water
10.00(ml)
Bromophenol Blue 25.00%
Neutralizing NaOH 1500.00
Solution Tris (pH7.4) 1000.00
^Non-Homologous Salmon Sperm DNA 10.00 (mg)
DNA Sterile Distilled 
Water
10.00 (ml)
Phenol Phenol (HPLC grade) 100.00 (g)
Chloroform Chloroform 100.00 (ml)
Mix Tris-HCl (pH8) to equilibrate.
73
Reagent Ingredients ^Quantity (mM)
Phenol Solution Phenol (HPLC grade)
8-hydroxyquinoline
TE Buffer (+  0 .1M NaOH)
500.00(g) 
0 .50(g) 
65.00 (ml)
Prehybridization 3 x SSC 15.00 (ml)
Solution 4 X Denhards solution
Non-homologous DNA 
(Salmon Sperm DNA)
Make up to 100ml with sterile 
deionzed distilled water.
4.00 (ml)
100.00 (fig)
RNAse RNAse 50.00 Oil)
Solution Sterile distilled 
water
950.00 Oil)
20 x SSC NaCl 175.32 (g/1)
Sodium citrate 88.23 (g/1)
74
2.2. Strain Maintenance,
2.2.1. Routine Maintenance of Strains.
(See Table 2.4 for media)
Streptomycete strains were maintained on slopes in sterile universals of both 
of GYM and oatmeal agar, at 30° C. B. subtilis was maintained on nutrient agar 
and cultured for use in bioassays in nutrient broth at 30°C. Aspergillus niger was 
maintained on malt extract agar at 30° C, but for bioassay A. niger spores were 
suspended in glycerol salts medium. E. coli strains were maintained on nutrient agar 
containing a concentration of 35 pg per ml of ampicillin. S. lividans (TK24) was 
maintained on R5 medium. Alternatively the plasmid bearing mycelium was stored 
as a frozen paste until required.
2.2.2. Culture Storage.
Short-term storage was on the above slopes at 4° C . Long term storage was 
in 20% glycerol solution at -20° C. Streptomyces strains w ere grown up on oatmeal 
agar slopes until they sporulated. 5 ml of 20% glycerol solution was added to each 
universal with a sterile wide bore pipette. The tip of the pipette was used to scrape 
the spores and mycelium from the surface of the culture. The resulting suspension 
was dispensed into a sterile bijoux and stored at -20° C . Log phase E.coli and 
B.subtilis were pelleted in a centrifuge (14,000g at 10° C for 5 mins.) and were 
also stored in 20% glycerol solution at -20° C.
2.2.3. Strain Resuscitation.
Ampoules-containing freeze dried mycelium were heated and dipped in cold 
water to break the glass. Dried down streptomycetes were then resuspended in 500 
pi YEME. Aliquots of this were used to inoculate Oatmeal plates and YEME broth. 
These were incubated at 28° C until the organisms had grown.
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Whenever it was necessary to standardize inoculum size between strains, 
spore and mycelial suspensions were counted using a haemocytometer slide (0.02  
mm Thoma). Four fields of view were counted for each sample. These were then 
averaged and used to calculate the number of spores and mycelia per ml. 
Suspensions were then standardized at 1 x 107 spores and mycelial fragments per 
ml.
2.3. Characterization o f Streptomycetes
2.3. l.Extraction of Bioactive Compounds.
For the extraction of non polar (lipophilic) compounds, Ehrlenmeyer flasks 
(230 ml) containing 30 ml A37 medium were inoculated with a loopful o f 
streptomycete spores from a slope. These were incubated at 28° C in an orbital 
shaker at 200 r.p.m .. After 6 days, 10 ml ethyl acetate was added to each culture. 
The flasks were stoppered with rubber bungs to prevent the solvent from 
evaporating and were shaken (200 r.p.m ) for 1 hour at room temperature. The flask 
contents were transferred to centrifuge tubes and spun at 14,000g at 10° C for 13 
mins. The solvent phase was removed, placed in a universal and vacuum evaporated 
to dryness in a desiccator. The dried extracts were resuspended in 200 pi ethyl 
acetate and analysed by thin layer chromatography.
For the extraction of streptomycin, a 6 day old culture was spun down at 
14,000g at 10° C for 3 mins. The supernatant was collected into a 100ml glass pot 
and dried down in an oven at 80° C. The residue was resuspended in 200 pi 
methanol (in which > 20  mg/ml of streptomycin was soluble) and used for TLC.
2.3.2. Thin Laver Chroma tngranhv ( T in .
TLC was carried out on 0.23 mm silica gel with fluorescent indicator 
(UV254). The baseline was 2 cm from the bottom of each plate. 20 p i of each
2.2.4. Standardization o f  Streptomvcete Inocula.
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sample was loaded as a 1 cm line along the baseline with a 1cm interval between 
each sample and a 1.5 cm margin at the edges o f the plate. Plates were run until the 
solvent front was 2 cm from the top of the plate. The following three solvent 
systems were routinely used: (1) ethyl acetate : n-hexane : dichloromethane : 
methanol (v/v 9:6:1:1); (2) dichloromethane : methanol (v/v 9:1) and (3) butanol : 
acetic acid : water (v/v 3:1:1). Table 2.7 shows the approximate Rf values of 
commonly used antibiotics in these solvent systems. Pure forms of relevant 
antibiotics were used as standards.
Table 2.7. Rf values o f antibiotics screened for TLC
Antibiotic
1 (RO
Solvent System 
2 (Rf) 3 (Rf)
Streptomycin 0.0 0.0 0.2
Novobiocin
p
o
o N .T. N.T.
Thiostrepton 0.00 0.68 1.73
Nigericin 0.72 0.84 N.T.
Herbimycin A 0.37 0.75 N.T.
Herbimycin C 0.31 0.86 N.T.
Geldanamycin
o
o
o
P
r?
0.84
(top
spot)
N.T.
Key to Table 2.7.: N .T . -  Not Tested.
Rf values were calculated by dividing the distance travelled by
compound by the distance of the solvent front from the base line. Replicate samples 
were used to give a mean Rf value for each compound.
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TLC plates were removed from the solvent tanks and air dried. A number of 
methods were used to detect antibiotics, but colouration under visible light and UV 
fluorescence at 254 nm were used routinely. Plates were also routinely sprayed with 
vanillin reagent (vanillin, 3.0 g; ethanol, 100.0 ml; Cone. H2SO4 , 0.5 ml) and then 
heated at 100° C for 10 mins. Other methods included covering the plates in a One 
spray o f 10% H2SO4  or with 0.2% ninhydrin in acetone. Plates treated in this way 
were also heated for 10 mins at 100° C. Table 2.8. shows the various reactions of 
commonly used antibiotics with these reagents.
2.3.3. Bioautography.
Antibacterial bioautograms involved inverting pre-run TLC plates were on a 
200 ml base layer o f nutrient agar in a Nunc bioassay dish. These were left for 30 
minutes to allow the metabolites to diffuse into the medium. The plates were 
removed and seeded overlays containing 200 pi log phase B. subtilis cells (lxlO6  
per ml) was poured evenly onto the base layer. These dishes were incubated at 
28°C overnight.
For antifungal bioautograms pre-run TLC plates were sprayed with A. niger 
spores (1x10^ per ml) in glycerol salts solution. Plates were then placed in bioassay 
dishes, supported on sterile bottle tops for 3-7 days at 30° C. They were suspended 
above wet filter paper to provide a humid environment. Zones of inhibition for both 
types o f bioautography were correlated with spots on replicate uninoculated TLC 
plates.
2.3.4. In vivo Agrochemical Screens.
Data relating to the bioactivity of the strains on in vivo agrochemical screens 
(herbicidal, insecticidal, fungicidal and plant growth regulator) was made available 
by Sarah Rees (ICI Agrochemicals). Information consisted of activities detected 
within each screening department and whether the activity was
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Table 2.8. Visualization o f antibiotics.
Anti­
biotic
Visible
Light
UV
Light
Ninhy-
drin
10%
h 2s o 4
Vanillin
Strepto
-mycin
- - - Brown Brown
Neomycin - + Plum Green Beige
Viomycin - + Violet - Lemon
Kanamycin - - Purple Brown Yellow-
Green
Blast-
icidin
+ + Green Purple Green
Oxytet
-racycline
Yellow - Yellow Rust Yellow-
Green
Erythro- 
- mycin
+ - Brown -
Novo-
-biocin
- + Brown Beige -
Thio-
-strepton
Yellow- + Brown Rust-
Brown
Orange-
Brown
Nigericin - - ND ND Scarlet
Herbi-
-mycin
Yellow + ND ND Green
Gelda-
-namycin
Orange-
yellow
+ ND ND Green
ND — Not Done 
- — Not Visible 
+  ■ Visible
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reproducible. However each screen comprised a range of assays to detect activity 
against a variety of agricultural pests. For example a typical plant pathology screen 
might comprise Rhizoctonia, Botrytis and Pythium species.
2.3.5. Taxonomic Identification.
Full taxonomic identifications were carried out on a random selection of the 
natural isolates in the study. This work was done by Dorothy A.Sanders, 
Department of Biological Sciences, University of Warwick, with the exception of 
the scanning electron microscopy data.
The taxonomical identities of streptomycete strains was done according to 
the probability matrix of Williams et al. (1983b).Good identifications were assessed 
as follows:
1. The Wilcox coefficient was greater than 0.85.
2. The taxonomic distance was equal to or less than 0.4.
3. The standard deviation was less than 2.
4. There was a low number of characters scored against the most suitable 
identification (ie the first numeral in the characters against and the identification 
columns respectively).
Ten strains gave good identifications whilst a further seventeen fell slightly 
short of the requirements. These identifications were used when a method was being 
assessed for use in taxonomy. This left 35 strains which did not identify closely 
with any species group on the Williams et al. (1983a) probability matrix. Although 
the identities of these strains remains unknown, much morphological, physiological 
and phenotypic information was generated about them. They may belong to minor 
clusters of the genus (Williams et a l., 1983a) and could be identified using the 
probabilistic identification matrix o f Langham et al. (1985), or else they represent 
rare streptomycetes.
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Table 2.9. Taxonomie data on natural isolates
Strain Wilcox
Coeff.
Tax.
Dist.
SD Characters Identity 
Against x > y > z
C1356 0.57 0.38 0.49 3:4:3 19:1:3
C24567 0.5 0.399 0.92 3:5:5 19:15:12
C2845 0.96 0.38 1.23 4:4:5 1:3:19
C33456 0.45 0.47 3.52 7:10:5 1:15:3
C4056 0.71 0.42 2.35 6:3:61 5:12:19
C535 0.94 0.403 1.75 4:5:5 12:19:15
C7045 0.91 0.44 2.7 5:10:10 12:15:18
C77456 0.52 0.45 2.19 7:5:7 19:3:5
C98456 0.91 0.39 0.69 4:7:6 19:21:15
C108456 0.46 0.43 1.73 - 19:1:3
C109456 0.95 0.35 0.28 3:4:6 1:19:15
C121456 0.73 0.37 0.19 3:3:4 19:3:1
C1294567 1.0 0.4 1.9 6:6:7 15:12:19
C U I456 0.66 0.42 2.13 4:5:5 6:1:3
C174 0.57 0.396 2.41 4:6:7 3:1:19
C l 77*56 0.97 0.42 2.1 6:6:7 1:15:19
C1844567 0.99 0.46 2.34 6 :8:11 19:12:15
C208456 0.8 0.36 0.0001 2:5:4 19:15:1
C2124567 0.98 0.41 1.17 4:6:7 19:18:1
C2224567 0.68 0.42 2.06 5:8:6 1:15:12
C229467 0.0 0.4 2.3 5:5:6 3:1:15
C2454567 0.8 0.46 3.3 6:9:10 12:15:29
D2456 0.76 0.49 3.1 8:7:8 12:18:15
D3456 0.42 0.42 1.48 5:5:5 19:15:3
D5567 0.67 0.42 2.1 5:4:7 1:3:19
• 1
Strain Wilcox Tax. SD Characters Identity
Coeff. Dist Against x > y > z
D9 0.89 0.42
D61456 0.93 0.4
D7956 0.75 0.37
D9856 0.96 0.38
D12556 0.66 0.35
D140456 0.76 0.4
D17945 0.8 0.38
E l4«7 0.88 0.34
£3 j4567 0.79 0.42
E464 0.78 0.44
E554 0.95 0.48
E574 0.87 0.4
F284 0.55 0.41
F53567 0.94 0.33
F664 0.87 0.44
CAG16-7 0.7 0.43
CAG26 -7 0.7 0.51
CAG36 "7 0.93 0.54
CAG46 -7 0.63 0.44
CAG56 -7 0.967 0.47
CAG66-7 0.97 0.42
CAG76-7 0.57 0.51
CAG86- 0.99 0.38
CAG96 - 0.98 0.37
CAG106-7 0.79 0.47
C A G ll6"7 0.91 0.47
2.35 7:5:5 15:1:9
1.06 3:5:7 19:1:5
0.19 2:4:9 19:1:15
1.23 4:4:9 1:19:15
1.04 3:6:5 3:15:19
1.97 5:6:7 15:19:1
1.16 4:7;4 1:15:19
0.84 3:5:5 3:1:19
3.57 5:6:7 32:15:12
2.02 6:7:9 19:12:-
3.77 7:10:9 12:19:18
1.7 6:4:5 15:12:19
1.99 6:6:9 1:19:15
0.15 4:5:5 12:15:19
2.76 6:7:6 12:19:15
2.5 5:7:7 12:18:19
3.7 10:8:10 19:18:12
4.35 12:10:9 19:29:18
1.69 5:6:4 18:19:6
2.77 8:8:6 19:37:6
1.4 15:6:7 18:15:12
3.76 9:9:6 19:61:6
1.22 4:5:6 15:18:19
0.09 3:6:5 18:15:19
2.58 7:8:6 19:18:15
3.64 7:9:10 15:18:19
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Strain Wilcox
Coeff.
Tax.
Dist
SD Characters Identity 
Against x > y > z
CAG126"7 0.61 0.51 3.74 9:9:9 19:1:37
CAG136"7 0.94 0.43 0.47 7:7:8 37:12:19
CAG166"7 0.55 0.53 4.18 9:10:12 19:18:15
CAG176" 0.94 0.39 1.38 3:4:6 1:19:12
CAG186"7 0.87 0.51 4.41 10:7:10 5:61:1
CAG196"7 0.62 0.44 1.84 6:6:5 12:19:15
CAG216" 0.67 0.44 2.8 7:7:6 15:12:19
CAG236"7 0.65 0.5 4.3 8:10:10 1:15:18
CAG246"7 0.97 0.4 0.97 4:6:7 19:18:12
CAG256"7 - 0.47 2.9 8:7:9 19:1:5
CAG266-7 0.76 0.47 2.9 8:8:9 19:12:18
The strains in this table were selected arbitrarily for identification. Various 
other strains had been identified prior to the work presented in this thesis. They 
were A10, A19, A39 and B4, which identified to cluster 19 and A26 and E44, 
which identified to cluster 12.
Key to superscripts and abbreviations used in Table 2.9.:
Wilcox Coeff. — Wilcox Coefficient.
Tax. Dist. ”  Taxonomic Distance.
x > y > z  -  x is the most probable identity; y is the next most likely identity; z is 
the third most likely identity.
*Used in Chapter 4; Fatty Acid Study.
^Used in Chapter S; Chemical Profile Study.
^Used in Chapter 6 ; Antibiotic Resistance Study.
**~Used in Chapter 6 , but not for clustering.
7Used in Chapter 7; Gene Probing Study.
(NB. where several superscripts have been used as in 456, this mean 4> 5 and 6.)
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Strains were grown on sterile glass coverslips, inserted into plates of oatmeal 
agar at an angle of 43°. 10 pi spore suspension was streaked between the interface 
of the coverslip and the medium. The plates were incubated at 30° C. When the 
streptomycete had sporulated the coverslips were removed (the mycelium and spores 
having adhered to them) and placed in an atmosphere of formaldehyde overnight. 
These were used for observation under the Scanning Electron Microscope. The glass 
coverslips were mounted onto electron microscope stubs using electrodag 913 high 
conductivity paint (Agar Scientific Ltd.). A fine layer of gold was deposited onto 
each sample for 80 secs, using a Biorad-E5200 sputter-coater (20 mA, 10 lb/square 
* Argon). Coated samples were observed under vacuum using a JEOL T330A 
scanning electron microscope.
Partial identifications were carried out on a large number of strains by 
examining their spore surface morphology in the scanning electron microscope. 73 
strains were randomly selected from the C, D , E  and F series (Table 2.1). This was 
done to establish the proportion of strains isolated on C32 medium (D,E and F 
series, Table 2.1.), which were S. viridoehnomogenes. The species is easily 
recognised by its characteristic rugose ornamentation and tightly spiralled spore 
chains. The exercise also provided an opportunity to form a library of photographs 
(Fig.2.1.), which help to reidentify strains and eliminate duplicates. Table 2.10. 
shows the results from the exercise. In addition, all strains in the MM and W series 
were preselected for spiral, rugose spore chain morphologies by examination under 
SEM by N. Cresswell (Department of Biological Sciences, Warwick University).
2.3.6. Scanning Electron Microscopy.
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Strain Wilcox
Coeff.
Tax.
Dist
SD Characters Identity 
Against x > y > z
CAG12**"7 0.61 0.51 3.74 9:9:9 19:1:37
CAG136"7 0.94 0.43 0.47 7:7:8 37:12:19
CAG166’7 0.55 0.53 4.18 9:10:12 19:18:15
CAG176- 0.94 0.39 1.38 3:4:6 1:19:12
CAG186-7 0.87 0.51 4.41 10:7:10 5:61:1
CAG196"7 0.62 0.44 1.84 6:6:5 12:19:15
CAG216" 0.67 0.44 2.8 7:7:6 15:12:19
CAG236"7 0.65 0.5 4.3 8:10:10 1:15:18
CAG246*7 0.97 0.4 0.97 4:6:7 19:18:12
CAG256-7 - 0.47 2.9 8:7:9 19:1:5
CAG266*7 0.76 0.47 2.9 8:8:9 19:12:18
The strains in this table were selected arbitrarily for identification. Various 
other strains had been identified prior to the work presented in this thesis. They 
were A10, A19, A39 and B4, which identified to cluster 19 and A26 and E44, 
which identified to  cluster 12.
Key to superscripts and abbreviations used in Table 2 .9.:
Wilcox Coeff. =  Wilcox Coefficient.
Tax. Dist. “  Taxonomic Distance.
x > y > z  -  x is the most probable identity; y is the next most likely identity; z is 
the third most likely identity.
*Used in Chapter 4; Fatty Acid Study.
^Used in Chapter 5; Chemical Profile Study.
**Used in Chapter 6 ; Antibiotic Resistance Study.
6~Used in Chapter 6 , but not for clustering.
7Used in Chapter 7; Gene Probing Study.
(NB. where several superscripts have been used as in 456, this mean 4’ 5 and 6.)
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Strains were grown on sterile glass coverslips, inserted into plates o f oatmeal 
agar at an angle of 45°. 10 pi spore suspension was streaked between the interface 
o f the coverslip and the medium. The plates were incubated at 30° C. When the 
streptomycete had sporulated the coverslips were removed (the mycelium and spores 
having adhered to them) and placed in an atmosphere of formaldehyde overnight.
These were used for observation under the Scanning Electron Microscope. The glass 
coverslips were mounted onto electron microscope stubs using electrodag 915 high 
conductivity paint (Agar Scientific Ltd.). A fine layer of gold was deposited onto 
each sample for 80 secs, using a Biorad-E5200 sputter-coater (20 mA, 10 lb/square 
" Argon). Coated samples were observed under vacuum using a JEOL T330A 
scanning electron microscope.
Partial identifications were carried out on a large number of strains by 
examining their spore surface morphology in the scanning electron microscope. 73 
strains were randomly selected from the C , D, E and F series (Table 2.1). This was
done to establish the proportion of strains isolated on C32 medium (D ,E and F
¿ v v f .A .  X
series, Table 2 .I.), which were S.viridochromogtnes. The species is easily 
recognised by its characteristic rugose ornamentation and tightly spiralled spore 
chains. The exercise also provided an opportunity to form a library of photographs 
(Fig.2.1.), which help to reidentify strains and eliminate duplicates. Table 2.10. 
shows the results from the exercise. In addition, all strains in the MM and W series 
were preselected for spiral, rugose spore chain morphologies by examination under 
SEM by N. Cresswell (Department of Biological Sciences, Warwick University).
2.3.6. Scanning Electron Microscopy.
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Figure 2.1. Scanning electron micrographs of streptomycete spore chains
Photograph.
A and B =  Rugose spore chains 
C and D =  Smooth and straight spore chains
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Table 2.10. Spore morphology of a selection of natural isolates.
Chain
Type
Spore
Ornamentation
C Series 
(No. strains)
D ,E,F Series 
(No. strains)
Spiral Rugose 2 6
Spiral Smooth 2 2
Straight Smooth 34 17
Hooked Smooth 4 2
Straight Warty 1 3
Total No. Strains 43 30
Six strains out of the thirty isolated on C32 medium were of the desired 
identity (16.7%). This compared with two out of forty-three strains isolated on AGS 
medium. From these results C32 is 3.8 times more successful for the isolation of 
S.violaceoniger strains, although the vast majority of strains isolated by both 
methods do not belong to this species group.
2.4. Fermentation Work.
2.4.1. Comparison of Antibiotic Production on Different Media.
A comparison of antibiotic production in Sautons medium with and without 
casein hydrolysate, R5 with and without casamino acids, MSG and ISP7 was made. 
Thirty ml medium in a 250 ml Erlenmeyer flask was incubated for six days at 28° 
C . After incubation antibiotics were extracted as in section 2.3.
2.4.2. Timecourses of Antibiotic Production in Strain D153.
Sixty ml ISP7 (500 ml flask) was inoculated with 60 p i spore suspension (1 
x 107 per ml). Incubation was at 28° C and 200 r.p.m . for 7 days. Samples (5 ml) 
were removed at 24 hourly intervals. After the samples were collected they were
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2.4.3. Oxygen Limitation Experiment.
Fifteen flasks containing ISP7 medium (30 ml) were inoculated with 60 ul 
spore suspension (1 x 107 per ml). These were incubated for 76 hours at 28° C. 
Then 5 control flasks were prepared as follows: 3 were left as they were and 2 were 
subasealed. The remaining flasks were also sealed with subaseals, but were flushed 
with nitrogen gas. A set volume of nitrogen was removed from the flask and an 
equivalent volume of oxygen was syringed in to make concentrations of 0, 5, 10, 15 
and 21% oxygen. Flasks containing 21% O2  were also controls. The volume of 
each flask was measured, prior to the experiment, by filling them with water up to 
the subaseal level and then weighing them. The precise volume of gas required for 
each oxygen concentration was then calculated. Samples (2 ml) were taken every 
twelve hours. Biomass was measured (dry weight) and the presence of antibiotics 
was detected using methods 1 and 2 in section 2.3.
2 .4 .4 . Dry Weight Measurements.
A known volume of filtered mycelium from a culture broth was dried down 
to constant weight in pre-weighed glass universal! at 100°C.
2.4.5 . Nutrient Gradients.
The defined medium was based on ISP7 with variation of either the 
nitrogen, carbon or phosphorus source. The carbon sources used were glucose, 
sucrose and glycerol,at concentrations between 0 and 20 g/1. Nitrogen sources were 
tyrosine asparagine and sodium nitrate, at concentrations between 0 and 4 g/1. 
Gradients of dipotassium hydrogen orthophosphate were examined between 0 tol 
g/1 ,0  to 5 g/1 and 0 to 10 g/1. The gradients were prepared by omitting the nutrient 
under scrutiny from the 50 ml base layer poured on a slant in a 10 x 10 cm bioassay
frozen until required. Biomass (dry weight) was measured for each sample and the
presence of geldanamycin and nigericin were determined by TLC.
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dish. The SO ml top layer was made at the maximum concentration for the test 
nutrient. This was poured onto the base layer to give a flat surface. Diffusion from 
the top layer to the bottom layer resulted in a plate with a continuous gradient from 
0 to maximum g/1 for each nutrient. 35 /¿I streptomycete spore and mycelium 
suspension (lxlO 7 per ml) was dispensed in an even line across the gradient and the 
plates were incubated at 30° C for up to 2 weeks. The growth on the plates was 
observed every day for diffusible pigments and to observe the growth and 
development o f each organism.
Antibiosis for selected strains was observed after 90 hours growth. 
Streptomycete cultures were killed by exposing them to S mins, shortwave (2S4 nm) 
UV light. Then the plates were overlaid with test organisms. For antifungal activity 
SO y1 A.niger spores (1 x 10^ per ml) were inoculated into IS ml YEME medium 
and used to overlay gradient plates. They were grown at 30°C for 3 days. The 
position and size of zones, where there was no fungal growth were measured. For 
activity against B.subtilis SO y\ log phase (1x10^ per ml) cells were used to 
inoculate IS ml nutrient agar. Gradient plates were overlaid and incubated at 28° C 
overnight. Clear zones were recorded with respect to their size and position on the 
gradient
2.5 Fatty Acid Analysis.
2.5.1. Extraction Procedure.
The following reagents were used during the analysis of whole cell fatty
acids:
Reagent 1.; Saponification reagent: 4Sg NaOH, Fisher certified ACS grade; ISO ml 
methyl alcohol HPLC or spectroanalysis grade; ISO ml deionized, distilled water. 
Reagent 2 .; Methylation reagent: 32S ml 6  N hydrochloric acid (HC1); 27S ml 
methyl alcohol (as above).
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Reagent 3.; Extraction solvent: 200 ml hexane, Fisher HPLC grade; 200 ml ethyl 
ether, anhydrous Fisher certified spectroanalysed.
Reagent 4 .; Base wash: 10.8g sodium hydroxide (as above); 900 ml deionized 
distilled water.
Streptomycetes were grown in 30 ml modified Sautons medium at 28° C for 
three days. Cells were harvested by filtration through Whatman 3 mm filter paper in 
a Buchner filter and washed with distilled water. The wet biomass w as dried at 100° 
C to a constant weight. 30 mg dried biomass was transferred to a Teflon stoppered 
"Pierce" reactivial and saponified in 1ml Reagent 1 at 100° C for 30 mins.The tube 
was vortexed for 3-10 secs, at times 0 and 3 mins. A 2 ml amount o f Reagent 2 was 
added to the tube, which was then vortexed for 3-10 secs. This was placed in an 80 
+ /- 1° C water bath for 10 mins, to carry out the methylation reaction. The Fatty 
Acid Methyl Esters (FAMES) were extracted into 1.23 ml Reagent 3 by rotating the 
tube end-over-end for 10 mins. The aqueous lower phase was discarded and 3ml 
Reagent 4 was added. The tube was rotated for 3 mins. Then 2/3 o f the organic 
extract was added to a Gas Chromatography (GC) sample vial after drying over 
anhydrous Na2SC>4 .
2.5.2. Combined Capillary Gas Chromatography Mass Spectroscopy fGCMSl.
GCMS was carried out by Sue Slade, Department of Biological Sciences, 
University o f Warwick.
A Krates MS25 RFA Mass Spectrometer in conjunction w ith a Carloerba 
MFC 500 Gas Chromatograph was used. The column was a Chrompack CP Sil5 
(non-polar) o f length 23m, inner diameter 0.33 mm and film thickness 0.12 pm. 
The carrier gas was helium, the temperature ramp 100° C for 8 m ins, then 4° C per 
min. to 250°C and the flow rate 2 cubic cm /min. A 1.5 pi aliquot (30% split ratio) 
was injected into the GCMS at 240° C. The source temperature was 200° C and an 
ionization an electron impact o f 70 eV was used. A qualitative standard mix of 
methyl esters, supplied by Supelco (Catalogue No. 4-7080) was used in order to
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detect the presence of specific compounds. For the timecourse experiments a 
quantified internal standard (methyl undecanoate) was used so that the amount of 
each methyl ester relative to this standard could be calculated using the area under 
each peak.
2.5.3. Timecourses.
Fatty Acid Analysis Procedure and GCMS Protocol were as above, except 
cells were harvested daily for 7 days. Biomass samples from each timecouse were 
frozen at -20° C until they had all been collected then the FAMES were isolated 
and analysed. Dry weight measurements were taken and antibiotic production was 
analysed in timecourse 2 .
2.6. Metabolite Profiles.
These were based on the results from extraction method 1, TLC system 1 
and visualization under ultra-violet light. For each strain the presence or absence of 
29 compounds was scored using an external standard to aid between plate 
comparisons. Method development is discussed in Chapter 5.
2.7. Resistance Profiles.
2 /L l.T h e Use of Antibiotic Gradient Plates to Determine Phenctic Resistance in 
Strentormces Strains.
Resistance was defined by reference to sensitivity of a large population of 
streptomycetes (193 strains). This was achieved by testing the population using 
gradient plates composed of AGS medium. To make antibiotic gradient plates, 150 
mis AGS medium was poured as a 0-5 mm slant in a bioassay dish (22 x 22 cm). A 
further 150 mis AGS, containing the prescribed antibiotic was poured on top of the 
base layer to give a flat surface. The plates were poured immediately prior to use 
and then 75 pi spore and mycelial suspension (lxlO7 spores and mycelial fragments
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per ml) was inoculated in an even line using a Finn pipette across gradient plates 
(containing one of the following antibiotics) and incubated for 6 days at 30° C. The 
antibiotics tested were thiostrepton (0 to SO ug/ml), neomycin (0 to 10 ug/ml), 
novobiocin (0 to 100 ug/ml), viomycin (0 to 30 ug/ml), streptomycin (0 to 10 
ug/ml), erythromycin (0 to 100 ug/ml), oxytetracycline (0 to 100 ug/ml), 
kanamycin (0 to 100 ug/ml), nigericin (0 to 17 ug/ml), blasticidin S (0 to 100 
ug/ml) and penicillin G (0 to 100 ug/ml). Growth across the gradient was measured 
in mm's and since the strains did not grow where an antibiotic had reached an 
inhibitory level, the measurement was related to the minimum inhibitory 
concentration. An extrapolated value was taken from these measurements using the 
following equation:
LENGTH OF LINE OF GROWTH x MAXIMUM ~ LEVEL OF
(mm)_____________________________ ANTIBIOTIC ANTIBIOTIC
TOTAL LENGTH OF GRADIENT CONC. RESISTANCE
(mm) (/tg/ml) (/tg/ml).
These tests were done in duplicate for each strain and the results were only 
scored when control plates containing no antibiotic showed growth, the distances 
(and extrapolated antibiotic concentrations) at which the population became constant 
were as follows; thiostrepton, 2.23 cm (3 /tg/m l); neomycin, 4.3 cm (2 /tg/ml); 
novobiocin 4.3 cm (20 /tg/ml); viomycin 4.3 cm (2 /tg/m l); streptomycin, 7.88 cm 
(3.3 /tg/m l); erythromycin, 9 cm (40 /tg/m l); oxytetracycline, 10.13 cm (43 
/tg/ml); nigericin, 19.93 (16 /tg/m l); blasticidin S 0.3 cm (2 /tg/m l); penicillin G 
21.38 cm (93 /tg/ml).
Antibiotics were obtained from the Sigma Chemical Company L td., except 
for viomycin, which was supplied by the Upjohn Company and blasticidin, which 
was a g ift from ICI Agrochemicals pic.
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2.7.2. Determination of the Relationship Between Antibiotic Concentrations 
Extrapolated from Gradient Plates and Corresponding Concentrations from Pour 
Plates.
AGS gradient plates and pour plates with the same depth of agar were poured and 
incubated at 28° C for S days. Pour plates contained the concentration o f the 
relevant antibiotic at its cut-off concentration (Section 6.2.1.). Plugs of agar were 
removed from duplicate AGS gradients at the position of the estimated cut-off point 
for thiostrepton, neomycin, kanamycin and streptomycin (6.2.1). These were 
placed, antibiotic side uppermost on nutrient agar seeded with E.coli (711) for 
streptomycin and B.subtilis (supplied by D. Sanders, Department of Biology, 
University of Warwick) for the other antibiotics (10 ul overnight culture per ml of 
medium). Controls were plugs, of the same dimensions as above, from the 
corresponding pour plates. Bioassays were carried out at 37° C overnight and the 
mean zone size of triplicate samples from duplicate plates were compared.
2.8. DNA Isolation and Prohiny.
2.8.1. Small Scale Alkaline Lysis for Plasmid Preparation of E.coli.
A single colony o f E.coli was inoculated into 3 ml L-broth which contained 
33 pg/ml ampicillin. After overnight incubation at 37° C the cells were pelleted and 
resuspended in 1 ml TE buffer. This suspension was pelleted in the microfuge and 
then resuspended by vortexing in 130 pi ice cold GTE. The sample was incubated at 
room temperature for 3 mins., after which 200 pi of 0.2N sodium hydroxide and 
1% SDS was added. The tube was inverted 2-3 times to mix the solution, which 
was kept on ice until it was clear (3 mins.). Ice cold potassium acetate (130 ul at pH 
4.8) was added and the tube inverted immediately (3 x) and then kept on ice for 3 
mins. After centrifuging at high speed in the microfuge for 3 mins the supernatant
92
was transferred to a fresh eppendorf. This was treated with phenol-chloroform and 
chloroform-isoamyl alcohol. The supernatant was ethanol precipitated and 
resuspended in TE buffer.
2.8.2. Maxi Preparation of  Plasmid from E.coli.
A single colony of plasmid-bearing E. coli was used to inoculate 10 ml L. 
Broth containing 35 pg/ml ampicillin. This was incubated at 37° C overnight and 
used to inoculate 11 of the same medium. After a further overnight incubation the 
cells were pelleted by centrifugation in 4 x 250 ml pots (4000g, 4° C, 10 mins).
8mls GTE was added to each pair o f pellets. The pooled volumes were 
placed into oakridge tubes and a spatula tip o f lysozyme was added to each. These 
were incubated for 10 mins, at room temperature. 15 ml of 0.2N NaOH with 1 % 
SDS was added and the tubes were gently inverted for 1 min. Then they were left 
for a further 10 mins, on ice. Vigorous sharp jerks were administered to the tubes 
upon addition of 12 ml of 5M sodium acetate (pH4.8), which were again left on ice 
for 10 mins. The tubes were then centrifuged at 39,000g at 4° C for 30 mins. The 
supernatant was isopropanol precipitated, the supernatant was discarded and the 
pellet was dried by inverting on a tissue for 30 mins. It was then resuspended at 37° 
C in 31 mis TE buffer. After the presence of plasmid DNA was confirmed by 
running some of the sample on a minigel, density gradient centrifugation was 
carried out.
2.8.3. Density Gradient Centrifugation.
The volume of the sample was measured and 1.05g caesium chloride was 
added per ml of sample. 50 pi ethidium bromide (10 mg/ml) was added. This 
mixture was pipetted into a centrifuge tube (Beckman T0S3OE), weighed and 
balanced with another tube. The tubes were heat sealed and spun at 55,000g for 18 
hours.
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The plasmid band was visualised by using a UV transilluminator. A sterile 
needle was used as a vent while another needle and a syringe facilitated the removal 
of the band. One volume of TE saturated with butan-l-ol (1:1) was repeatedly 
added, shaken and the solvent phase removed until the lower phase was clear. The 
remaining volume was measured and mixed with two volumes of water and six 
volumes o f ice-cold ethanol. This was placed at -20° C overnight, the solution was 
centrifuged at 39,000g and 4° C for IS mins. The ethanol was discarded and the 
tube vacuum desiccated to dryness. The DNA was then resuspended in an 
appropriate volume of TE buffer.
2.8.4. Large Scale Isolation of Plasmid DNA from Streptomycetes.
500 ml of S.lividans TK24 containing either pU673 or pU680 was grown for 
2-3 days in shake flasks of TSB supplemented with ampicillin (35 pg/m l) were spun 
down at 4,000g for 20 mins. These were resuspended in 5ml of lysozyme solution 
and incubated for 30 mins, at 37° C. The cells were gently mixed and 2.5 ml 
alkaline SDS solution added. This was thoroughly mixed by pipetting up and down, 
incubated for 20 mins, at 700 C with slightly unscrewed caps and then cooled to 
room temperature. Phenol chloroform (acid) extraction was then carried out on the 
sample followed by isopropanol precipitation and caesium chloride centrifugation.
2.8.5. Isolation of Streptormces " Total" DNA.
Streptomycete spore suspensions (200 pi) were inoculated into YEME, 
supplemented with 3% glycine. After 2-3 days the mycelium was harvested by 
filtration using a Buchner filter, through two sheets of Whatman No 1 filter paper. 
The mycelium was washed with 10% glycerol and stored as a paste at - 20° C.
50 mg of mycelium was resuspended in 500 pi lysozyme solution and 
incubated at 37° C for 30 mins, in an eppendorf tube. Then 250ul 2% SDS was 
added and the solution vortexed for 1 min. This solution was then extracted with 
neutral phenol-chloroform and isopropanol precipitated.
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2.8.6. Phenol Extraction
An equal volume of neutral phenol-chloroform was added to the sample. The 
solution was vortexed for 1 min. and centrifuged at 20,000g for 15 mins. The upper 
phase was transferred to another container leaving the white interface behind. This 
was repeated until no interface was seen. Then half the volume of chloroform : iso­
amyl-alcohol (25 : 1) was added and the solution was again vortexed for 1 min, but 
centrifuged at 20,000g for 2 mins.
2.8.7. Quantitation of DNA
Readings were taken at 260 nm and 280 nm. An OE>260 of 1 was taken to 
be equivalent to 50 pg/m l DNA and an OD260/OD280 ratio 1-8 taken to be pure 
DNA.
2.8.8. Restriction Endonuclease Digestion of DNA
Ingredients Volume(pl)
10 x Enzyme buffer 2.0
DNA in TE buffer 2.0
Restriction endonuclease 2.0
Sterile distilled water to 20.0
The above mixture was incubated at 37° C for 1-3 hours. Double digests were made 
up as above, but made up to 19 pi. They were incubated for an appropriate time and 
then 2 p i o f the second enzyme was added and the incubation was continued for 
another 1-3 hours.
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2.8.9. Dot Blots,
Streptomyces chromosomal DNA was denatured by adding an equal volume 
of denaturing solution and incubated at room temperature for 10 mins. The reaction 
was neutralized with four volumes of 0.5M  HC1, O.SM Tris (pH 7.4) and 1.5M 
NaCl, 20 x SSC, mixed together as a 1:1:2 ratio.
Hybond nylon filters were prewetted in 10 x SSC and placed in a 
commercial dot blotting apparatus (Hybri-Dot Manifold-1050MM. Bethesda 
Research Laboratories, Life technologies Incorporated PO Box 6009, Gaithersberg, 
MD 20877 U.S.A). Samples, containing 1 pg DNA were ejected rapidly into the 
sample wells and transferred under vacuum onto the nylon filter. The filter was 
removed from the manifold and dried. The DNA was fixed by UV cross-linking on 
a longwave transilluminator for 4 mins. Filters were heat sealed in plastic bags until 
use.
2.8.12. Aparose Gel Electrophoresis.
A 1% agarose solution was prepared by boiling in 1 x TBE. Ethidium 
bromide was added to make a final concentration of 0.5 pg/m l. The cooled agarose 
was then poured into the gel apparatus( BRL minigel 1060 or BRL 1087 model H5); 
this having been prepared by taping the ends and inserting a comb to make the 
wells. The set gel was submerged in TBE and DNA samples containing 0.2 volumes 
of loading buffer were injected into the wells. Electrophoresis was carried out at 
75V for 3 hours or at 20V overnight. Restriction digested lambda bacteriophage 
DNA was used as molecular weight markers of 23.31, 9.416, 6.557,4.361, 2.322, 
2.027, 0.564 and 0.125Kb. (Hopwood el a l., 1985)
2.8.13 Ethanol Precipitation.
DNA was precipitated by mixing with 0.1 volume of 3M sodium acetate and 
2 volumes of ice cold ethanol. After chilling for 3 hours at -20° C the precipitate
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was centrifuged at 14,000g for IS mins., washed in ice cold 70% ethanol and 
recentrifuged at 14,000g for a further S mins. The DNA pellet was dried under 
vacuum and resuspended in TE buffer.
2.8.14. Isopropanol Precipitation.
One tenth of a volume of 3M sodium acetate (pH4.8) was added and mixed 
into the sample, followed by 1 volume of isopropanol. This was incubated at room 
temperature for S-1S mins and then spun at lS,000g for 2 mins. The supernatant 
was discarded and the pellet dried. The DNA pellet was then resuspended in an 
appropriate volume of TE buffer.
2.8.15. Electroelution.
The required band was excised from an agarose gel using a sharp scalpel, 
having been visualised under long wave ultra-violet light (300-360 nm) to avoid 
damage to the DNA. The band was placed in a well in the IBA electroeluter with 
TBE with the valve in the "up-position”. The channels were filled with 7.SM 
ammonium acetate, using a syringe and making sure that there were no air bubbles. 
The apparatus was run at 100V for 20 mins. The absence of the DNA from the 
band of agarose was checked under the transilluminator. The ammonium acetate and 
DNA was removed from the appropriate channel using a needle and syringe and 
placed in an eppendorf. The DNA was then precipitated in 2 volumes o f ice cold 
ethanol for 3 hours at -20° C. The precipitate was centrifuged at 10K for IS mins., 
washed in 70% ethanol and recentrifuged at 10K for a further S mins. The DNA 
pellet was then dried under vacuum and resuspended in 10 /*1 TE buffer. 3 n1 was 
then run on an agarose gel to check for the presence of the DNA.
2.8.16. Prehybridization.
Filters were sandwiched between layers of nylon mesh (no more than 4 
filters per stack). Any air bubbles between the layers were removed and the stack
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was rolled up and placed in a Hybaid tube, along with a small amount of 2 x SSC 
The roll was unravelled until it stuck to the walls of the tube. Any air bubbles 
between the wall and the filters were removed. The liquid in the tube was 
exchanged for 15 ml prehybridization solution. The sealed tube was placed in the 
Hybaid Oven overnight at 70° C.
2.8.17. Preparation of the Probe.
Random primed labelling was carried out using the following mixture.
Ingredients H1
Probe DNA 
(preboiled for 10 mins)
5.0
dATP 1.0
dTTP 1.0
dCTP 1.0
Reaction Buffer 2.0
Sterile distiled water 7.0
Klenow 1.0
dCT32P 2.0
Ingredients were added in the order shown to keep handling o f the 
radioactive nucleotide to a minimum. During the preparation the mixture was kept 
on ice. Following addition of dCT32P the mixture was incubated at 30° C for 30 
mins. The reaction was quenched using 160 ul TE buffer containing 0.1% SDS.
2.8.18. Removal of Unincorporated Nucleotides.
A Sephadex 050 column was prepared in a 150 mm Pasteur pipette with a 
glass wool filter. The 180 pi reaction mixture was run through the column, using 
180 pi amounts of TE buffer with 0.1% SDS to wash it through. Each 180 ul
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elution was collected in an eppendorf. The first peak was incorporated DNA and 
could be followed down the column using a giegercounter. Eluent was collected up 
to the beginning of the second peak (unincorporated nucleotide). Samples belonging 
to the first peak were pooled and used in the hybridization reaction.
2.8.19. Hybridization.
The radioactively labelled DNA was boiled for 10 mins, with 500 ul salmon 
sperm DNA (10 mg/ml) and then snap cooled on ice. 10/tl of this was removed for 
Cherenkov counting. The rest was added to the prehybridized filters after 10 ml of 
prehybridization solution had been removed, leaving 5 ml for the hybridization 
reaction. Hybridization was at 70° C overnight in the Hybaid oven.
2.8.20. Stringency.
For the purposes o f dot blotting filters were washed twice for 30 mins., in a 
volume o f 50 ml, at each of three levels of stringency. These were 3 x SSC and 
0.1% SDS, 1 x SSC and 0.1% SDS and 0.2 x SSC and 0.1% SDS, all at 70° C. 
Autoradiography was carried out at each stringency. For southern blotting filters 
were washed twice for 30 mins, in 2 x SSC; 0.1% SDS and twice for 30 mins in 
0.2 x SSC; 0.1% SDS, again at 700 C. Autoradiography was carried out after the 
highest stringency wash.
2.8.21 Cerenkov Counting.
This was carried out in a Beckman LS700 scintillation counter, using 
program 10 (1 min.). 10 /*1 radioactive sample in an eppendorf tube was placed 
inside a scintillation vial. Disintegrations per min., per 700 til sample were 
calculated. This was multiplied by 2.5 to approximate to Cerenkov counts per min.
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2.8.22. Detection of Radioactivity.
Depending on the specific activity of each probe varying times of exposure 
were used, but in general these were one week after the first wash, two weeks after 
the second and four weeks after the third. For autoradiography, X-ray film (Fuji X- 
Ray) was exposed to hot filters in Harmer autoradiography cassettes containing 
intensifying screens. The time of exposure was variable. X-ray film was developed 
by placing in developing solution (Kodak LX-24) for S mins, and washing in water. 
The developed film was fixed (Kodak FX-40) for 5 mins, and rinsed in water again. 
Alternatively a Beta-Scope (Betagen, 100 Beauer Street, Walton, MA 02154, 
U.S.A) or Phosphorimager (Molecular Dynamics Ltd., 4, Chaucer Buisiness Park, 
Kemsina, Sevenoaks, Kent, TN15 6PL, U.K.) were used and so exposure times 
were greatly reduced by direct counting. Positive hybridizations were scored on 
filters where the negative controls did not hybridize and positive controls (1 ng 
DNA from the plasmid containing the gene and 1 ¡ig DNA from the source 
organism).
2.9. Cluster Analysis. fFig.2.U.
Data was stored in Foxbase (Fox Software Inc., 118 W.South Boundary, 
Perrysberg, Ohio, 43551.) and in Paradox Relational Database version 3.5 (Borland 
International, 1800, Greenhills Road, PO Box 660001, Scotts Valley CA 95067- 
0001). Data matrices, taken from the database provided input for NTSYS-pc 
(Exeter Publishing, Ltd, 100 North Country Road, Building B, Setauket, New York 
11733), where either the SIMINT (interval data) or SIMQUAL (binary data) 
programs were used to give similarity and dissimilarity matrices. In SIMINT either 
the Manhatten distance (Lance and Williams, 1967) or euclidean distances were 
calculated, whilst the simple matching coefficient (Sokal and Michener, 1958), 
Jaccard's coefficient (Jaccard, 1908) and the Dice coefficient (Dice, 1945) were 
used in SIMQUAL.
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Hierarchical clustering was performed in SAHN, using algorithms for Single 
Linkage (Florek et al., 1951a and b), Complete Linkage (Lance and Williams, 
1967b) and the Unweighted Pair Group Method with Arithmetic Averages (Sokal 
and Michener, 1958). Graphics hardcopy of phenograms were provided by the 
treeG program. Cophenetic matrices were obtained using COPH and cophenetic 
correlations with MXCOMP and MXCOMPG. Multivariate analysis in the form of 
principle components analysis (PCA) was performed either by using MACSPIN on 
an Apple Mackintosh or by using the EIGEN and PROJ programs in NTSYS. 
MXPLOT and MXPLOTG were used to obtain plots of the data.
Clusters were defined by eye when PCA was used, however special purpose 
computer program was used in conjunction with hierarchical clustering (PI, Fig. 2). 
The PI program was able to list all alternative similarity levels, at which clusters 
could be defined. After the computer operator had chosen one of these levels the 
relevant clusters of strains were defined and the strains in each group listed. A 
second program (P2) established the percentage of strains in each group with 
various characters from the original data matrix. These were then listed in 
descending order within each cluster. Each possible position for a character was 
given a value, which increased the further a value was from the central row of the 
table. All values for a given character were added to give a final score. High final 
scores, corresponding with high standard deviations were regarded as good 
distinguishing characters and of value for numerical taxonomy. In order that 
correlations between different data sets could be established (for example, do 
clusters based on antibiotic resistances correlate with bioactivity?) a third program 
(P3) was written. The percentage of strains in each group, as defined by P I, with 
any type of data stored in the database(s) could be calculated. A fourth program 
(PO) was designed to run within paradox. This used Ssm in SIMQUAL and 
UPGMA from SAHN as defaults and automatically fed into PI and P2.
Computer programs were written by G Barry Joyce and Steve Green sides 
(Department of Mathematics, University of Warwick).
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Fie. 2.2. Summary of data handling procedures used in this re s^ rrh
The diagram shows the stages used when carrying out both heirarchical 
clustering and ordination. PO, P I, P2 and P3 refer to special purpose programs, 
which were written by Greg King, Barry Joyce and Steve Green sides.
Two databases (Paradox and Foxbase) were used, whilst NTSYS was used 
for cluster analysis and special purpose programs allowed some additional 
datahandling.
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Chapter 3.
The Distribution and Expression o f Antibiotic Production in Natural Streptomvces 
Isolates.
3.1. Introduction.
Streptomycetes are usually cultivated in nutritionally rich media and 
antibiotic production normally begins when the culture conditions become limiting 
(Hutter, 1982); this shows that antibiotic biosynthesis is regulated. The major 
factors involved in the control of secondary metabolism are carbon and nitrogen 
catabolites, phosphorus, inorganic salts, trace metals (Vanek and Mikulik, 1978; 
Martin and Demain, 1980; Iwai and Omura, 1981) and other bioregulators, such as 
A-factor (Beppu, 1985; Horinouchi and Beppu, 1986). Cultural conditions such as 
oxygen tension (Yegneswaran et al., 1988) are also known to be important 
influences on the biosynthesis of bioactive metabolites.
Carbon catabolite regulation inhibits the synthesis or activity of enzymes 
involved in antibiotic production (Katz et al., 1984; Jones, 1985). A variety of 
carbon sources gives rise to catabolite repression including glucose (Belousova et 
al., 1985; Behai, 1985; James and Edwards, 1988) plus glycerol and sucrose 
(Sanchez, 1984; Demain, 1985). Similarly, nitrogen catabolites have been shown to 
inhibit enzymes which are important for secondary metabolism (Katz et al., 1984); 
for example, rapidly utilized nitrogen sources such as nitrogen, ammonium and 
amino acids inhibit the production o f a variety of antibiotics (Sanchez et al. , 1984; 
Omura, 1984a and b; Demain, 1985). Many idiolites are produced at sub-optimal 
phosphorus concentrations (Demain, 1985) and this is due to the control of either 
phosphatase enzymes (Iwai and Omura, 1981, Muller and Ozegowsld, 1985) or 
antibiotic synthases (Hotter, 1982).
One aim of the research presented in this thesis was to investigate the 
distribution of antibiotic production in natural Streptomyces isolates and to discover 
phenotypic and genotypic characters which correlated with it. Bioactivity was
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measured for the strains concerned by use of a variety of complex and defined 
media, extraction procedures and screens (Sections 2.3.1 - 2.3.4.). However, the 
proposed study was limited by the screening methods used and the literature 
indicated that unconventional media often yielded interesting observations about 
antibiotic production. Imanaka and co-workers (Arima et al., 1963; Miyairi et al., 
1970; Miyoshi et al, 1972) discovered new antibiotics on high phosphate media and 
high glucose concentrations have been shown to favour the production o f some 
antibiotics (Boeck et al., 1971). A smaller study, which involved testing the 
expression of antibiotic production with fewer strains, but under a wider set of 
conditions enabled the larger bioactivity study to be assessed in an objective manner 
(Section 3.3).
Results
3.2. Bioactivitv as Measured Under Standard Conditions.
Anti-B.subtilis and anti-A.niger bioautograms were used to measure 
antibacterial and antifungal activity and this was supplemented with data from in 
vivo agrochemical screens, which measured activity against a wide range of 
organisms. Typical activity spectra for nucleoside, polyether, nonactin and 
cycloheximide producers were detected on the in vivo screens, whilst nigericin, 
geldanamycin and herbimycins A and C were detected using TLC. An example of 
an antibacterial bioautogram is shown in Fig. 3.1.
3.2.1. Antibacterial Activities.
Twenty-three strains showed activities against B.subtilis (Fig. 3.2.), which 
were not due to any of the specific compounds tested for. Eight of these strains 
were replicated, but, although each replicate was bioactive, the antibiotic profiles 
were variable, suggesting that the range of substances with biological activity for 
some producers might be diverse.
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Fig 3.1. Example of an antibacterial bioautogram.
The diagram shows a bioassay dish, containing a base layer of nutrient agar, onto 
which a TLC plate, containing extracts from streptomycetes was inverted for 30 
mins. This was then removed and the base layer was overlayed with nutrient agar 
seeded with B.subtilis. The plate was photographed after overnight growth at 28°C 
and shows zones of clearing where antibacterial compounds have diffused from the 
TLC plate onto the bioautogram.
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ANTIBACTERIAL
Fig. 3.2. Summary of activity against B.subtiUs, which was shown by various 
streptomycete strains during this research.
The diagram represents a stylized thin layer chromatography plate. Each strain has 
been given a symbol, which is positioned at Rf values where the extract from the 
relevant strain gave an antibacterial zone on a bioautogram. Sometimes several 
zones were merged and this is represented on the diagram by an adjoining line. 
Certain strain labels are followed by R1 or R2 and this indicates that the strain was 
replicated.
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C90C10BR
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C106 R2 C1O0 R3C106 R4 
C10Q 
C208 
E8 E31 and E33E100 F13S R1 F13B R2
Standard conditions were used throughout this work, except for a variable inoculum 
density (a loopful of spores) which may have caused changes in the rates of 
substrate utilization and oxygen demand and may have had an adverse effect on 
antibiotic production. Factors which affect the reproducibility of TLC are 
in Chapter S.
3.2.2. Antifungal Activities.
Of eight strains which were active against A.niger (Fig 3.3), four produced 
compounds that were possibly novel antibiotics. Three others belonged to the MM 
series of isolates, which were not assessed on agrochemical screens. However, they 
showed additional activity against S.endus (091) during plug assays, which were 
part of a series of tests aimed at distinguishing between duplicate strains within the 
MM and W series isolates (data not shown). The remaining strain was a nonactin 
producer (C208).
Apart from MM44.2, strains which showed antifungal activity were also 
active against B.subtilis (Fig 3.2.), however different solvent systems were used for 
the different types of bioautogram, so it is difficult to comment on whether this was 
caused by the same compounds. Strains E35 and E100 appeared to have identical 
bioactivities because they gave the same profile on both types of bioautogram, but 
their profiles on agrochemical screens differed. F139 (R2) and E8 also appeared 
similar, although F I39 produced geldanamycin and nigericin, whilst E8 did not.
All strains with antifungal activity (apart from C208) were identified by 
SEM as S.violaceoniger (C32) strains. This species group contains many strains 
which produce bioactive secondary metabolites (Arai et at., 1976) and includes the 
S.hygroscopicus sub-species group, whose products have frequently been patented 
as novel antibiotics (DeBoer et al., 1970; Iwai et at., 1980). Strains of 
S.hygroscopicus autolyse during short term storage and it was noted that F139 and 
E3S
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Fig. 3.3. Summary of strains showing activity against Aspergillus niger.
The diagram is a stylized bioautogram, showing the Rf values at which specific 
strains showed antifungal activity. Each strain has been given a symbol, which ii 
positioned at the Rf value corresponding to the centre of the zone o f clearing. 
Sometimes zones were merged and this is indicated by an adjoining line. Strain 
names are sometimes followed by R1 or R2 and this indicates that they have been 
replicated. E35 and E100 gave a similar profile and are represented by the same 
symbol.
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also possessed this trait.
3.2.3. Specific Biological Activities.
Table 3.1 shows profiles of the natural isolates in which bioactivity was 
confirmed. Many of these strains were used in other work in this thesis and are 
therefore marked with a superscript to indicate which strain was present in which 
study. All strains were used in Chapter 5 for chemical profiles and so the 
superscript identifying these strains has been omitted. Strains marked4 were used in 
Chapter 4 for fatty acid analysis, strains denoted^ were used in Chapter 6 for 
Resistance work and strains indicated by^ were used in Chapter 7 for gene probing.
3.2.4. Agrochemical Activities.
A large number of strains were given to ICI when the original isolation work 
was done, including most of the random subset of strains chosen for this work. ICI 
provided summaries of agrochemical activities for all of the strains they had been 
given, enabling bioactivity in many of the strains presented in Table 3.1. to be 
confirmed and indicating additional bioactive strains (also placed in Table 3.1.). 
Additional strains (C47, D l, E92, E33, F150) which produced compounds that 
might be novel were selected from the larger culture collection and were used to 
confirm trends observed during this research.
C47 was later confirmed to produce cycloheximide and borrelidin and Dl 
produced nigericin and nonactin. In addition to their novel activities E92 produced 
nigericin and geldanamycin, and E33 and F150 produced nigericin. E92, E33 and 
F139 were thought to produce the same new compound, whilst E33 (Table 3.1.) 
produced 2-deoxycytosine in addition to the profile shown.
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Table 3.1. Bioactive Streotormces isolates discovered and used during this researrh
Strain
Geld
Type of Activity 
Nig HA H
Detected 
C Cyc Act Nuc Ab Af
A1067 - + - - - - . . •
A14 - - - - - - - + -
A4646 - + - - - - - - -
A 73-67 - - - - - - - + -
C3 - - - - - - - + -
C284 - - - - ? - ? - -
C3867 - + - - - - • - .
C7045 - - - - - - - + -
C77456 - - - - - - - + -
C90 - + - - - - - - -
C10846 - - - - - - - + -
C10946 - - - - - - - + -
C20846 - - - - - + - - -
C2224 - - - - - - - + -
C3144 - - - - - - - + -
C337 - - - - - - - + -
C3386 - + - - - - - - -
C40267 - - + + - - - - -
D567 - - + + - - - - .
D1256 - + - - - - . . .
D153467 + + - - - . . . •
E l4«7 - + - . . . . . •
E8467 - - - - - - . + +
E31467 - + - - - . . + .
E33467 + + • • . • • + +
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Strain
Geld
Type of Activity Detected 
Nig HA HC Cyc Act Nuc Ab Af
E100467 + + • _ + +
F5367 - ? - ? - ? - -
F139467 + + - - - - + +
RB2596 - + - - - - - -
RB2866 - + - - - - - -
MM44.26 + + - - - - + +
MM58.267 + + - - - - + +
MM82.267 + + - - - - + +
2813 + + - - - - - -
2817467 + + - - - - . .
2818467 + + - - - - - -
Kev to Table 3.1.
+  — Present 
- =  Absent
? =  one of the compounds marked by ? can be produced by the relevant strain but 
which one has not been confirmed.
Geld — Geldanamycin Act ■ Nonactin
Nig *  Nigericin Nuc ■ Nucleoside
HA — Herbimycin A Ab — Antibacterial
HC “  Herbimycin C 
Cyc -  Cycloheximide
Af — Antifungal
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3.3. Factors Affecting the Expression of Bioactivity.
A selection of streptomycetes which produced different combinations of 
nigericin, geldanamycin and other activities were chosen to investigate the 
expression of these antibiotics in a more detailed manner. These were A10, A46, 
C38, C338, C402, D5 , D125, D153, E l, E31, E35, E100, F139, 2813, 2818, 
MM44.2, MM58.2, MM82.2, RB259, NR3602. The strains were streaked across 
carbon, nitrogen and phosphorus gradients and examined for changes in 
differentiation and antibiotic production.
3.3.1. Choice of Medium.
The original bioactivity data (excluding that done at ICI) were generated on 
a complex medium (A37), but in order to examine the effects of various media 
components on the secondary metabolism of the strains, it was necessary to rind a 
defined medium on which antibiotic production could occur. The liquid form o f the 
medium was used in antibiotic production timecourses, which could also be related 
to alterations of fatty acids in the culture (Chapter 4), whilst the solid form was 
used for nutrient gradients.
Table 3.2 shows how different media initiated differences in the expression 
of antibiotic production. The three strains gave similar profiles, apart from F139, 
which did not produce geldanamycin on R2 and which did not grow on either R" or 
S ' media. Geldanamycin production was only observed on media, which contained 
trace elements (eg. ISP7). Production of both antibiotics was also greatly enhanced 
on ISP7 and so this medium was chosen for work on the expression and repression 
of antibiotic production in the above sub-set o f strains.
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Table 3.2. The expression of geldanamvcin and nigericin production on different 
media.
Medium Growth 
F139 D153 E100
Antibiotic Production 
F139 D133 E100
R2 + + + G G
R2- - + + G G
S + + + - -
S- - + + - -
ISP7 + + + G +N *G +N *G +N *
MSG + + + N N N
* =  Large amounts of metabolites 
- =* Absent 
+  — Present 
N =  Nigericin production 
G = Geldanamycin production 
R2 — R2 medium
R2- — R2 medium without casaminoacids.
S »  Sautons medium
S- “  Sautons medium without casein hydrolysate 
MSG -  Mineral salts and glucose
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3.3.2. Effects o f  Nutrient Gradients on Differentiation,
Tables 3.3. and 3.4 summarize observations made about the differentiation 
responses observed within geldanamycin and nigericin producers when they were 
grown on nutrient gradients. Plating out was in triplicate and the positions of one 
strain relative to the others was changed for each replication in order to minimize 
the effect o f temperature and oxygen gradients and to prevent any diffusible 
products from one strain affecting another more than once. Plates with strains 
grown only on ISP7 were used as a comparison, but the results were not judged 
relative to this medium since the carbon and nitrogen sources had been altered.
The trends summarized in Table 3.3 and 3.4 were first observed after 3 days 
and remained stable throughout the experiment (14 days), apart from those seen on 
the sucrose gradients which disappeared with time. Mycelium progressed through 
the streptomycete lifecycle at a different rate depending on its position along the 
gradient and some strains remained immature for 2 weeks at specific positions on 
the gradients.
Ten strains were affected by Pi gradients and most had differentiated 
mycelium from mid-plate to the highest concentrations, which were above the 
normal phosphorus concentration of ISP7 (i.e. 0 .3  g/1).
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KEY to Tables 3.3  and 3.4
The tables illustrate where fully differentiated mycelia were observed 
amongst the strains and gradients studied. The figures given refer to the position of 
sporulating mycelia along the gradient, unless a superscript has been given. a 
indicates that aerial mycelium was present over the range given and v indicates that 
only substrate mycelium was present. - denotes that the mycelium was at the same 
stage of development along the whole gradient.
The nutrients are expressed in grams per litre on these tables. These 
values were extrapolated from measurements of distance along gradient plates.
115
Table 3,3. Summary of the effects of nitrogen and phosphorus gradients on
differentiation.
Strain Pi Tyrosine NaN0 3 Asparagine
D5 5.5-10 _v 0 -2.6 0-1.8
C402 6-10 .V 0-2.5 0-0.8
2818 .a 0 -1.2* 0-3* 2.3-4*
2813 6-10* _v _v 2.8-4*
MM82.2 7-10* 1-2.4* 0-1.6* 2-4*
MM58.2 0-7.5* .V 0-2.4* .a
MM44.2 7.5-9.5* _v 2.6-4» 0-1
D153 - 2.4-4* 0-2.4 0 -2*
A10 .a .V 0-2.2 _v
A46 .V 0-1.8* _v .V
D123 - .a - .V
C38 - 0 -1.2 - 0-2
C338 3-10 .a - 2-4
RB259 .V 0-1.4 0-2.4 0 .8-1.8
3.6-4
El 5-10 - 1.2-4 0-1
2-4
E31 -a .a 0-2.4 0-2
E35 .a 2.8-4 0-2.8 0 -1.6
E100 6-10 2.2-4* 0-2.8 0 -1.6
2.4-4
F139 3-10 0-1.4* 2.8-4 0 -1.2
2.4-4
116
Table 3.4. Summary o f  the effects o f  carbon source gradients on differentiation
Strain Glucose Sucrose Glycerol
D5 0-10.5 - 0-8
C402 0-10 - 0-5
2818 0-14 0-6* .a
2813 0-10 0 -12* 0-4*
MM82.2 0-12 0 -8* 0-13.3
MM58.2 - 0-4* -
MM44.2 0-10 - 0-10
D153 0-10 - -
A10 0-8.5 .a 0-10
A46 0-7.5 0-8* 0-10
D125 0-9 - -
C38 0-5.3 - 0-9
C338 0-10 - -
RB259 0-10 0-8 -
E l 0-5 - .a
E31 0-6 0-16 -
E35 13-20 - 0-8
E100 0-8 - 0-8
F139 12-20 - .a
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When carbon source gradients exhibited an effect, differentiation was usually 
most advanced at concentrations below IS g/1, whereas higher concentrations 
seemed to inhibit morphological differentiation. Strains E3S and F139 had immature 
mycelia at concentrations below 12 g/1 on glucose, and the mature forms occurred 
up to the most concentrated point on the gradient. Depending on the strain, high and 
low concentrations of the nitrogen sources could encourage differentiation, although 
low to mid levels were predominant and asparagine sometimes encouraged 
differentiation at two separate ranges of concentrations within a single replicate 
strain. E100 caused some adjacent strains (E31, E35 and 2813) to mimic its 
differentiation pattern on the nitrogen gradients (not shown in Table 3.3), but this 
was not observed when these organisms were grown on plates without E100, 
suggesting that a diffusible substance was responsible. All strains affected were 
thought to belong to the S.violaceoniger species group, suggesting an intra-species 
regulator. There are many examples of inter-species (Landau et al., 1984; Barabas 
and Szabo, 1977) and strain-specific effectors, including both antibiotic and non­
antibiotic substances (Beppu, 1983; Pogell, 1984; Horinouchi and Beppu, 1986; 
Chater et al. , 1989).
1 3 .3 . The Effects of Nutrient Gradients on Antibiotic Production in a Selection of 
Streptomvcetes.
A smaller selection of isolates, which had varied bioactivity spectra were 
selected to examine how nutrient gradients affected the production of antibacterial 
(Tables 3.3. and 3.6) and antifungal compounds (Tables 3 .7  and 3.8). A herbimycin 
producer was not selected because no simple assay procedure was available for 
detecting the compound directly on agar plates.
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Table 3.5. Antifungal activity on nitrogen gradients.
Strain Tyrosine
Nutrient g/1 
NaNOs Asparagine
C338 NA 0 -0.2 NA
D153 CA CA CA+
MM82.2 0-1.2 - CA*
+<U
E100 O > + CA 0-3.4*
D125 NA NA NA
F139 0.4-3.8" CA
+<U
Table 3.6. Antifungal activity on carbon source gradients.
Strain Glucose
Nutrient g/1 
Sucrose Glycerol
C338 NA NA NA
D153 8-20 NA 9-20
MM82.2 0-8 0-14- 0-18-
E100 0-16m NA 5-13m
D125 NA NA NA
F139 12-20 NA 10-20
Key to Tables 3.5. and 3.6.
NA -  No activity.
CA *  Activity over total gradient length.
+  ”  Larger zone diameter at higher nutrient level.
* -  Larger zone diameter at lower nutrient level 
m “  Larger zone diameter in the centre of the range.
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Table 3.7. Antibacterial activity on nitrogen gradients.
Strain Tyrosine
Nutrient g/1 
NaN0 3 Asparagine
C338 CA 0-3' 2.S-3.2
3.6-4.0
D153 CA' CA' CA
MM82.2 0 -2.2 0-3.4+ 0-2
E100 0-3.2- CA+ 0-2 .6 '
D123 NA NA NA
F139
i 
! 
•<u 
[
CA NA
Table 3.8. Antibacterial activity on carbon source gradients
Strain Glucose
Nutrient g/1 
Sucrose Glycerol
C338 NA NA CA
D153 6-13+ NA CA+
MM82.2 CA NA CA'
E100 10-20+ NA 5-20+
D12S NA NA NA
F139 NA NA CA+
Kev to Tables 3.7. and 3.8.
NA -  No activity.
CA — Activity over total gradient length.
+  “  Larger zone diameter at higher nutrient level. 
'  -  Larger zone diameter at lower nutrient level
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Even when strains were thought to produce the same compounds, nutrient 
gradients affected antibiotic production in a strain-specific manner. For example, 
two strains were thought to produce nigericin as a single product and because this 
compound has both antibacterial and antifungal activity, such a strain might be 
expected to show the same trends on both type of assay. However, C338 showed 
correlating antibacterial and antifungal activity only on very low levels of NaN0 3 > 
Antibacterial activity without antifungal activity was observed on glycerol, 
asparagine and tyrosine gradients, suggesting that this strain might be capable of 
producing an additional compound. No antibiosis was detected for D125, indicating 
that the conditions required for antibiotic production in this strain had not been met.
MM82.2 and D133 were previously (Table 3.1.) reported to produce 
nigericin and geldanamycin, but they gave different responses on some gradients. 
C338 produced an antifungal compound, which inhibited A.niger at low sucrose 
concentrations, but there was no corresponding antibacterial activity, suggesting that 
a different antibiotic was being produced. Wherever C338 or D133 showed 
corresponding antifungal and antibacterial activity, it overlapped rather than was 
exactly equivalent. Interestingly, bioautography of D133 grown in ISP7 later 
showed three additional antifungal zones, which were not due to nigericin.
F139 and E100 had already been shown to produce additional antibacterial 
and antifungal activities to geldanamycin and nigericin. The results from this study 
confirmed the additional antifungal activity in both cases, although geldanamycin 
could not be distinguished from any other antibacterial activity by this assay.
3.4. The Characterization of Antibiotic Production in D133.
3.4.1. Timecourses.
Timecourses of D133 cultures showed the onset of geldanamycin production 
at 82-106 hrs (82-94 hrs., rep. 2; 94-106 hrs.,rep. 1) and of nigericin biosynthesis 
at 106 hours (Fig.3.4). The intensity of both types of bands became progressively
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Fig. 3.4. Timecourse of geldaiuunycin production by D153.
The photograph illustrates the results of an experiment, which determined the 
profile of geldanamycin production on ISP7 medium (28°C; 200 rpm) over a period 
of 6 days.
Geldanamycin can be recognized by comparing the pure antibiotic with 
corresponding bands within the strain extracts.
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Fig. 3.4. Timecourse o f geldanamycin production by D153.
The photograph illustrates the results of an experiment, which determined the 
profile o f geldanamycin production on ISP7 medium (28°C; 200 rpm) over a period 
of 6  days.
Geldanamycin can be recognized by comparing the pure antibiotic with 
corresponding bands within the strain extracts.
122
4 ¡3 ¿8 70 82 9U 166 lte 1±9 1 2^
TIME
HOURS
GELDANAMYCIN
STANDARD
stronger with time. This information was used to design an experiment which would 
investigate the impact of reduced % O2 on antibiotic production in this strain.
3.4.2. Repression of Nigericin Biosynthesis.
Nigericin can prevent the discovery of narrow spectrum compounds on 
agrochemical screens because it has a very potent broad spectrum of activity and 
can therefore mask the presence of narrow spectrum compounds within the same 
extract. Certain strains (eg. A10, A46, C90, D72) only produced nigericin on solid, 
but not in liquid media, whilst other strains (eg E l, E31, E33) produced higher 
levels of this compound on solid media (Data supplied by ICI). It was o f interest to 
try to discover the reason for this and differences in oxygenation were hypothesized 
as a possible cause. The cultures were treated as described in section 2.4.3. and the 
atmosphere inside the flasks was altered at 76 hrs, because this was assumed to be 
prior to the onset of antibiotic production.
Geldanamycin biosynthesis in D153 was unaffected by the experimental 
conditions and the onset of production in the batch culture control was similar to 
that in the previous timecourse (section 3.4.1). However, nigericin was not 
observed in any of the cultures grown in reduced atmospheres of oxygen, whilst the 
subasealed control cultures were delayed in the onset of biosynthesis. However, 
nigericin production occurred earlier than previously observed in the 2 1 % O2 
control, and presumably more O2 was present here than in flasks which were 
subasealed without disturbing the internal atmosphere.
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Table 3.9. The effect of oxygen on geldanamvcin and nigericin production in D153.
Onset of Antibiotic Production (hrs)
%02 Nigericin Geldanamycin
0 absent present at 94
5 absent present at 94
10 absent present at 94
15 absent present at 94
Controls
Normal atmosphere 94 76 to 94
Normal atmosphere 94 present at 94
2 1 * 0 2 *94/103 present at 94
Subasealed 1117/129 present at 94
Key to superscript
1 refers to the first instance at which production was detected within each duplicate. 
3.5. Discussion
3.5.1. The Distribution of Antibiotic Production in Streptomvces Isolates.
The compound found most frequently in natural Streptomyces isolates was 
the ionophoric polyether nigericin. This compound perturbs ion gradients across cell 
membranes by complexing specific cations (eg. Na+ ) and encasing them in an 
ampiphilic shell, which can then passively diffuse through membranes. There is 
evidence that some polyethers carry out specific functions for their producers, 
therefore the high incidence of producers might relate to nigericin serving a  useful 
function in Streptomyces. Lasalocid and monensin are closely related to nigericin 
and have been shown to bind to spore surfaces in a manner similar to the 
germination inhibitor of S. viridochromogenes (Grafe et al., 1986; Ensign, 1976).
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Interestingly, these compounds are often found in streptomycete extracts from solid 
surface cultures (J. Benner, personal communication). Other evidence for the 
natural role of polyethers has been presented by Williams et al. (1989a) who argue 
that the highly sophisticated receptor-antibiotic complementarity, as seen for 
example in the lasalocid-Barium complex, implies active evolution towards a 
survival strategy. Grabley et al. (1990) provided similar evidence for nigericin, in 
that the antiviral and antibacterial properties and the binding of Na+  and K+  to this 
polyether were not improved when its C l carboxyl group (which participates 
directly in ligand binding and is implicated in the biological effect) was chemically 
altered.
Production of the ansamycin antibiotic, geldanamycin was also common. 
This is an inhibitor of bacterial and eukaryotic RNA polymerase and blocks 
initiation during the early stages of transcription. Rothrock and Gottlieb (1984) 
demonstrated geldanamycin production by S.hygroscopicus var geldanus in 
sterilized soil and showed that the compound controlled the level of Rhizoctonia 
solani without harming the host plant. If  production can occur under natural 
conditions then geldanamycin producers might have a selective advantage when 
competing with other soil microflora. Interestingly, S.hygroscopicus var geldanus 
was observed to produce nigericin during this research.
The co-production of related idiolites, as observed for the herbimycins is not 
unusual (Tanida et al., 1980; Lazar et a l., 1983,) and the co-synthesis of 
herbimycins A and B has been already been reported (Iwai et a l., 1980). Reasons 
for the frequent association between production of geldanamycin and nigericin may 
lie in the fact that both antibiotics have portions of their structure that are 
biosynthesised via the polyketide pathway. Geldanamycin is derived from 3-amino- 
5-hydroxybenzoate, but also has a polylcetide-derived handle stretched between 
adjacent benzenic portions. The aromatic moiety comprises acetate and propionate 
units, with O-methyl groups derived from methionine, and two C2 units from 
glycolate (Ghisalba, 1983).
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Nigericin is a fairly lipophilic molecule made up of cyclic ethers and is 
formed by the condensation of C2, 3 and 4 units into a polyene precursor via a 
triepoxide intermediate (Cane et al., 1983). The discovery of the biosynthetic route 
of polyethers lead to the proposition that there was a common genetic basis 
influencing the synthesis of both polyenes and polyethers, O'Hagan (1988) indicated 
that there were similarities between the structures of certain macrolides and 
polyethers, suggesting that both polyether and macrolide antibiotics also had a 
common genetic source and that the stereochemical similarities between them were 
dictated by a common enzyme system. It is interesting to hypothesize that 
geldanamycin production could share biosynthetic enzymes with the nigericin 
pathway, especially in view of the fact that genes, involved in the early stages of 
polyketide biosynthesis, have been shown to hybridize strongly with one another 
(Malpartida et a l., 1987; Kakinuma et al., 1991). Alternatively, the two antibiotics 
may have simply co-evolved in the same progenitor strain. Strains which do hot 
express geldanamycin production may contain silent genes or represent a second line 
of descendants which retained only the nigericin pathway. A gene transfer event 
could also have caused the two lines of descent.
The data presented in Table 3.1. suggest that 20% of strains from a random 
selection of streptomycetes could produce a known broad spectrum antibiotic 
(mainly nigericin). Three of these were also considered to be potential producers of 
novel agrochemicals (E35, E100 and F139). In addition, 3 new strains with 
potentially novel activities (section 3.2.4.) produced broad spectrum compounds and 
there are similar cases cited in the literature where novel compounds have been 
discovered in nigericin producers (Grabley et al., 1990a). Both nigericin and 
geldanamycin are broad spectrum antibiotics and a novel metabolite might only be 
discovered if part of its spectrum of activity was different. This led to the 
hypothesis that other potentially novel antibiotics might be found by close 
examination o f strains, presumed to produce only unwanted broad spectrum 
metabolites.
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3.5.2. Factors Effecting Differentiation and Antibiotic Production.
It is well known that nutrient depletion induces sporulation and secondary 
metabolite biosynthesis (Iwai and Omura, 1981; Demain, 1984 and 1985). The 
metabolism of glucose and other carbon sources usually accompanies growth, with 
differentiation occurring when they become growth limiting. Where low nutrient 
levels illicited positive differentiation the cause was probably nutrient limitation. 
The trend of high Pi levels to permit a positive differentiation response seems 
unusual and may be related to pH effects rather than Pi concentration. The pH of 
the gradient should be 7.3 at the time of inoculation, but since a culture might 
metabolize at different rates along the gradient, a pH gradient might also form. It is 
also possible that pH effects occurred in other gradients, for instance the 
fermentation of sugars tends to decrease the pH, whilst the fermentation of amino 
acids and nitrate increase pH. Changes in pH may trigger differentiation before 
nutrient depletion occurs or might provide an additional inhibitory factor. The 
concentration of H +  and OH* ions are known to cause changes in membrane 
properties and cell wall formation (Bader, 1986) and these are both important 
factors in the morphological development of streptomycetes.
The different response profiles of individual strains indicates that 
differentiation in streptomycetes is strain specific and may reflect differences in 
rates of substrate utilization, thresholds for responses to nutrient limitation, or the 
presence of special mechanisms for the uptake of nutrients, which are in short 
supply.
A wide variety of pigment effects accompanied growth on nutrient gradients, 
including differences in the colouration of vegetative mycelium, aerial mycelium 
and spores, diffusible pigments and the presence of pigment droplets on culture 
surfaces. This tendency for polymorphism may be related to an evolutionary 
strategy, which helps streptomycetes to cope with a changing environment, and 
since pigments are often secondary metabolites, a close association between
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cytodifferentiation and secondary metabolism was suggested. For instance, the two 
herbimycin producers showed similar morphologies on different gradients.
The antibiosis profile of an organism seemed to depend on its nutrient 
environment; for example, bioactive strains did not biosynthesize their products 
under some conditions and new activities were found in certain strains, indicating 
that they showed a more varied product spectrum when observed under more 
diverse conditions. Differences in the detection limit o f  the antibacterial and 
antifungal assay could have influenced results and it is possible that non-bioactive 
strains could contain hidden activities if they were grown under the correct 
conditions. It is also relevant that high levels of ions can reverse the biocidal 
activity of ionophores and this may help to explain specific cases where zone sizes 
were smallest at high nutrient concentrations (eg. on the NaN0 3  gradients).
Alterations in differentiation are often accompanied by changes in secondary 
metabolism. During this work, antibiotic production was observed in both 
differentiated and non-differentiated mycelia on nutrient gradients and this may 
suggest that whilst the production of some antibiotics is closely associated with 
cytodifferentiation, others provide other functions within the cell, which may or 
may not be related to the availability of nutrients.
Certain strains produced nigericin on solid but not liquid media, and it was 
hypothesized that the circulation of air in a bioassay dish would be slower than in a 
shake flask, causing diffusion gradients of oxygen. The best aeration might be 
expected to occur at the edges of the plates and that this might be responsible for the 
predominance of nigericin biosynthesis on solid media. However, the above results 
indicated that reduced oxygenation prevented nigericin biosynthesis.
A major difference between solid and liquid cultures is agitation; fragmentation 
has been observed in the shake flask cultures of several nigericin-producing strains 
and it is thought that this might be a negative influence on antibiotic production. 
Small mycelial fragments may be incapable of antibiotic production due to 
insufficient capacity for oxygen transfer (Personal communication, M.E. Bushell).
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Other theories include speculation that diffusible products capable of inducing 
secondary metabolism might reach higher concentrations at localized areas on solid 
media than if they were subjected to rapid distribution during batch fermentations. 
Nutrient limitation is a less favoured theory because the effect is observed on a 
variety of media, some of which are highly complex.
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Chapter 4
The Use of Fattv Acid Profiles for Grouping Streptomvces Species.
4.1.Introduction
Fatty acids are building blocks of bacterial membrane constituents (eg. the 
acyl components of cellular lipids) and they are synthesized by a specific pathway, 
in which a single starter unit and a small number of malonate units are joined 
together by condensation. A beta-keto group is formed at each of these steps and it 
is subsequently modified by reduction, dehydration and by hydrogenation prior to 
the next chain extension. The biosynthesis of fatty acids was reviewed by Martin 
(1977) and Kaneda (1991) who described two major families of fatty acids, which 
were derived from different precursors. The branched chain fatty acids include iso-, 
anteiso- and acyclic forms. Odd chain iso-branched fatty acids use isovaleryl-CoA 
as a precursor, whilst even chain iso-branched forms use isobutyryl Co A. Anteiso- 
branched fatty acids have 2-methylbutyryl-CoA as the initiator and acyclic forms 
originate from cyclic carboxylic acid primers, (ii) The straight chain fatty acids are 
synthesized from acetyl-CoA (gives an even number of C atoms) or propionyl-CoA 
(gives an odd number of C-atoms) as the primer molecule.
Fatty acid analysis has frequently been used to distinguish between bacterial 
genera (Lechevalier, 1977; Goodfellow, 1989; Kaneda, 1991), but they have also 
proved useful in the delimitation of species groups in Bacte nodes, (Brondz et al., 
1991) and for strain determination in a  variety of bacteria (Gudmestad et al., 1988; 
Cacciapouti et al., 1991). Members of the genus Streptomyces have fatty acid 
profiles which comprise straight chain, iso- and anteiso-branched chain fatty acids 
with a carbon chain length between 14 and 18 atoms (Hofheinz and Grisebach, 
1965; Lechevalier, 1977; Popisil et a l., 1985; Saddler et al. 1986 and 1987). 
Hydroxylated methyl esters have been observed in some Streptomyces species
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(Kroppenstedt, 1985), but there is little information about the distribution of 
cyclopropane fatty acids in streptomycetes, apart from the presence of Me. cis-9,10- 
methylenehexadecanoate in S. cinnamonensis (Popisil et al., 1985).
One approach to the discovery of new microbial metabolites is to target 
taxonomic groups, which have a high incidence of antibiotic producers; the 
S.violaceoniger group fits into this category (Williams et a l., 1983 a and b; Arai et 
al., 1976). These organisms have a characteristic spore chain morphology, which 
distinguishes them from other streptomycetes and it was of interest to know if they 
differed in any other respects. In 1987, Saddler et al. demonstrated that fatty acid 
profiles could be used to cluster S.cyaneus strains away from other members of the 
genus and this success indicated that it might be interesting to determine the fatty 
acid profiles of S.violaceoniger. However, the evidence that Saddler et al. (1987) 
used to suggest that fatty acid profiles in streptomycetes remained stable during 
batch culture growth (Saddler, 1986) was weak because it was based on the 
reproducible profile of only one strain, NCIB 9616. Quantifying fatty acid levels 
might accentuate variations due to differences in growth rates between strains under 
standard conditions. Therefore a study which examined qualitative differences 
between strains was designed to find any major differences between the fatty acid 
profiles of S.violaceoniger strains compared with other streptomycetes.
There is a close relationship between fatty acid metabolism and the 
polyketide pathway of secondary metabolite biosynthesis (Martin, 1977, Hopwood 
and Sherman, 1990, Fig. 1.1). Intermediates of fatty acid biosynthesis and the fatty 
acids themselves have been shown to be precursors of polyketides and related 
antibiotics and certain studies have indicated that polyketide producers might 
contain more iso-branched fatty acids (Popisil et al., 1985; Hafner et al., 1991). 
Two common products of natural Streptomyces isolates (nigericin and 
geldanamycin) were derived from polyketide pathways and so a second study was 
undertaken, using an antibiotic production medium to examine the relationship of 
geldanamycin and nigericin production with fatty acid profiles.
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4.1.2. Choice of Strains and Test Materials.
Twenty-six type strains were used for this study (Tables 2.2 and 4.1.), 
including eleven S.violaceoniger strains and seventeen S.griseoruber strains, which 
have been taxonomically well studied. Both groups represented tight, clearly 
defined clusters and were therefore good marker strains. A small selection of other 
type strains was included to give a broader view of the genus.
A selection of natural isolates was chosen arbitrarily from several of 
the series shown in Table 2.1. (Table 4.1). They comprised, 1 A, 25 C, 9 D, 8 E, 7 
F and 11 MM groups of strains. Thirty-five were isolated by specific procedures for 
cluster 32 streptomycetes (series D, E, F and MM) whilst twenty-six were not. 
Twenty-eight natural isolates were fully identified (Table 2.9); nine gave high 
Wilcox probability identification scores and five gave acceptable values (Table 4.2). 
A further twelve strains were identified as S.violaceoniger (C32's) by their rugose 
spore chains (Table 2.10). The remaining strains were unidentified, but were not 
cluster 32's, since scanning electron microscopy indicated a non-rugose spore chain 
morphology. Three type strains and five natural isolates were duplicated. This is 
10.6 % of the total sample set and is twice the number of replicates recommended 
for use in cluster analysis by Saclrin (1983).
Fig.4.1 shows the mixture of FAMES, used in this study. Twenty-five 
compounds were observed, including branched, straight chain, hydroxy- and 
cyclopropane fatty acid methyl esters.
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Fig. 4.1. Fatty acid methyl ester profile of the qualitative standard used for this 
research.
The diagram is a GCMS profile of the qualitative FAME profile (supplied by 
Supelco) which was used to identify fatty acids present in strain extracts.
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Table 4.1. Type strains and Natural Isolates in fattv acid study.
Species Cluster Number of Number of
Group Number Type Strains Isolates
S.aibidoflavus C l 2 3
S.atroo-
livaceus
C3 0 1
S.roseus C l 1 0
S.rochei C12 0 2
S.virid-
osporus
CIS 0 2
S.cyaneus C18 1 0
S.diasta-
tochromogenes
C19 1 6
S.griseoruber C21 7 0
S.violaceo-
niger
C32 11 13
S.pactum C44 1 0
S.lavendulae C61 1 0
S. spp. 0 32
Total 26 59
Key to Abbreviations 
S. refers to Streptomyces.
C refers to cluster group, as defined by Williams et id., 1983a.
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4.2.-4.S. Results,
4,2. The Distributions of Fattv Acid Methvl Esters Within Streptomycetes.
4.2.1. The Distribution of Individual FAMEs and FAME Classes Within 
Representatives of the Genus Streptomvces.
Fifteen methyl esters, comprising FAMEs with 14-19 carbon atoms were 
found in the population of streptomycetes studied (Table 4.2), although more than 
17 carbon atoms was rare. Variations of octadecanoate were found in three 
S.violaceoniger strains (S.hygroscopicus var geldanus, NR3602, S.endus, ISP4213 
and a natural isolate, MM 2817) and a S.griseoruber strain (S.violaceolatus, 
DSM40438), which also contained nonadecanoate. This was in agreement with the 
14 and 18 carbon atoms quoted in the literature as typical for the FAMEs of 
streptomycetes (Lechevalier, 1977; Saddler el al. 1986 and 1987; Popisil et al., 
1983; Hofheinz and Grisebach, 1963), apart from nonadecanoate, which might 
indicate that the strain was a member of the genus Actinomyces (Kroppenstedt, 
1983). However, S. violaceolatus was a type species and was unlikely to have been 
misidentified. Pentadecanoate was the only ubiquitous fatty acid, but six other fatty 
acids were common (Table 4.2.).
All organisms contained both branched and straight chain FAMEs and this 
was in accordance with the work of Saddler et al. (1987), Popisil et al (1983) and 
Kroppenstedt (1983). A cyclopropane FAME was found in approximately 30% 
strains. The majority of streptomycetes (93%) had at least one hydroxylated methyl 
ester, which was in contrast to previous work and might be explained by the 
instability of hydroxy fatty acids (Kroppenstedt, 1983).
All three strains containing cis-9, 12-octadecanoate also had cis 9,10- 
methylenehexadecanoate, which was only present in twenty-six strains. The latter 
fatty acid was associated less frequently than average with all forms of 
tetradecanoate.
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Table 4.2. The distribution o f FAMEs in streptomvcetes.
No. FAME NAME No. Strains.
7. 14:0 Me. tetrad ecanoate 81
8. i-15:0 Me. 13-methyltetradecanoate 23
9. a-15:0 Me. 12-methyltetradecanoate 80
10. 15:0 Me.pentadecanoate 85
11. 2-OH 14:0 Me. hydroxy tetrad ecanoate 81
13. i-16:0 Me. 14-methylpentadecanoate 44
14. 16:1 Me.cis-9-hexad ecanoate 84
15. 16:0 Me. hexadecanoate 60
16. i-17:0 Me. 15-methylhexadecanoate 84
17. 17:0 > Me.cis-9,10-methylene 
hexadecanoate
26
18. 17:0 Me. hep tad ecanoate 83
19. 2-OH 16:0 Me.hydroxyhexadecanoate 22
20. 18:2 Me.cis-9,12-oc tad ecanoate 3
23. 18:0 Me. octadecanoate 1
25. 19:0 Me.nondecanoate 1
N.B. The total number of strains in the study is 85, but including duplicates there 
are 93 OTUs.
Key to abbreviations used in Table 4.2.
Me. denotes Methyl.
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4.2.2. The Diversity of FAME Pattern Types Within Streptomvcetes.
The strains in the study differed by the number of FAMEs, which ranged 
from 6-11 and the diversity of types, which could include hydroxy-, cyclopropane- 
and long-chain FAMEs. Table 4.3. illustrates how this diversity was distributed and 
shows how unique fatty acid profiles were observed for seven type strains and ten 
natural isolates, whilst sixteen further patterns were replicated amongst the 
remaining strains.
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Table 4.3. Fattv acid profiles observed within streptomycetes.
PATTERN
TYPE 14:0 i-15:0 a-15:0 15:0 2-OH 14:0 1-16:0 16:1 16:0
1 1 0 1 1 1 0 1 0
2 1 0 1 1 1 1 1 1
3 1 1 1 1 1 1 1 1
4 1 1 1 1 1 0 1 1
5 1 0 1 1 1 1 1 1
6 1 1 1 1 1 1 1 1
7 1 0 1 1 1 1 1 1
8 1 0 1 1 1 1 1 1
9 1 0 1 1 1 0 1 1
10 1 0 0  1 1 0 1 1
11 1 1 1 1 1 0 1 1
12 1 0 1 1 0 1 1 1
13 1 0 1 1 0 1 1 1
14 1 1 1 1 1 1 1 1
13 1 0 1 1 1 0 1 0
16
17-33
1 0 1 1 
Various
1 0 1 1
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Table 4.3. Fattv acid profiles observed  within streptomycete!
PATTERN 
TYPE 1-17:0 17:0 > 17:0 2-OH 16:0 18:2 18:0 19:0 No.
1 1 0 1 0 0 0 0 18
2 1 0 1 0 0 0 0 11
3 1 0 1 1 0 0 0 5
4 1 0 1 0 0 0 0 4
5 1 0 1 1 0 0 0 4
6 1 0 1 0 0 0 0 4
7 1 1 1 0 0 0 0 4
8 1 1 1 1 0 0 0 3
9 1 0 1 0 0 0 0 2
10 1 1 1 1 0 0 0 2
11 1 1 1 0 0 0 0 2
12 1 1 1 0 0 0 0 2
13 1 1 1 0 0 0 0 2
14 1 1 1 0 0 0 0 2
15 1 0 1 1 0 0 0 2
16 1 1 1 0 0 0 0 2
17-33 Various 1
Key to Table 4.3.
1 “  FAME present 
0 -  FAME absent
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— Hierarchical_Clustering tQ__ Determine Inter-relationshins Between
Streptomvcetes Based on their Fattv Acid Profiles.
The binary data, discussed in section 4.2., was used for conventional 
taxonomic clustering and resulting groups were tested by comparing the topologies 
of 2 phenograms (Figs. 4.2 and 4.3.). Fig. 4.2. was created using the Dice 
coefficient (S^jr f ) and the UPGMA algorithm, whilst Fig. 4.3. was obtained by the 
same method, but using Ssm. Good group formation was characterized by clearly 
well separated tight clusters at a similarity level of 83.6% for Fig. 4.2. and 89% on 
Fig. 4.3., where two sets of seven identical groups were defined. Three strains 
proved to be exceptions and were in different clusters for each phenogram.
The point of major change on the dendrograms was where there were many 
short stems, above and below which groups merged or separated. This occurred at a 
similarity level of 89 % for Fig. 4.2. and 93% for Fig. 4.3. where sixteen and 
seventeen groups, respectively, were defined. Comparison o f the two sets showed 
that 9 groups remained intact apart from 4 strains and groups 10 and 11 (Ssm) 
merged to form group 6 (Sd) and groups 3 and 9 (Ssm) merged to form group 3 
(Sd), whilst the three remaining groups were partially disrupted between the two 
phenograms. This coupled with the fact that short stems can often be highly 
insignificant indicated that the data was stable and the cophenetic correlation 
supported this, giving a mantle coefficient of 0.802 for Fig.2.
The groupings were subsequently examined for correlations with taxonomic 
data and bioactivity. Figs. 4.4 and 4.3 illustrate the distribution of these two factors 
across the 7 groups of the phenogram shown in Fig.4.2. No correlations between 
fatty acid profile and either antibiotic production or Streptomyces phena (Williams 
et al., 1983a and b) were found, nor did the distribution contain particular strain 
series grouped together. Most of the S. violaceoniger strains, which were thought to 
produce nigericin clustered to group 2 , whilst the nigericin producers found in 
group 1 also produced geldanamycin. All the strains, which produced compounds
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Fig. 4.2. Phenogram based on fatty acid profiles, created using and UPGMA.
The diagram illustrates the groups which formed at two similarity levels (83.6% and 
89%) on a phenogram, created using fatty acid profiles. Similarity was calculated 
using the Dice coefficient and UPGMA was used to form the phenogram.
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Fig. 4.2. Phenogram based on fatty acid profiles, created using and UPGMA.
The diagram illustrates the groups which formed at two similarity levels (83.6% and 
89%) on a phenogram, created using fatty acid profiles. Similarity was calculated 
using the Dice coefficient and UPGMA was used to form the phenogram.
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FIG .4.3 .
Fig.4.3. Phenogram based on fatty acid profiles, created using S sm and UPGMA.
The diagram illustrates the groups, which were chosen at two similarity levels (89 X 
and 93%) on a phenogram, created using fatty acid profiles. Similarity was
calculated using the simple matching coefficient and UPGMA was used to form the 
phenogram.
0.70i—
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The diagram indicates where various streptomycete taxa clustered on a phenogram 
created using fatty acid profiles, whose similarities were assessed using the dice 
coefficient. These relationships were presented as a tree by use of UPGMA, whilst 
the streptomycete taxa which are shown were defined by Williams et al. (1983a) 
The group number is given from the top of the phenogram downwards at a 
similarity level of 83.6.
NB. Duplicate strains are included in this diagram.
Fig.4.4. The distribution o f Streptomyces species across a phenogram (Fig. 4.2.)
based on fatty acid profiles.
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17 59
25
No. Strains in Group 
1 1  3 1
S.violaceoniger
C32
S.dlastatochromogenes
C19
S.griseoruber
C21
S.albldiflavus
Cl
Fig. 4.5. The distribution of antibiotic producers across a phenogram (Fig.4.2.)
based on fatty acid profiles.
The diagram shows where groups of strains, which were classified by the chemical 
structure of the antibiotics which they produced, clustered on a phenogram created 
using Sdice and UPGMA and based on fatty acid profiles.
NB. duplicate strains are included in this diagram.
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No. Strains in Group
17 59 3 1 1 3 1
Group Number
■ PolyeneProducers ■ PolyetherProducers
Nigeridn + Ansamycin 
Producers
Macrolide
Producers
that might be novel agrochemicals were in group 2, apart from one E100 duplicate, 
which formed group S. Six out of eight duplicated strains clustered to group 2, but 
2 duplicates were split. E100 was in group 2 and group 5, whilst A1002 had two 
replicates in group 2 and one in group 1.
4.4. Distributions of FAMEs Within Sub-groups of the Population.
No general relationship between fatty acid profiles and taxonomic status or 
antibiotic production was found in section 4.3.2. Closer examination of the raw data 
was made to see if any specific relationships existed between individual FAMEs and 
particular groups of strains.
4.4.1. The Distribution of FAMEs in Streptomvces Species Groups.
Specific FAMEs were assessed for their ability to distinguish between 
Streptomyces species groups. A FAME was evaluated as a good distinguishing 
character if it had a high standard deviation and was present in different groups at
<  20 and >  80% strains. In addition 2 x Sd from the mean was used to assess 
significant differences, although the small size of the sample sets was taken into 
account when making observations. All S.diastaochromogenes (C19) strains lacked 
Me.heptadecanoate. These strains could also be differentiated from the remaining 
population, by being less likely to have Me. 14-methylpentadecanoate (present in 
one strain) and Me.hexadecanoate (present in 2 strains), although the desired split of
<  20 and >  80% was not observed. Significantly fewer S.violaceoniger (C32) 
strains contained Me. 13-methyltetradecanoate when compared with the mean for the 
entire population. The distributions of Me.2-hydroxytetradecanoate in 
S.diastatochomogenes (C19), Me.2-hydroxyhexadecanoate in S.albidqflavus (Cl) 
and Me.octadecanoate in S.griseoruber (C21) showed significant differences from 
the mean. However, the small sample sizes of some of the above groups meant that 
these latter observations were not statistically valid. More strains would need to be
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Table 4.4. The distribution o f FAMEs within Strentotmces Species.
FAME C l C19
% Strains 
C21 C32 Other Mean Sd
14:0 100.0 85.7 100.0 95.8 95.2 95.4 2.9
i-15:0 20.0 42.9 42.9 4.2 35.7 27.1 15.2
a-15:0 100.0 100.0 10.0 91.7 92.9 94.2 3.2
13:0 100.0 100.0 100.0 100.0 100.0 100.0 0.0
2-OH
14:0
80.0 100.0 85.7 87.5 90.5 89.4 4.2
i-16:0 40.0 14.3 42.9 29.2 73.8 51.8 22.8
16:1 100.0 100.0 100.0 100.0 97.6 98.8 1.2
16:0 60.0 28.6 57.1 41.7 97.6 70.6 27.8
i-17:0 100.0 100.0 100.0 100.0 97.6 98.8 1.2
17:0 20.0 0.0 42.9 29.2 35.7 30.6 10.5
17:0 > 100.0 100.0 100.0 95.8 97.6 97.6 31.5
2-OH
16:0
40.0 28.6 28.6 25.0 23.8 25.9 3.9
18:2 0.0 0.0 0.0 12.5 0.0 3.5 5.7
18:0 0.0 0.0 14.3 0.0 0.0 1.2 4.0
19:0 0.0 0.0 14.3 0.0 0.0 1.2 4.0
Number
Strains.
5 7 7 24 42 85 85
This table shows the distribution of specific fatty acids amongst strains which have 
been grouped by their taxonomic identity (Williams et al., 1983a).
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examined before further comments could be made.
4.4-2. The Distribution of FAMES Within Producers of Specific Claw.« nf 
Antibiotics.
It was interesting to see if information could be gleaned by comparing the 
general FAME profiles of producers of specific classes of antibiotics (Table 4.S). 
The same rules as in section 4.2.2 were used to assess this data.
The FAME profiles of all groups of strains were fairly similar and there 
were no FAMEs which could be classed as good distinguishing characters. This 
explained why these strains did not emerge as related groups during the cluster 
analysis. However, some interesting observations were made from Table 4.5. None 
of the twenty polyether producers contained the iso-branched fatty acid Me. 13- 
methyltetradecanoate and the rare Me. cis-9,12-octadienoate was only found in 
polyene or polyether and ansamycin producers. Unfortunately there were only 5 
producers of macrolides and macrolide-like antibiotics in the study, but preliminary 
observations suggested that the fatty acid profiles of these strains could be different 
in several respects. They could be more likely to contain the iso branched Me. 13- 
methyltetradecanoate and the cyclopropane FAME, Me.cis-9,10- 
methylenehexadecanoate and they may be less likely to have anteiso-branched 
Me. 12-methyltetradecanoate, Me.heptadecanoate and Me.hydroxytetradecanoate.
4.4.3. Distribution of FAMEs Amongst Isolates from Specific Geographical 
Locations and Isolation Procedures.
The different strain series were examined for a predisposition towards any 
specific fatty acids which could reflect differences in the environment from, which 
they were isolated or even in the isolation procedure used. The results are shown in 
Table 4.6., which indicates that there were no instances, where differences in 
specific FAMEs related to strain series.
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Table 4.5. The distribution of FAME'S within specific antibiotic producers
The table shows the distribution of Catty acids amongst strains which have 
been grouped by the chemical class of their antibiotic product. The ansamycin 
producers were geldanamycin apart from 3672 the herbimycin producer and 
nigericin belongs to the polyether class of antibiotics.
Key to superscripts used in Table 4.5.
^There were 57 other strains but 2 of them produced fatty acid derived metabolites. 
These were A3(2) S.coelicolor and KCC S-0785 S.lusitanus the tetracycline 
producer. These were included in the column for all fatty acid derivatives.
^The mean and standard deviation refer to columns 1-5.
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Table 4.5. The distribution o f  FAMEs within specific antibiotic producers.
Strains with Specific Classes of Antibiotic Product (% strains)
FAME Poly
ene
Niger
-icm
Nig+
Ansa
Macro
lide
Others zMean zSd All
Ab.
Prods.
14:0 100.0 100.0 93.3 100.0 94.6 96.4 3.4 96.7
i-15:0 33.3 0.0 0 .0 40.0 29.1 10.7 17.3 16.7
a-15:0 100.0 100.0 93.3 80.0 96.4 92.8 6.8 93.3
15:0 100.0 100.0 100.0 100.0 100.0 100.0 0.0 100.0
2-OH
14:0
100.0 100.0 100.0 80.0 90.9 96.4 7.8 96.7
i-16:0 0.0 60.0 26.7 20.0 54.6 28.6 17.0 33.3
16:1 100.0 100.0 100.0 100.0 98.2 98.8 8.6 100.0
16:0 66.7 60.0 100.0 60.0 50.9 82.5 19.6 83.3
i-17:0 100.0 100.0 100.0 100.0 96.4 97.6 1.7 100.0
17:0> 33.3 40.0 20.0 60.0 23.6 32.1 15.4 33.3
17:0 100.0 100.0 100 80.0 100.0 96.4 7.8 96.7
2-OH
16:0
0.0 40.0 33.3 20.0 20.0 28.6 11.9 30.0
18:2 33.3 0.0 13.3 0.0 .00 10.7 10.1 10.0
18:0 0.0 0.0 0 .0 0.0 1.8 1.2 0.9 0.0
19:0 0.0 0.0 0.0 0.0 1.8 1.2 0.9 0.0
No
Strains
3 5 15 5 *55 83 83 30
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Table 4 .6 . The distribution of FAMES amongst various strain series.
FAME MM C D E F Mean Sd
14:0 90.1 91.3 100.0 100.0 100.0 94.7 4.5
i-15:0 100.0 30.4 44.4 12.5 28.6 24.11 4.7
a-15:0 100.0 87.0 88.9 100.0 100.0 93.1 6.3
15:0 100.0 100.0 100.0 100.0 100.0 100.0 0.0
2-OH.
14:0
100.0 95.7 100.0 87.5 100.0 96.6 4.2
i-16:0 18.2 65.2 44.4 75.0 100.0 58.6 24.8
16:1 100.0 100.0 88.9 100.0 100.0 98.3 4.1
16:0 18.2 78.3 66.7 87.5 100.0 69.0 26.5
i-17:0 100.0 95.7 100.0 100.0 100.0 98.3 2.1
17:0 > 18.2 21.7 11.1 37.5 42.9 24.1 10.2
17:0 100.0 100.0 100.0 100.0 100.0 100.0 0.0
16:0
2-OH
36.4 21.7 22.2 25.0 28.6 25.9 5.6
18:2 9.1 0.0 0.0 0.0 0.0 1.7 3.4
18:0 0.0 4.4 0.0 0.0 0.0 1.7 2.2
19:0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Total No. 
strains
11.0 23.0 9.0 8.0 7.0 58
The table shows the distribution o f fatty acid profiles amongst strains which 
have been grouped by their isolation series. The MM series were all S. violaceoniger 
and therefore would interfere with any observations made in this section.
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4.5. Alterations in the FAME Profile of D153 During Batch Culture and its 
Relationship to Secondary Metabolite Biosynthesis.
Qualitative fatty acid data was not related to secondary metabolism in a 
general way and could not be used to predict bioactivity. It was hypothesized that 
changes in the levels of Catty acids through the growth cycle might be more 
indicative o f a  strains bioactive capabilities. A feasibility study was carried out to 
test this hypothesis. The common occurence of geldanamycin and nigericin in 
streptomycetes has been discussed in Chapter 3 where it was mentioned that both 
antibiotics have portions manufactured by the polyketide route, therefore a strain 
(D153), which produced these compounds was chosen for this work. D153 was not 
included in the initial population study, but was chosen because it was a good 
canidate for chemostat work. Consequently this strain contained some additional 
FAMEs, which can be found listed in the key (Fig. 4.1.).
4.5.1. Choice o f Medium.
Sautons medium was used to generate fatty acid profiles, but it was 
discovered that antibiotic production for a number of strains was not expressed on 
this medium and so ISP7 was chosen for this study, after it was shown to be 
compatible with GCMS procedures (Table 4.7).
Fatty acid profiles of D153 were similar for the two media, although 
Me.tridecanoate, Me.trans-9-octadecanoate and Me.octadecanoate were not 
observed using Sautons medium and the cyclopropane FAME Me.cis-9,10- 
methylenoctadecanoate was not observed on ISP7 cultures (NB. all of these 
compounds were only observed in single replicates). Five other peaks were detected 
which were not present in the standard mix but which were consistent for all 
replicates on both types of media. An example o f a GCMS trace is given in Fig.4.5.
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Table 4.7. The effect of Sautons medium and ISP7 on the FAME profile o f D153
13:0 14:0
Fatty Acid 
i-15:0a-15:0 2-OH 14:0 i-16:0 16:1 16:0
Sautons Repl
0 1 1 1 1 0  1 1
Sautons Rep2
0 0 1 1 1 0  1 1
ISP7 Repl
1 1 1 1 1 0  1 1
ISP7 Rep2
0 0 1 1 1 0  1 1
i-17:0 17:0 > 17:0 2-OH 16:0 18:2 18:1 18:0 19:0 >
Sautons Repl
1 1 1 1 0 0 0 1
Sautons Repl
1 1 0 0 0 0 0 0
ISP7 Rep 1
1 1 1 1 0 1 1 0
ISP7 Rep 2
1 1 1 1 0 0 0 0
The table shows the qualitative FAME profiles of strain D153 in replicate on 
Sautons and ISP7 media. The data was taken after 3 days growth.
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Fig. 4.6. Example of a GCMS trace from strain D1S3.
This diagram shows a GCMS trace from a fatty acid extract of D1S3, which was 
taken after 3 days growth at 28°C, in ISP7 medium.
Key to Peak Numbers
8 =  Me. 13-methy ltetradecanoate
9 “  Me. 12-methyltetradecanoate
10 «■ Me. pentadecanoate
13 — Me. 14-methylpentadecanoate
14 =  Me. cis-9-hexadecanoate 
13 =  Me. hexadecanoate
16 =  Me. 13-methylhexadecanoate
16a =■= Me. cis-9, 10-methylenehexadecanoate
17 =  Me. heptadecanoate
18 =  Me. 2-hydroxyhexadecanoate
21 =■ Me. trans-9-octadecanoate
Me cis-11-octadecanoate
22 — Me. octadecanoate
23 — Me. cis-9, 10-methyleneoctadecanoate
153
FIG.4.6
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4.5,2. Timecourse o f Fattv Acid Biosynthesis Versus Antibiotic Production in 
D153.
Quantitative and qualitative changes in the fatty acid profile of a selected 
strain were examined over 7 days, with the aim of detecting shifts in the nature and 
levels of fatty acids and to try to correlate them with onset of antibiotic production.
Table 4.8. shows the results of the qualitative experiment where FAMES 
with chain lengths of between C14 and C18 carbon atoms were first detected at day 
2. On day 3, this range was extended to include Me. tetradecanoate, Me. 
octadecanoate and Me. cis 9-10 methyleneoctadecanoate. FAMEs with a chain 
length of 18C appeared transiently.
Fig. 4.6. shows part of a separate experiment where an internal standard 
which allowed relative quantifications was included in the fatty acid samples. 
Fig.4.7. shows the corresponding antibiotic profile for D153, with respect to batch 
culture growth. Geldanamycin production began at day 3, peaked between days 4-5 
and then remained constant up to day 7, whilst nigericin production peaked at day 
7, although small traces began to appear at day 3. Fatty acids which appeared 
transiently in the above experiment were not detected this time and this could be due 
to these compounds being produced at very low levels, which fluctuated about the 
detection limit of the GCMS.
All fatty acid levels increased up to day 2 and this was in line with a 
logarithmic increase in biomass. Subsequently all fatty acids, apart from Me 
pentadecanoate, Me. heptadecanoate, Me. cis-9-hexadecanoate and Me. 15- 
methylhexadecanoate, followed a similar profile (ie decreased until day 3, then 
began to rise until day 6 , when levels fell with the onset of cell death). However 
from day 2 Me. pentadecanoate and Me. heptadecanoate levels continued to 
increase, until the onset of stationary phase at day 3 (this was also the onset of 
antibiotic production). The levels of these fatty acids and Me. cis-9-hexadecanoate 
fell until day 4, when they began to rise, but then followed the pattern of the other
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Table 4.8. Qualitative differences in the fattv acids of D153 with time.
FAME (Day +  
Blank
rep)
Blank DIRI D1R2 D2R1 D2R2 D3R1 D3R2
14:0 0 0 0 0 0 0 1 1
i-15:0 0 0 0 0 1 1 1 1
a-15:0 0 0 0 0 1 1 1 1
2-OH 
14:0
0 0 0 0 1 1 1 1
i-16:0 0 0 0 0 1 1 1 1
16:1 0 0 0 0 1 1 1 1
16:0 0 0 0 0 1 1 1 1
i-17:0 0 0 0 0 1 1 1 1
17:0 > 0 0 0 0 1 1 1 1
17:0 0 0 0 0 1 1 1 1
2-OH
16:0
0 0 0 0 1 0 0 1
18: l9 0 0 0 0 1 0 0 0
18:1U 0 0 0 0 1 0 0 1
18:0 0 0 0 0 0 0 0 1
19:0 > 0 0 0 0 0 0 0 1
1 denotes the presence and 0  the absence of a fatty acid.
fatty acid graphs. The level of Me. 15-methylhexadecanoate showed less fluctuation 
than other fatty acids in the study.
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Table 4,8. Qualitative differences in the fatty acids of D153 with time.
FAME D4R1 D4R2 D5R1 DSR2 D6R1 D6R2 D7R1 D7R2
14:0 1 1 1 1 1 1 1 1
i-15:0 1 I 1 1 1 1 1 1
a-15:0 1 1 1 1 1 1 1 1
2-OH
14:0
1 1 1 1 1 1 1 1
i-16:0 1 1 1 1 1 1 1 1
16:1 1 1 1 1 1 1 1 1
16:0 1 1 1 1 1 1 1 1
i-17:0 1 1 1 1 1 1 1 1
17:0 > 1 1 1 1 1 1 1 1
17:0 1 1 1 1 1 1 1 1
2-OH
16:0
1 1 1 1 0 1 0 0
18: l 9 0 0 0 0 0 0 0 0
18:ln 0 0 0 0 0 0 0 0
18:0 0 0 0 0 0 0 0 0
19:0 > 1 0 0 1 0 0 0 0
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Fig. 4.6. Changes in the fatty acid profile of D1S3 through a cycle of batch culture 
growth.
The graphs show how the levels of FAMES, which were present within D153 
during batch culture growth on ISP7, changed relative to the concentration of an 
internal standard (a known amount of which was introduced into each sample prior 
to GCMS).
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Fig. 4.7. Profile of antibiotic production by strain D153.
The photograph shows a TLC plate which contains ethyl acetate extracts from a 
culture of D1S3 which were taken at different times during batch culture growth. 
The green compounds were geldanamycin, whilst the scarlet red compound was 
nigericin; the pure antibiotics are present in the centre of the TLC plate and helped 
to identify the compounds in the extract.
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Fig. 4.8. Growth curve of D1S3 through batch culture growth.
The graph shows changes in the levels of biomass in D1S3 during batch culture 
growth. (Biomass is given as the log of the dry weight).
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Me. IS methylhexadecanoate showed no significant difference in amount between 
days 2 and 4, but followed the same trend as the others after day 4.
It is not possible to say from this data whether the observed fluctuations in 
fatty acid levels related to geldanamycin and nigericin biosynthesis, but fluctuations 
in cellular fatty acids in D1S3 did not follow the same profile as cellular biomass. 
The ratio of fatty acid to biomass increased during stationary phase, whilst antibiotic 
production was occurring. Prior to the onset of stationary phase and secondary 
metabolism there were major changes in the levels of fatty acids. More experiments 
would be required to establish exactly how or if  these events are interconnected.
4.6. Discussion.
New information on the presence of certain fatty acids in streptomyetes was 
uncovered during this work; hydroxylated fatty acids were much more common 
than has previously been thought (Kroppenstedt, 1985). These fatty acids are fairly 
unstable and their absence in other studies may be due to their degradation rather 
than an inability of the organisms under study to produce them. R. Kroppenstedt 
(personal communication) has found that hydroxy fatty acids are highly diagnostic 
for some streptomycete species, including S.violaceoruger, although a similar 
observation was not made during this work. There is no information in the literature 
about the distribution of cyclopropane fatty acids in populations of streptomycetes 
and this work has shown that 30% of the genus might produce at least one 
cyclopropane fatty acid.
Although, there were 33 FAME patterns in 85 strains, the attempt to delimit 
S.violaceoniger (Williams et al., 1983a and b) from other streptomycetes failed. 
Reasons for this may lie in differences between this study and the successful study 
of Saddler et al. (1987). Both studies used type strains which represented tight 
clusters, and markers from other groupings were also included. However, natural 
isolates were pre-selected by spore morphology in the study of Saddler et al. (1987) 
compared to an arbitrarily chosen selection that comprised a variety of species and
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unidentified strains (in this study). Work presented in Chapter 2 has shown that 
many of these isolates did not conform to described streptomycete taxa and if this 
was reflected by their fatty acid profiles they may have prevented the delimitation of 
tight groups for more typical strains.
Streptomyces species delimitation may require quantitative data, as opposed 
to the qualitative data used in this study. Saddler (1987) based an assumption that 
fatty acid profiles remained constant during logarithmic growth and stationary phase 
on a study based on one strain, grown in Sautons medium, with three day intervals 
between readings (Saddler, 1986). However, fluctuations in fatty acid levels 
occurred on a daily basis for D1S3 in ISP7 medium (section 4.5). Kroppenstedt 
(personal communication) suggested that changes in fatty acid composition at 
different growth states were responsible for his failure to cluster S.violaceoniger 
amongst a tree comprising 12 different Streptomyces taxa; clustering was however, 
achieved by removing three C32 strains (Williams et a l., 1983a), two of which 
were present in this study. Kroppenstedt's work comprised entirely type strains 
which may be biased towards strains, which have been patented for antibiotic 
production. They would differ from many of the antibiotic producers included here, 
since industrial strains are selected for the production o f  either one or a group of 
related idiolites. Antibiotic-producing isolates often produce several different 
compounds (Chapter 3), which may or may not relate to fatty acid profiles. Work 
carried out with D153, a producer of nigericin and geldanamycin, suggested that 
this was possible. The levels of fatty acids in this strain fluctuated in line with 
changes in secondary metabolism, although this was not known to be correlated in 
any way. However this study was carried out in a production medium (ISP7), 
compared to Sautons medium, which aims to optimize biomass for taxonomic 
studies. D153 did not produce antibiotics in Sautons medium (Chapter3).
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CHAPTER 5
The Relationship Between Chemical Profiles. Taxonomic Status and Biological
Activity.
5.1. Introduction.
The classification and identification of streptomycetes has generally relied on 
numerical methods which use a wide variety of tests to obtain polythetic taxa 
(Williams et al., 1983a and b; Langham et al., 1989; Kampfer et al., 1991a and b), 
although studies comprising large numbers of substrate utilization tests have also 
given good data for classification studies (Bochner, 1989; Goodfellow et a l., 1987). 
In the above studies the nature of what is being scored is fairly clear (eg. the 
presence of an enzyme), but other work has generated patterns which have been 
used to classify strains and species, when the precise nature of the components 
involved are not known. Protein profiling is an example o f this, where unidentified 
cellular proteins are submitted to electrophoretic separation and the banding patterns 
of different strains or species are compared (Kersters, 1985, Vesselinova and 
Tsvelkov, personal communication).
Pattern recognition has also been used during the drug discovery process to 
predict the likely chemical nature of specific bioactive products and a variety of 
schemes have been developed to reduce the time spent analysing unknown chemical 
compounds (Aszalos, 1980). For example, Aszalos et al. (1965) described how they 
used 14 solvent systems to assign sub-group classifications to 84 known antibiotics, 
unknown compounds were then processed by TLC and placed in a sub-group and 
although they were not identified, the list of possible chemicals was shortened.
Thin layer chromatography was used to determine the bioactivity of isolates 
used for this thesis (Chapter 3); during that work, a banding pattern comprising a
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variety of unknown metabolites was observed within each strain extract and it was 
interesting to see if these profiles correlated with phenetic relationships.
The profiles were also assessed for their use in forecasting bioactive natural 
isolates. This was done in two ways, firstly with respect to the whole profile and 
secondly by following the hypothesis of Zahner et al. (1982), who described how 
TLC could be used to predict novel compounds by selecting unique spots for further 
examination.
5.1.1. Characteristics of Strains Chosen for this Study.
A random selection of streptomycetes, comprising members of various 
isolation series (Tables 2.1., 2.9., 3.1. and 5.1) were selected.
Table 5.1. Origins of strains used in this study.
Strains
A 
B 
C 
D 
E 
F
MM 
W 
RB 
Other 
Types
Total 173
No.
7
1
79
32
6
5
14
3
2
5
19
163
Taxonomic characterisation resulted in identification of 41 natural isolates to 
the species level. This is illustrated in Table 5.2., which also summarizes the 
identities of the type strains. Characterization of the strains with respect to their 
bioactivity and or antibiotic activity is given in Table 3.1.
Table 5.2. Streptomvces species involved in this study,
Spp. No.Natural Isolates No.Type Strains.
C l 5 0
C3 1 0
C12 3 0
C15 2 0
C17 0 1
C19 9 2
C21 0 4
C32 21 7
C44 0 1
S.spp. 123 4
Total 164 19
C refers to taxonomic cluster as defined by Williams et al., 1983a.
5.2. The Development of Methodology.
5.2.1. Scheme for the Numbering and Scoring of TLC Spots.
TLC profiles, which were generated by ethyl acetate extraction and run on 
TLC, using solvent system 1 were visualized under UV light (sections 2.3 and 2.6). 
When these were examined for all of the strains studied, 16 regularly observed spots 
and 13 rare compounds were revealed. Each of these spots was assigned a number 
from 1-29 (Fig. 5.1.).
164
Fig S .l. Diagram to show the numbering system used to score spots on TLC plates.
The photograph shows the TLC profiles of 5 strains, which are denoted A to 
E; these strains were morphologically very similar and were thought to be replicates 
and so their extracts were run alongside one another. The profiles provided a good 
example of the way in which spots were scored because the sixteen most frequently 
observed spots were present (marked 1-16).
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The plates were examined by eye and scored for the presence and absence of these 
metabolites. The negative control comprised uninoculated, incubated and extracted 
medium, whilst positive controls were provided by running a standardized strain 
extract on every plate. The negative control gave 4 spots, which had similar Rf 
values to test spots, but development of plates with vanillin always showed that they 
were different from those being scored.
5.3. Results.
5.3. The Frequency of Occurrence of Different Spots.
Metabolites in the study were not identified, except if they corresponded to 
an antibiotic standard. A detailed discussion on the distribution of these unknown 
compounds is therefore unnecessary, except to discuss briefly what types of 
compound they might be.
5.3.1. Distribution of Metabolites.
The silica adsorbent on the TLC plates was hydrophilic and bound to and 
immobilized polar compounds. Conversely, the extraction solvent (ethyl acetate) 
and the solvent system (No.l, Chapter 2.3.2.) were non-polar and compounds 
which were extracted and separated the most successfully were lipophilic. The 
closer a compound was to the bottom o f the plate, the "more polar" it was. Spots 
near the baseline were as common as the "more lipophilic" spots but were usually 
fainter (Table 5.3.).
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Table 5.3. The frequency of the spots scored bv TLC.
Spot No.
1 182
2 116
3 171
4 173
5 177
6 86
7 63
8 83
9 75
10 176
11 182
12 61
13 95
14 119
15 126
16 132
. Strains with Spot
This table shows the total number of strains which were examined and includes 
replicate strains.
Other factors which could have affected the mobility of compounds in the 
extracts included the presence of double bonds and certain functional groups on 
molecules, which raise their adsorption affinity to the silica. For example, saturated 
hydrocarbons are highly mobile in lipophilic solvents, methyl groups have little 
effect and carbonyls adsorb less strongly than amino or hydroxy groups. The
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possession of several functional groups are only partially additive because steric 
effects are also important.
5.4. The Estimation of Test Error Involved in Scoring Metabolite Patterns.
5.4.1. The Effect of Operator Error in Scoring Metabolite Patterns.
Ten plates containing 64 strain profiles were chosen to rescore several 
months after they had first been assessed. Both sets of results were then compared 
and the number of different answers noted down; 6.4% of the 16 most common 
spots were recorded differently between the two sets of observations. This value 
was above the desired figure of 5%, but below the 10% level of acceptability set
down by Sneath and Johnson (1972). 90.63% of the profiles examined were 
affected by this error, with an average of 1.9 discrepant spots for every strain (Sd 
=  1.47). The spread of the discrepancies is shown in Table 5.4.
Table 5.4. The number of soots in a subset of 64 strains affected bv onerator error.
No. Discraps. No. Strains Tot. No. Disc reps.
0 6 0
1 28 28
2 12 24
3 9 27
4 4 16
5 3 15
6 2 12
Total 64 122
Discrept. -  discrepancies; Tot. ■ total.
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Certain spots were prone to more error than others (Table 5.5.).
The two compounds nearest the base line accounted for 35% of the total 
errors made, whilst another 30% was contained in spots 11-13 and the remainder 
(35% error)
Table 5.5. The distribution of operator error amongst the 16 most common spots 
scored.
Spot No. Errors. P erroneous result 
(Sneath and Johnson, 1972)
1 5 0.041
2 3 0.024
3 1 0.008
4 4 0.032
5 5 0.041
6 6 0.049
7 7 0.058
8 7 0.058
9 3 0.024
10 1 0.008
11 10 0.085
12 13 0.145
13 4 0.032
14 10 0.085
15 20 0.194
16 23 0.245
The total number of errors was 122 and this save an overall test error of 0.064.
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was dispersed amongst the first 10 spots. Interestingly the operator error for spots 
1-10 was 3.4%, which is acceptable for taxonomic data (Sneath and 
Johnson, 1972). The increase in error towards the base line may be related to poor 
resolution between weakly eluted compounds. Spots 11-16 were confined to the 
bottom quarter of the developing distance (Fig.5.1.) and were closer together than 
the other spots. Due to the proximity of these compounds, a large quantity of one 
might result in difficulty in scoring neighbouring metabolites and also the amount of 
a substance can sometimes affect the Rf value if very low and high concentrations 
are compared.
The Rf value of a pure compound can be affected by the presence of 
impurities and because the samples in this study were mixtures of metabolites and 
the Rf values of individual compounds may have varied depending on the total 
composition of the extract. Variation between and within TLC plates might also 
exert an influence on operator error, but the presence of an external standard meant 
that these should not be major factors. Purified antibiotics which were used to 
identify specific antibiotics allowed between plate variation to be measured. The Rf 
of a geldanamycin standard from 10 different TLC plates gave a standard error of 
0.013. (The mean Rf was likely to lie + /- 0.0257 from the measured spot in 95% 
of cases and + /- 0.034 in 99% cases).
The humidity at the time of application and during development in the tank 
can cause variations in Rf and this is especially true for lipophilic substances. A 
multi-component solvent system was used and therefore the development distance 
was important because the solvent system would partially separate along the 
chromatograph, making the Rf value dependent upon the developing distance in 
relationship to the starting point. TLC plates were therefore developed to 1cm 
below the top of the plate and the tank atmosphere was kept saturated to prevent the 
solvent from evaporating off the layer during chromatography.
The measurement of within plate variation required an internal standard to 
be present within each extract; this was difficult because it had to be distinguishable
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from other spots in the study (Fig S .l) and also the RF of any standard might be 
affected by the other compounds in the extracts. It was possible to take various 
precautions, which might prevent plate effects; the tank atmosphere was kept 
saturated and TLC plates did not touch each other or the filter paper (used to 
saturate the atmosphere) and so the solvents could not rise by capillary action. (A 
non-saturated atmosphere would allow mote volatile constituents of the multi- 
component solvent to evaporate from the TLC plates in a preferential manner; the 
rate of evaporation would decrease from the edge to the middle of the plate, causing 
Rf values to increase from the centre to the edge of the plate.)
5.4.2. Reproducibility of Samples.
Forty sets of strains, which were duplicated from growth in a shake flask up 
to TLC, were included in the study. The mean probability o f erroneous spots 
between duplicate strains was 10.6% (Sneath and Johnson, 1972) and 97.5% 
duplicates contained erroneous results. The error between replicated strains was 
probably partially due to operator error, which was 6.4% (Table 5.5) and so an 
additional 4.2% error was due to inconsistency between replicates. Table 5.6. 
shows the spread of errors for each of the most common spots.
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Table 5.6. The distribution of errors for different spots.
Spot No. Errors PI P2 P3
1 12 0.184 0.041 0.143
2 15 0.25 0.024 0.226
3 12 0.184 0.008 0.176
4 10 0.147 0.032 0.115
5 16 0.276 0.041 0.235
6 17 0.306 0.049 0.257
7 16 0.276 0.058 0.218
8 18 0.342 0.058 0.284
9 10 0.147 0.024 0.123
10 10 0.147 0.008 0.139
11 16 0.276 0.085 0.191
12 13 0.25 0.145 0.105
13 18 0.342 0.032 0.31
14 21 0.388 0.085 0.303
13 18 0.342 0.194 0.148
16 17 0.306 0.245 0.061
The total number of errors was 241 and this gave an overall test error of 10.6%.
Key:
PI ■ P erroneous result (between duplicate strains).
P2 -  P operate»' error (taken from Table S.S.).
P3 -  P1-P2: Strain error.
The "No. Errors" column refers to the number of errors, which were observed 
between duplicate strains (PI).
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The reproducibility of two standard producing strains was examined in 
detail. These were NRRL 3602 and AM 3672, producers of gddanamycin and 
herbimycin respectively. Extracts that had been taken from different cultures of 
these strains, which were produced on different dates were run alongside one 
another (Fig. 3.2.) and were found to be highly variable. A second series of 
extracts, which had been produced in different flasks, but at the same time (Fig 
3.3.) were also highly variable. This problem was overcome by making large 
extractions, freezing them and using the same samples as external strain standards 
on all subsequent plates.
Variations in inoculum size might have been an important factor in 
determining the metabolic status of a culture at the time of extraction and because a 
complex medium (A37) was used the probability of creating alterations in gene 
expression might have been increased. Variation of physical factors, such as 
opening and closing incubators, switching the shaker and lights off and on could 
have caused transient changes in temperature, oxygenation, shear factors and 
illumination. All these variables could happen at random at any point along the six 
day incubation time; the data was accumulated over several seasons and duplicates 
were done randomly within this time period. These variables coupled with the many 
possible thresholds of nutrients and cofactors might be capable of initiating many 
different metabolic effects. In addition, certain metabolic triggers in streptomycetes 
may be intrinsically variable.
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Figs. 5.2. (A; top photograph) and 5.3. (B: bottom photograph)
Fig. S.2. Extracts of AM 3672 and ATCC 3602, which were produced at different 
times.
Key
1 NRRL 3602; extract produced on 1/11/88
2 NRRL 3602; extract produced on 2/11/88
3 NRRL 3602; extract produced on 4/10/88
4 NRRL 3602; extract produced on 10/11/88 
3 NRRL 3602; extract produced on 20/10/88
6 ATCC 3602; extract produced on 1/11/88
7 ATCC 3602; extract produced on 2/11/88
8 ATCC 3602; extract produced on 4/10/88
9 ATCC 3602; extract produced on 10/11/88
10 ATCC 3602; extract produced on 20/10/88
Fig. 3.3. Extracts of different cultures o f AM 3672 and ATCC 3602, which were 
produced at the same time.
1 to 4 -  ATCC 3672 (AM -  ATCC)
5 to 8 -  NRRL 3602
The extracts of all of these samples were produced on the same day, but from 
different cultures, which had been incubated alongside each other.
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5.5. Cluster Analysis
Although the estimates of error showed that the data were not suited to 
clustering, the aim of the study was to assess chemical profiles as both a taxonomic 
tool and a means of predicting bioactivity. An example of clustered data is therefore 
presented in this section. In addition to the sources of error discussed above there 
were probably additional errors which affected the calculation of similarity between 
strains. For example, different compounds could have had the same RF value and 
identical compounds might have been biosynthesised by different biochemical 
routes. This meant that observed similarity did not necessarily equal true phenetic or 
genetic similarity.
5.5.1. The Distribution of Streptomvcetes Based on Chemical Profiles Using 
Hierarchical Methods.
Figures 5.4 and 5.5 show phenograms created using the chemical profiles of 
natural isolates and type strains. Both diagrams were produced using the Dice 
coefficient and UPGMA. Comparison of fig. 5.5. with a phenogram clustered with 
the simple matching coefficient and UPGMA, showed fragmentary resemblance. 
For example, the phenogram based on natural isolates, single member groups were 
intact, but larger groups were separated via groupings of 4-8 strains.
Neither of the phenograms showed a correlation with taxonomic identity or 
with bioactivity. Figs 5.6. and 5.7. illustrate this for 54 groups, taken at 70% 
similarity on the phenogram comprising natural isolates (Fig.5.5). In addition, most 
replicate strains were placed distantly from one another on the dendrograms. Nine 
of the bioactive strains with rare spots (section 5.6) and five other bioactive strains 
were placed in single member groups. However three out of the four producers of 
antibiotics with possible novel activities were in the two groups with the largest 
numbers of members.
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Fig. 5.4. Phenogram showing relationships between type strains, based upon TLC 
profiles.
Binary data based on TLC profiles were used to create the phenogram; 
similarity values were calculated using the Dice coefficient and the UPGMA 
algorithm was used to form the diagram.
The names of the type strains used are given on the diagram.
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Fig. 5.5. Phenogram showing relationships between natural isolates, based upon 
TLC profiles.
Binary data based on TLC profiles were used to create form the phenogram; 
similarity values were calculated using the Dice coefficient and the UPGMA 
algorithm was used to form the diagram.
Binary data based on TLC profiles were used to create form the phenogram; 
similarity values were calculated using the Dice coefficient and the UPGMA 
algorithm was used to form the diagram.
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PHENOGRAH BASED ON TLC PROFILES
Fig. 5.6. The distribution of Streptomyces species across the phenogram (Fig. 5.4.).
The diagram is a stacked bar chart showing the proportion of strains in each 
of 54 groups (as shown in Fig. 5.4.), which identified to strain clusters as defined 
by Williams et al. (1983a).
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Fig. 5.7. The distribution of bioactive natural isolates across the phenogram (Fig.
5.4.).
The diagram illustrates how bioactive natural isolates were distributed with respect 
to their TLC profiles and shows that no discrimination was made between antibiotic 
producers and non-producers. In addition (not illustrated by the diagram) no pattern 
was observed with respect to the distribution of producers of chemically related 
antibiotics.
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5.5.2. Ordination o f Streptomvcete Chemical Profiles.
Principle components analysis was carried out on the binary data from this 
study where cluster 32 strains tended to be located either side of the y axis 
(Fig.5.8.). A small group of strains which produced both nigericin and 
geldanamycin remained closely associated as the ordination diagram was rotated 
(Figs. 5.9. and 5.10.); one of these strains (present in replicate) also produced a 
compound which might have novel agrochemical activity. The formation of this 
group may be explained by the fact that geldanamycin (and possibly spots 
correlating with the production of nigericin and other antibiotics) would be present 
within the profile. Apart from these two observations, no other correlations were 
observed amongst these data.
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The diagram illustates how most S.violaceoniger strains clustered to an area, 
which surrounded the y-axis.
S.violaceoniger strains are shown by circles as opposed to spots, which 
denote other strains.
Fig. S.8. Principle components analysis o f TLC profiles to show the position of
members of the S.violaceoniger group.
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1
The diagram shows how nigericin producers did not form a cluster, apart 
from a small group of strains, which also produced geldanamycin.
The nigericin and geldanamycin produce» are shown by a circle and a 
number, which refers to their position within the original data matrix. Other strains 
are represented by a spot.
Fig. 5.9. Principle components analysis o f TLC profiles, to show the position of
nigericin producers.
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The diagram is the same as Fig. S.9., but is presented in a different orientation. It 
shows the position of a small group of strains, which produced both nigericin and 
geldanamycin.
The nigericin and geldanamycin producers are shown by x and a number, 
which refers to their position within the original data matrix.
Fig. 5.10. Principle components analysis o f TLC profiles, to show the position of
nigericin producers.
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5.7. Recognising Interesting Strains Using TLC 
Table 5.7. Strains with rare spots.
Spot No. Strains Strain Names
17 4 C70 C129 D5 F89
18 6 C6C11C15C33C212 D153
19 10 C3 C4 C52 C70(2) C77(4) 
C108(2) C206(2) C314 C341 E8
20 6 C ll  C141 C212 C314 C341 W98.1
21 3 C52 C203 F53
22 4 C141 D2 F53 F139
23 2 C77 C141
24 2 C70 D52
25 3 C ll C32 F89
26 1 C15
27 2 C208 C212
28 2 C208 C314
29 2 C222 F89
Total 47 29
The rare spots are numbered from 17 to 29 and the strains, whose extracts contained 
each of the rare spots is given in the last column with the number of replicates, 
which gave a spot in parentheses, if it was more than one.
Twenty-nine spots were scored in all, but thirteen o f these were very rare 
(Table 5.7.)and were only observed in twenty-nine strains (NB. six of these strains
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contained two rare spots, whilst a further six had three). Approximately 25% of the 
strains examined in Chapter 3 proved to be bioactive, compared with 45% of strains 
which could be selected because their extracts contained an unusual spot. There 
were two strains in this study, which produced compounds which might be novel 
agrochemicals (E8 and F139), although it is not known whether the rare spots 
comprised bioactive compounds. Zahner et al (1982) carried out a similar study and 
tested unique spots for biological activity. He found that 3 out of 5 compounds 
comprised novel antibiotics with slight antibacterial properties. The antibacterial 
activities observed in this work were not followed up, but six strains showed 
unidentified activities against B.subtilis.
5.7. Conclusions.
The errors observed in this study meant that the data collected were poorly 
reproducible and therefore were unsuitable for taxonomy. Hierarchical and non- 
hierarchical cluster analysis did not allow the delimitation of species-groups or the 
prediction of bioactivity. However, TLC was of possible use for predicting 
bioactive strains by choosing those with unusual spots.
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CHAPTER 6
Relationship Between Antibiotic Resistance Phenotype and Biological Activities. 
6.1.1. Introduction.
Selected Streptomyces species have distinctive antibiosis and resistance 
patterns, therefore resistance to antibiotics has been used for both classification 
(Wellington et al., 1987) and selective isolation (Wellington et al., 1990), but in 
general, antibiotic production and resistance is strain specific (Hotta et al., 1983a 
and b, Okami and Hotta, 1988). Characterization by resistance to a wide variety of 
macrolide and aminoglycoside antibiotics has shown that many streptomycetes have 
individual patterns o f multiple resistance. Fujizawa and Weisblum (1981) reported 
finding a diverse range of resistance phenotypes to macrolide, lincosamide and 
streptogramin antibiotics and Hotta et al. (1983a) showed a wide variety of 
aminoglycoside-resistance patterns in type strains and natural isolates.
A number of studies have reported that biosynthesis and resistance genes are 
genetically linked (Chater and Bruton, 1983; Murakami et al., 1986; Skeggs et al., 
1987), but few studies have been concerned with the distribution of antibiotic 
production (Chapter 3) and resistance phenotypes or their corresponding genotypes 
in natural populations of streptomycetes. It is known that producers of auto-toxic 
compounds require self-defence mechanisms to secure survival against their own 
products (Cundliffe, 1986, 1989), but resistance mechanisms are not limited to such 
strains (Fujizawa and Wiesblum, 1981). For instance, resistance to kanamycin is 
exhibited by the producer, S.kanamyceticus (Murakami et a l., 1983, Cundliffe, 
1986) and S.griseus (Hotta, 1988), S.tenebralus (Skeggs et al., 1987) and 
S.tenjimariensis (Skeggs et al., 1986 and 1987), which are also aminoglycoside 
producers, but do not produce kanamycin. More strikingly, the non-producer 
S.Uvidans has an inducible rRNA methylase (Jenkins et al., 1989) and a variety of
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strains, which do not biosynthesize chloramphenicol are known to produce O- 
acetyltransferases, which detoxify this drug (Murray et a l., 1989).
The requirement for self-resistance determinants has been used in certain 
studies to demonstrate that strains which produce identical compounds can be 
grouped together on the basis of resistance to antibiotics of the same chemical 
family (Fujizawa and Weisblum, 1981; Hotta et al., 1983a; Bibikova et al., 1990). 
There is also evidence that novel compounds can be found by selecting strains with 
unusual resistance profiles and indolizamycin was discovered during protoplast 
fusion experiments because the resistance patterns of the producing strain differed 
from those of the two parental strains (Yamashita et al., 1983b).
There may be a link between unusual resistance profiles and the production 
of specific secondary metabolites. If so, antibiotic-resistance profiles could be used 
to select strains capable of producing certain classes of biologically active 
compounds from natural populations. This work was aimed at testing this hypothesis 
and at evaluating the phenotypic diversity of streptomycete populations based on 
antibiotic-resistance profiles. Such information is also o f  ecological interest, since 
the survival of soil microorganisms depends upon their ability to find suitable niches 
in which they can grow and survive. Antibiotic production and resistance are 
specializations, which have been attributed with survival functions (Williams et al., 
1989). Expression of antibiotic resistance in soil isolates could have implications for 
the production of antibiotics in the natural environment and may reflect selection 
pressures, which influence Streptomyces species in situ. Other implications of the 
work concern the evolution of secondary metabolism and the dissemination of 
relevant genes. The distribution of a variety of antibiotic-resistance phenotypes was 
therefore determined within a selection of soil isolates.
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6.1.2. Choice of Strains,
145 strains were chosen to represent a heterogeneous group of 
streptomycetes from different geographical locations and which were obtained using 
a variety of isolation methods (Tables 2.1 and 6 .1).
Table 6.1. Natural isolates selected for the study of antibiotic resistance patterns.
Strain
Series
No.Strains
A 7
B 1
C 58
D 26
E 6
F 2
MM 5
MEL 6*
CAG 22*
RB 3
JHCC 9*
Total 145
* The CAO, MEL and 5 of the JHCC strains were not used in the clustering 
described in section 6.4. This leaves 112 strains which were used in the cluster 
analysis.
A variety of type strains were chosen to represent a selection of known 
antibiotic producers and these are indicated in Table 2.2. Table 6 .2 . summarizes the
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cluster groups (Williams et al., 1983a) to which the type strains and any identified 
isolates belong. More details about identified isolates are given in Table 2.9.
table t.2 . Taxonomic identity ot strains used for analysis of antibiotic resistance.
Cluster Group No. Type Strains No. Isolates
C l 14 (1) 4(3)
C6 K D 0
C12 0 2 (2)
CIS 0 2 ( 1)
C18 K D 2 (0)
C19 2 (1) 8(5)
C21 5(5) 0
C32 9(9) 10 (10)
C37 0 1 (0)
C44 K D 0
C61 4(1) 0
C64 KO) 0
C68 K D 0
S.spp. 6(4) 116(91)
Srv.spp. 3(1) 0
Total 48 (26) 145(112)
Numbers in parenthesis refer to the number of strains used in the cluster analysis 
(Section 6.4). Details on individual strains are presented in Table 2.9. and the 
products o f the type strains are given in Table 2.2., whilst the bioactivity of the 
natural isolates included in this study is presented in Table 3.1.
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Results.
6.2. The Distribution of Antibiotic Resistance in Streptomvcetes.
6.2.1. The Distribution of Antibiotic Resistance in Natural Isolates.
Figures 6 .1 and 6.2. show the distribution of ten antibiotic resistances within 
a random population of Streptomyces isolates and type strains used for cluster 
analysis (Section 6.4.). There were two forms of distribution for antibiotic 
resistance within the population; increasing concentrations of some antibiotics 
elicited an exponential decrease, followed by a major change in gradient, where the 
resistant population became more constant and this identified populations of 
resistant and sensitive strains. The second type of resistance distribution occurred 
when antibiotics had a linear graph, showing a more gradual variation of phenotype. 
It was difficult to define resistant and sensitive populations for this type of 
distribution and so for the purposes of clustering an arbitrary value was assigned. 
Consequentially these data had a greater probability of giving an erroneous result 
(Table 6.4.). The most commonly occurring resistances within the population of 
isolates was also illustrated by Figs.6.1. and 6.2. Resistance to aminoglycosides was 
rare and only seen at low levels of the antibiotics, whilst penicillin, nigericin and 
oxytetracycline resistances were common.
The quantitative data were converted to qualitative data, using the 
distribution of each antibiotic resistance as a guideline. Strains, which showed a 
minimum inhibitory concentration before the elbow of a curve were designated as 
sensitive and those showing growth beyond it were called resistant. The extrapolated 
cut-off values were 2 pg/ml for neomycin, blasticidin, kanamycin and viomycin, 
3.5 pg/ml for streptomycin, 5 ug/ml for thiostrepton, 15 pg/ml for nigericin, 20 
Mg/ml for novobiocin, 40 jxg/ml for erythromycin, 45 pg/ml for oxytetracycline and
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The graphs show the distribution of resistance to 8 antibiotics, within the random 
population of streptomycetes isolates, studied. The y axis shows the proportion of 
the population that were resistant, whilst the x-axis shows a range o f antibiotic 
concentrations, which were extrapolated from the distance of mycelial growth, 
which occurred along antibiotic gradient plates.
Fig. 6.1. The distribution of antibiotic resistance phenotypes within a population of
Streptomyces natural isolates.
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The graphs show the distribution of resistance to 2 antibiotics, within the random 
population of streptomycetes isolates, studied. The y axis shows the proportion of 
the population that were resistant, whilst the x-axis shows a range of antibiotic 
concentrations, which were extrapolated from the distance of mycelial growth, 
which occurred along antibiotic gradient plates.
NB. Kanamycin resistance is omitted from the diagram because it was only 
observed at a low level for a single replicate of one natural isolate.
Fig. 6.2. The distribution of antibiotic resistance phenotypes within a population of
Streptomyces natural isolates.
192
PE
NI
CI
LL
IN
 G
 
BL
AS
TI
CI
DI
N
_
95 fig/ml for penicillin, but these could also be given as distances of the lines of 
growth along the gradient (Section 2.7.1). Test error calculations, pattern analysis 
and clustering were carried out on these binary data.
Some of the extrapolated cut-off values determined for this work appeared to 
be at low antibiotic concentrations, but they reflected the distribution of antibiotic 
resistance and sensitivity within the population studied. A similar study to the above 
was carried out by Shaw et al. (1991), who correlated antibiotic-resistance patterns 
in clinical isolates with hybridization to resistance gene probes. In that study a cut- 
off-point between resistance and sensitive strains was determined by using known 
concentrations of antibiotics in disc susceptibility assays, where a minimum zone 
size was used as a guideline for delimiting the population.
6.2.2. The Diversity of Antibiotic Resistance Profiles.
Table 6.3. gives the profiles of resistance, which were observed for 193 
different strains. The duplicates of each strain were merged into one profile by 
assigning a mismatch as positive arbitrarily (this was not done for the cluster 
analysis, where duplicated data were included). Although there are 4 x 107 (11!) 
theoretical antibiotic-resistance profiles, 83 strains exhibited unique patterns, whilst, 
a further 21 patterns were distributed amongst 110 different strains. One hundred 
and ninety strains contained at least one of the three most common antibiotic 
resistances and 25% isolates had a sensitive phenotype apart from showing 
resistance to penicillin.
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Table 6.4. The distribution of antibiotic resistance patterns within a population of
Streptomyces isolates.
The table shows 21 resistance profiles, which were present in more than one strain 
each, but there were also a wide variety of unique antibiotic resistance patterns.
Key:
+  means that resistance was shown at the cut-off concentration 
- means that sensitivity was shown at the cut off concentration
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6.2.3. A Comparison Between Resistance Phenotypes Observed on 
Complex and Defined Media.
Resistance was determined on antibiotic gradient plates made from AGS, 
which is a defined medium and is different to the complex medium A37, which was 
used to generate bioactivity. It was of interest to know how the expression of 
resistance would differ on a complex medium and therefore a solid form of A37 
(15g/l agar) containing the antibiotic viomycin (in the gradients) was examined with 
the use of 64 duplicate strains from the above study. Results showed 4 resistant 
strains on A37; two of these had not shown resistance on AGS, whilst the others 
had grown to a greater distance along the A37 gradient. The latter might reflect 
differences in expression levels or differences in diffusion effects along the two 
types of gradient (see also section 6.3.3.)
6.3. Examination of Reproducibility and Test Error.
The data were assessed for suitability for use in cluster analysis, by 
determining error found within tests and duplicate OTUs.
6.3.1. Error Within Tests.
Table 6.4. shows the error found in each resistance test, calculated according 
to Sneath and Johnston (1972), from a total of 130 duplicates (138 had been used 
for the cluster analysis, whilst the additional 12 pairs comprised replicates of some 
of these strains). The mean test error fell below the recommended value of 3%. 
Although the test for penicillin resistance showed error above the 10% level of 
acceptability.
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Table 6.4. Table to show the presence of error in antibiotic resistance tests.
Resistance No. Discrepancies Test Error %
Penicillin G 33 12.383
Nigericin 26 9.386
Blasticidin 19 6.795
Erythromycin 19 6.795
Oxytetracycline 19 6.795
Thiostrepton 11 3.812
Novobiocin 9 3.096
Viomycin 6 2.042
Streptomycin 5 1.695
Neomycin 4 1.352
Kanamycin 1 0.335
The error for the whole series of tests was 4.84
Error increased as the occurrence of an antibiotic resistance increased and 
there was also a high probability of error when there had been difficulty in 
assigning a cut-off concentration, which distinguished between resistant and 
sensitive populations (penicillin, nigericin, oxytetracycline). The strains responsible 
for the erroneous results were examined in detail (section 6.3.2.).
6.3.2. Examination of the Stability of Resistance in Strains Causing Erroneous 
Results in Antibiotic-Resistance Profiles.
Two types of discrepancy could occur. Either a strain showed resistance in 
both replicates of the test, but one of the duplicates fell below the level at which a 
strain was called resistant (section 6 .2 . 1) or a strain was completely resistant in one
1 9 6
test and completely sensitive in another. Table 6 .S. shows the distribution of 
discrepant results in ISO pairs of OTU's and gives the mean probability of error for 
the two types of discrepancy.
laDie t o .  m e distribution of two types of discrepancy for antibiotic resistance 
profiles.
Total Discrepancy Resistant
Resistance Number Around Versus
Cut-Off Point Sensitive
Penicillin 33 22 11
Nigericin 26 11 15
Blasticidin 19 9 10
Oxytetracycline 19 14 5
Erythromycin 19 11 8
Novobiocin 9 8 1
Thiostrepton 11 4 7
Neomycin 4 0 4
Streptomycin 5 1 4
Viomycin 6 0 6
Kanamycin 1 0 1
No Errors 152 80 72
P error 4.84 2.49 2.23
In an attempt to understand errors between duplicates further, the lowest level of 
resistance, for a discrepant pair, was subtracted from the highest resistance and the 
resulting value was divided by the highest concentration on the gradient plate. The 
resulting figure (the fraction of the gel, involved in the discrepancy) was used for a 
comparison of all discrepancies from all antibiotics. An average of 40.1% of the
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gradient was involved in strains with a discrepancy about the cut-off point (Sd = 
0.249). The mean % gradient involved in the second type of discrepancy was 
51.3% (Sd ■* 0.326). The distribution of discrepancies amongst the strains was also 
examined and 17 strains with 3 or 4 anomalous results each, were highly variable 
with respect to expressing antibiotic resistance and they contained 35.5 % of all 
errors. A further 20 strains, with 2 errors each, had 26.2% of the error. Minor 
discrepancies could be due to error in pouring gradient plates and differences in test 
conditions affecting antibiotic diffusion in the plates, whilst other anomalous results 
may have been due to differences in resistance and may have been caused by 
differential gene expression.
6.3.3. The Estimation of Minimum Inhibitory Concentrations from Antibiotic 
Gradient Plates.
Antibiotic in the top layer of a gradient plate might be expected to diffuse to 
the base layer in a complex manner, therefore some work was carried out to see 
how closely antibiotic concentrations estimated from gradient plates reflected 
antibiotic levels found in pour plates at the corresponding concentration. The results 
are shown in Table 6.7.
A log-dose response curve was produced for streptomycin and found 
to be linear from 1 fig to 10 mg (Fig 6.3.). This involved a filter paper assay and 
was intended to be used for the quantification of streptomycin in TLC extracts, 
rather than for use in this experiment and was therefore not done for the other 
antibiotics. However it may allow a rough idea of the extent to which antibiotic 
concentrations changed with differences in zone size (although diffusion from the 
plug onto the assay would be slower than from a filter paper disc and might retain 
more o f the antibiotic). The zone size for 3.5 fig of streptomycin was 18.2 mm on 
the conventional log dose response curve, whilst 15.7 mm was given as the average 
zone size corresponding to 3.5 fig/ml in an agar plug (2 fig/ml on the log dose 
response curve). The zone size from the gradient plate was larger (17.3 mm) and
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corresponded to 2.5 pg/ml on the log dose response curve. Some diffusion of 
antibiotic from the more concentrated to the less concentrated areas of gradient 
plates has taken place, but the extent of diffusion effects may differ along the 
gradient (perhaps with more downward diffusion at the lower concentration, but 
more sideways diffusion at the higher concentrations). The smallest and most polar 
antibiotics in this study were the aminoglycosides and one might therefore expect 
that any diffusion observed for other antibiotics would be less than for these; 
although more experimentation would be required before this could be assumed.
Table 6 .6 . Comparison of bioassav from antibiotic gradient and pour plates.
Antibiotic Concent- 
- ration 
0 *g/ml)
Pour Plate 
mean diam. 
(mm)
Gradient Plate 
mean diam. 
(mm)
Thiostrepton 5 26 25
Neomycin 2 11 12
Kanamycin 2 13 16.7
Streptomycin 3.5 15.7 17.3
Agar plugs were removed from pour plates and gradient plates, containing known 
and estimated antibiotic concentrations; these were then compared by use of an 
inhibition assay (section .2.7.2.)
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Fig.6.3. Log dose response curve for a streptomycin bioassay.
The graph shows a log dose response curve for streptomycin on filter paper discs. 
The graph was linear from lpg to lQmg; the units for the zone diameters were in 
mm and the antibiotic concentrations in ng.
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6.4. Hierarchical Clustering on Qualitative Resistance Profiles.
6.4.1. Comparison of Phenoerams Formed Using Different Coefficients and
Algorithms.
The nature of the data was carefully considered prior to clustering. It was 
concluded that a negative match was not always a true measure of similarity 
between strains, because it was possible that some strains were measured as 
sensitive when they were observed under incorrect conditions for expression of 
resistance. Consequentially a similarity coefficient, which did not consider negative 
matches was thought useful (eg. S^ice and Sj). Since duplicates were computed a 
mismatch might also be due to strain variability and so the Dice coefficient was 
chosen over Jaccard's because it weights against mismatches relative to matches and 
would prevent the underestimation of similarity values. The error calculated in 
section 6.3. relates to clustering using the simple matching coefficient, but could 
exert a greater effect on the clustering when using a coefficient which ignores 
negative matches. Clustering was therefore also done using the simple matching 
coefficient for comparison.
Figs. 6.4. and 6.3. show 4 phenograms made using the resistance data. The 
first two use Ssm and with UPGMA. Close examination of groupings showed 
that the same strains remained close relatives in each phenogram and although some 
group distortions were observed, there was good agreement with respect to 
observations made below (section 6.4.2.). Cophenetic correlation of the phenogram, 
which used Dice, gave a mantle statistic of 0.78, which showed reasonable 
agreement with the similarity matrix.
A comparison of different clustering algorithms was also made to minimise 
the chances of accepting misleading results. The phenograms of Fig. 6.3. show 
single and complete linkage with the Dice coefficient. Single linkage showed poorer 
group integrity, whilst complete linkage made groups which were more spread out, 
although
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A shows a phenogram created using and UPGMA.
B shows a phenogram created using Ssm and UPGMA.
The position of group 3 is highlighted on both phenograms to illustrate that the 
trends, which are discussed in Section 6.4. were apparent in all of the phenograms 
studied.
Fig. 6.4. Phenograms, which show relationships between natural isolates based on
their antibiotic resistance profiles.
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0.78 l.i
A shows a phenogram created using S^ice suid Complete Linkage.
B shows a phenogram created using S^ice and Single linkage.
The position o f group 3 is highlighted on both phenograms to illustrate that the 
trends, which are discussed in Section 6.4. were apparent in all of the phenograms 
studied.
Fig. 6.5. Phenograms, which show relationships between natural isolates based on
their antibiotic resistance profiles.
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Group 3
Group 3
there was still good agreement with respect to observations made below (section
6.4.2. ). The phenogram, which was formed, using average linkage was chosen to 
present results (Fig. 6 .6 .), but it is emphasised that all phenograms allowed the 
delimitation of clusters with differing bioactivity in terms of agrochemical interest 
(Fig. 6.7.).
6.4.2. The Distribution of Bioactive Strains in the Major 
and Minor Clusters.
The strains formed 5 major and S minor clusters at 51% similarity (Fig.
6 .6 .). When the distribution was examined with respect to bioactivity (Fig. 6.7.), 
cluster 3, which contained 37.59% of all strains in the study was comprised mostly 
of the strains which did not produce biologically active compounds. Those which it 
did contain were all natural isolates comprising a nonactin producer (C208), which 
has since been shown to have novobiocin resistance, a producer of either 
cycloheximide, nonactin or nigericin and two strains which produced antibacterial 
compounds which were inactive on agrochemical screens. All antibiotic-producing 
type strains were distributed outside cluster 2. There was no correlation between the 
class of antibiotic a strain produced and the group to which it clustered.
6.4.3. The Distribution of Resistance Phenotypes in the M^jor and Minor Clusters. 
Table 6 .8 . illustrates how groups of strains in cluster 3 were phenotypically
less resistant than the other groups of strains. The main resistance exhibited by 
strains in this cluster was penicillin, the most commonly observed resistance for the 
population (Figs. 6.1. and 6.2.). Penicillin resistance was present in large numbers 
o f strains in all mqor clusters, but was rare in the minor clusters (6-10). It did not 
contribute to the separation of bioactive from non-bioactive strains, but its rarity in 
the less similar clusters (6-10) showed that penicillin sensitivity could be useful in 
identifying unusual strains.
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The diagram illustrates the 10 groups of strains, which were defined at 51% 
similarity. It also shows how the phenogram could be divided into 4 areas.
Area 1 comprised clusters 1 and 2, which contained strains with multiple resistance, 
many of which produced antibiotics.
Area 2 comprised cluster 3 and antibiotic production was not observed in strains 
which clustered to this group
Area 3 comprised clusters 4 and S, which contained strains with multiple resistance, 
many of which produced antibiotics.
Area 4 comprised the 3 minor clusters (6-10) and contained strains with the more 
unusual or least similar profiles.
Fig. 6.6. Phenogram to show the relationships o f  Streptomyces strains based on
their antibiotic-resistance phenotypes.
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The diagram is a stacked bar chart and illustates the percentage of strains, which 
produced antibiotics and the percentage of strain, which were resistant to 4 or more 
antibiotics. Obviously a strain can have both attributes and the height of the bars can 
exceed 100%.
Fig. 6.7. The distribution o f multi-resistant and biologically active strains across a
phenogram based on antibiotic resistances (Fig. 6.6).
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Table 6.1. The distribution o f antibiotic resistance in the major and minor clusters.
Cluster % Strains with Resistance to:
(No.) Thio Strep Vio Pen Blast Nig
1(60) 35.0 10.0 11.7 76.7 88.3 76.7
2(21) 4.8 71.4 0.0 33.3 0.0 0.0
3(103) 0.0 0.0 2.9 100.0 0.0 1.0
4(59) 35.6 1.7 3.4 83.1 0.0 86.4
5(17) 41.2 5.9 11.8 100.0 35.3 17.7
6(2) 50.0 0.0 0.0 0.0 100.0 0.0
7(5) 20.0 100.0 0.0 60.0 40.0 0.0
8(7) 14.3 71.4 0.0 42.9 28.6 0.0
9(2) 100.0 0.0 0.0 0.0 0.0
10(3) 0.0 0.0 0.0 0.0 0.0 0.0
Mean 19.0 5.0 6.8 87.8 24.0 40.4
SD 18.7 4.2 4.3 23.3 36.6 39.5
Mean values were calculated from the % strains, which were resistant within each 
cluster group and took into account the number of strains, present in each group.
Key:
Thio *  Thiostrepton Novo — Novobiocin
Strep — Streptomycin Ery — Erythromycin
Vio -  Viomycin Oxyt -  Oxytetracycline
Pen =* Penicillin O Neo ”  Neomycin
Blast -  Blasticidin Kan — Kanamycin
Nig -  Nigericin
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Table 6.7. The distribution of antibiotic resistance in the major and minor clusters.
Cluster % Strains with Resistance to:
(No.) Novo Ery Oxyt Neo Kan
1(60) 23.3 33.3 71.7 0.0 0.0
2(21) 100.0 0.0 0.0 0.0 0.0
3(103) 1.9 0.0 0.0 0.0 0.0
4(59) 13.6 3.4 5.1 5.1 1.7
5(17) 0.0 100.0 11.8 5.9 0.0
6(2) 0.0 100.0 0.0 0.0 0.0
7(5) 0.0 40.0 20.0 0.0 0.0
8(7) 0.0 28.6 14.3 0.0 0.0
9(2) 0.0 0.0 50.0 0.0 0.0
10(3) 33.3 0.0 0.0 0.0 0.0
Mean 0.0 13.4 15.8 1.4 0.4
SD 25.6 26.7 28.6 0.5 0.7
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The remaining groups contained a variety of antibiotic resistances and each 
cluster had a specific profile, which was responsible for its separation from the 
others. All nine clusters, which contained bioactive strains were distinguished from 
cluster 3 by containing strains with resistances other than penicillin. The 3 minor 
clusters (6-10) comprised smaller ranges of resistance than clusters 1, 2, 4 and 3 
and contained strains with the most unusual profiles. The milbemycin producer 
(A1002) was the only producer of a xenotoxic compound in the study. It grouped to 
cluster 8 , showing it had a very different resistance profile.
6.4.6. The Use of Resistance Profiles to Aid the Selection of Strains for Screening.
Four o f the strains included in the study had individual activity spectra that 
indicated the presence of potentially novel compounds and which warranted 
chemical characterization. This level of interest was typical for the sample size and 
the screens used. In order to test the hypothesis that antibiotic-resistance profiles 
could help select strains for screening, a selection o f 7 new strains were put through 
the clustering system. These strains also produced compounds with possible novel 
agrochemical activity. The results showed that all of the 7 new strains and the 4 
original strains had multiple patterns of between 4 and 7 antibiotic resistances (mean 
— 3.7). Consequentially all of these strains exhibit resistance characteristics which 
would place them in an area of a phenogram that would reinforce their selection as 
worthy candidates for screening.
Strains with multiple resistances appeared to be more likely to produce 
bioactive metabolites and so besides the 21 antibiotic producing type strains 
included in the phenogram, an additional 21 antibiotic producing type strains were 
also examined for antibiotic resistance. 81.4% of these had 3 or more resistances 
and 48.8% had 4 or more. The number of resistances ranged from 1-10 and the 
mean was 4.2 (Sd ■ 2.3). Four type strains had only one resistance, but the 
resistance was not one, which could place them in cluster 3. Consequentially all 
antibiotic-producing type strains would be selected for screening. A total of 6  type
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strains with no reported product were also examined and these also showed multiple 
antibiotic resistance.
6.4.7. The Distribution of Taxonomicallv Identified Strains Across the Phenogram.
Fig 6 .8 . shows the distribution of Streptomyces clusters as defined by 
Williams et al. (1983a), across the phenogram (Fig 6.4). It is apparent from this 
diagram that conventional taxonomy bears no general relationship to antibiotic 
resistance profiles. Table 6 .8. shows the average profile for 4 clusters as defined by 
Williams et al. (1983a). It includes strains shown on the phenogram plus additional 
strains.
A good distinguishing character would be one which was present in 80% or 
more of strains in one group and 20% or less in another group. Only clusters 1, 19, 
21 and 32 had sufficiently large sample sizes for comments to be made.
Streptomycin resistance distinguished cluster 1 streptomycetes from clusters 19, 21 
and 32. Streptomycin resistance has previously been shown to be common in cluster 
1 streptomycetes (Wellington and Cross, 1983). Cluster 32 streptomycetes differed 
to clusters 19 and 21 by their resistance to nigericin. Many more C32s showed 
resistance to nigericin, but it was below the cut-off point for binary data. Many 
C32s produce nigericin and some of these producers were scored as sensitive in the 
binary data.
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Fig. 6 .8 .The distribution of Streptomyces clusters as defined by Williams et al. 
(1983a) across the phenogram (Fig 6.4).
The diagram shows the distribution of 8 Streptomyces species groups (Williams et 
al., 1983a) within 10 groups, which were defined at a similarity level of 51 % on 
Fig. 6.4.
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Table 6.8. The distribution of antibiotic resistance in Streptomvces species,
Cluster
(No)
Thio Neo Novo Vio Strep Nig
32 (19) 15.8 5.3 31.6 10.5 10.5 20.1
1(18) 50.0 27.8 38.9 61.1 83.3 61.1
19 (10) 40.0 10.0 60.0 20.0 20.0 80.0
21(5) 20.0 0.0 60.0 20.0 20.0 80.0
Cluster
(No)
Pen G Oxyt Ery Blast Kan
32 (19) 57.9 20.1 15.8 26.3 0.0
1(18) 88.9 44.4 44.4 0.0 5.5
19 (10) 90.0 60.0 30.0 50.0 0.0
2 1 (5 ) 100.0 40.0 20.0 80.0 20.0
The table shows the distribution of antibiotic resistance within four cluster groups, 
which were defined by Williams et al. (1983a). The figures in parentheses refer to 
the number of strains, which were involved in the calculation.
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6.5. Relationship Between Phenetic Resistance and Antibiotic Production
Subsequent to screening for antibiotic resistance a search was made for 
producers of streptomycin, thiostrepton, novobiocin and blasticidin amongst the 
resistant isolates. This was done to determine i f  resistance was confined to 
producers of the relevant compounds because if this was not the case then the 
observation of a general relationship between multiple antibiotic resistance and 
bioactivity, above, was reinforced.
If any specific relationships were found between specific antibiotic producers 
and bioactivity then this would also be of interest, since one of the problems of drug 
discovery is that novel compounds can be produced in conjunction with known 
broad spectrum antibiotics and this can mean that the novel compounds remain 
unobserved if their spectrum o f activity is similar to that of the known antibiotic. 
For example nigericin is a potent antibiotic produced by many streptomytcetes and 
many nigericin producers also synthesize other bioactive compounds. A second 
problem is the rediscovery of known compounds. It would be of value to predict 
both novel and known broad spectrum compounds prior to screening. The 
relationship between nigericin producers and their antibiotic resistance profile is 
discussed below. Table 6.9. summarises the results discussed.
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Table 6.9. To show the number o f producers o f  specific antibiotics found in this
study.
Antibiotic No Resistant 
Strains 
Tested 
for
Production
No.
Producers
Found
Total No. 
Resistant 
Isolates 
at any 
cone.
Blasticidin 39 1 47
Geldanamycin * 9 *
Nigericin 96 18 96
Novobiocin 11 1? 41
Streptomycin 7 K+D 15
Thiostrepton 7 0 24
The table shows how many of the strains which were phenotypically resistant 
to one of 6 antibiotics were also found to produce that antibiotic. The full 
complement of resistant strains was not always tested and so the final column refers 
to the total number o f strains tested. The figure in parenthesis refers to a sensitive 
strain, which was thought to produce streptomycin.
* A small pilot study to develop gradient plates for the detection of 
geldanamycin failed to find sensitivity to this compound in 25 randomly selected 
strains. A larger study was therefore not undertaken. Although not proven to be 
ubiquitous, resistance to this compound was believed to be highly common. Blanco 
et al. (1986) have shown that certain other producers of RNA polymerase 
inhibitors, show resistance to geldanamycin at a variety of different levels. For 
example Streptomyces lydicus, which produces streptolydigin, was only resistant to 
geldanamycin up to 25 pg/ml. This level was within the range of concentrations 
tested in the pilot study for geldanamycin resistance.
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6.5.1. Nigericin Producers.
Nigericin producers did not cluster to a specific region in any of the 
phenograms studied because each nigericin producer had a unique antibiotic- 
resistance profile. In order to investigate their distribution across the phenograms 
and to assess its predictive value, clusters which contained more than 2 SD above 
the mean number of nigericin producers were selected. 17 strains (64% nigericin 
producers in the study) were detected by using both single and complete linkage 
with the Dice coefficient. When using this system an additional 12 strains which did 
not produce nigericin were diagnosed as being possible nigericin producers.
An alternative means of identifying the producers of specific compounds 
would be to use resistance profiles based on a single subfamily of compounds as in 
the work of Hotta el a l., (1983), who found that specific aminoglycoside resistance 
profiles could be used to predict the aminoglycoside products of various strains. 
Similarly, resistance profiles to a range of polyether antibiotics might prove 
predictive for strains which produce specific polyether compounds.
Nigericin resistance was not useful in predicting production because although 
15% of strains produced it, 40% of strains were resistant to it. Not all of the 
confirmed nigericin producers showed resistance to this compound above the cut-off 
level. This may reflect a difference in the type of resistance mechanism favoured by 
nigericin-producing strains compared to non-producers. Alternatively, the cut-off 
could have been selected at an inappropriate antibiotic concentration, due to the 
shape of the graph or range of concentrations used or else the work carried out on 
an inappropriate medium for the expression of nigericin resistance in some strains.
6.5.2. Producers of Other Compounds.
From 7 natural isolates, which were resistant to streptomycin, one (D147) 
appeared to produce the compound. Another strain (C ll) which was sensitive to 
streptomycin also appeared to produce this compound. One of the novobiocin
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resistant strains was identified as a possible producer of the compound and no 
thiostrepton producers were found. Similarly, blasticidin resistance did not seem to 
be an indicator of the production of blasticidin or of any other nucleoside. O f 39 
blasticidin-resistant strains analysed, only one strain was a blasticidin producer 
(JHCC a type strain supplied by ICI).
6.6. Discussion.
Examination of the resistance and bioactivity data of the total collection of 
strains gave a clear indication that there were two populations of strains; one with 
multiple resistance and the other with multiple sensitive phenotypes. This may be a 
reflection of the natural population and so provided an insight into the distribution 
of antibiotic resistance and biosynthesis genes in the natural environment. If strains 
which do and do not express antibiotic production under laboratory conditions, 
showed similar trends for gene expression in the natural environment, then one 
might expect those which expressed antibiotic production to have a survival 
advantage. It is then interesting to try to understand why strains which do not 
express antibiotic production and resistance have managed to survive alongside 
producing strains. Perhaps antibiotic production does not occur in the natural 
environment, although there is some evidence to suggest that this is possible 
(Demain, 1981 and 1984; Rothroclc and Gottleib, 1984; Martin and Demain 1980). 
Otherwise, these strains may have developed other specializations, which are 
advantageous to survival and might therefore inhabit different microniches than 
antibiotic producers. These could be separated in either time (the organism might 
have a specialization, which allows them to proliferate at a different stage in the 
decomposition cycle) or space (the organism might survive well in microniches, 
which have extreme environmental conditions).
The clustering data supported the observations of others that a correlation 
exists between multiple resistance and antibiotic production (Hotta et al., 1983a).
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An observation made in this study and that of Fujisawa and Weisblum (1981) is that 
antibiotic resistance may not be confined to producers o f these compounds. 
Although, it may be that some strains exhibiting resistance possess a silent form of 
the antibiotic production genes. This is also interesting in ecological terms if 
reflected in the natural environment. Such strains might represent opportunists, able 
to share nutrient pools with antibiotic producers, without expending energy on 
antibiotic production. This distribution of this type of strain may be important for 
understanding the selection pressures, which are present in the soil, if antibiotics are 
present. If not, one wonders why such genes are present in non-producers; perhaps 
they have evolved to carry out other functions or else represent gene transfer events, 
which then proved useful to the organisms.
Resistance profiles obtained using a range of diverse antibiotics were useful 
for predicting bioactivity. Reasons for this could be due to resistance being linked 
with the production of a closely related compound. For for example, Skeggs et al. 
(1987) have shown that single aminoglycoside-resistance determinants can confer 
resistance to several different 2-deoxystreptamine derivatives, namely kanamycin, 
apramycin and gentamycin. Resistance may be linked to another class of compound, 
perhaps with a similar mode of action. An example of this is the erm gene encoding 
for an RNA methylase, which simultaneously confers resistance to a selection of 
compounds from three antibiotic families; macrolides, lincosamides and 
streptogramin B 's (Fujizawa and Weisblum, 1981; Jenkins et al.,1989; Zalacain and 
Cundliffe, 1989). This type of mechanism would also explain certain patterns of 
multiple resistance. Other patterns of multiple resistance may be due to strains 
having an array o f different resistance determinants. It is already known that some 
antibiotic producers have several self-resistance determinants (Rosteck et al., 1991), 
and that others have supplementary genes, which confer resistance to foreign 
products (Skeggs et al., 1986 and 1987; Hotta et at., 1988). Although in these cases 
the foreign compounds are chemically structurally and biosynthetically related to the 
product.
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Exceptions to the trends seen during this work might be better understood by 
considering the role of antibiotics in the natural environment. Certain antibiotic 
resistances in some strains may be present to confer protection against the 
metabolites of other streptomycetes. For example, organisms which produce 
nigericin and penicillin are commonly isolated from the soil. If these compounds 
were produced in the natural environment this could result in a selection pressure 
for antibiotic resistance in streptomycetes. The large numbers of penicillin- and 
nigericin-iesistant strains observed in this study provide evidence for this 
hypothesis.
Alternatively a gene conferring resistance could do so fortuitously, having an 
entirely different function in the host. For example some streptomycetes have two 
pathways of ammonium assimilation and these organisms are resistant to the 
herbicide bialaphos, the target of which is glutamine synthetase. Also some 
resistance genes may not be expressed under laboratory conditions.
These data have lead to many interesting questions about the role of 
secondary metabolism in the natural environment. It also presented an ideal 
opportunity to find out more about the genetic and mechanistic nature of antibiotic 
resistance. By relating antibiotic resistance and sensitive phenotypes to genotype, it 
was hoped that we might come closer to understanding populations of 
streptomycetes in natural ecosystems.
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Chapter 7,
The Distribution of Sequences Hybridizina to Selected Antibiotic Resistance Gene 
Probes and their Correlation with Phenotypic Resistance.
7.1. Introduction.
Antibiotic resistance has been used with other phenetic characters to group 
members of the Sireptomyces genus (Williams et al., 1983a), but species-groups 
formed in this way have been shown to be heterogeneous at the DNA level (Labeda 
and Lyons, 1991) and by 16S rRNA analysis (Stackebrandt et al., 1991). Although 
selected Streptomyces species do have distinctive antibiosis and resistance patterns 
(Wellington and Cross, 1983), there is generally little correlation between antibiotic 
production and taxonomic groupings.
Reasons for the poor correlation between conventional taxonomy, which 
mainly relates to primary metabolism, and antibiotic resistance may include the 
diversity of resistance mechanisms, which exist in nature (Tables 1.2., 1.3. and
1.4.). For example, producers of the same antibiotic may sometimes rely on 
different mechanisms for self-defense. Mosher et al. (1990) showed that the 
chloramphenicol resistance gene of S.venezuelae did not hybridize to the DNA of 
S.phaeochromogenes, although both strains produced this antibiotic. Other antibiotic 
producers, such as S.fradiae, the tylosin producer, contain several resistance 
determinants (four in this case) for the inactivation of a single product (Rosteck et 
al., 1990). Antibiotic resistance has also been found in non-producers (Fujizawa 
and Weisblum, 1981; Jenkins et al., 1989) and also in antibiotic producers against 
foreign metabolites (Skeggs et al., 1986 and 1987; Cundliffe, 1987). Some 
resistance determinants confer resistance to more than one antibiotic in the same 
chemical family (Skeggs et a l., 1987) and others confer resistance to compounds 
which belong to different chemical classes, but have similar modes of action. For
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diversity of resistance mechanisms, which exist in nature (Tables 1.2., 1.3. and
1.4.). For example, producers of the same antibiotic may sometimes rely on 
different mechanisms for self-defense. Mosher et al. (1990) showed that the 
chloramphenicol resistance gene of S.venezuelae did not hybridize to the DNA of 
S.phaeochromogenes, although both strains produced this antibiotic. Other antibiotic 
producers, such as S.fradiae, the tylosin producer, contain several resistance 
determinants (four in this case) for the inactivation of a single product (Rosteck et 
a l., 1990). Antibiotic resistance has also been found in non-producers (Fujizawa 
and Weisblum, 1981; Jenkins et al., 1989) and also in antibiotic producers against 
foreign metabolites (Skeggs et al., 1986 and 1987; Cundliffe, 1987). Some 
resistance determinants confer resistance to more than one antibiotic in the same 
chemical family (Skeggs et a l., 1987) and others confer resistance to compounds 
which belong to different chemical classes, but have similar modes o f action. For
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example the erm gene confers resistance to antibiotics from three chemical classes 
of antibiotic (Fujisawa and Weisblum, 1981; Jenkins et at., 1989; 7.alar»in and 
Cundliffe, 1989). Multiple antibiotic resistance is also an established phenomenon 
(Fujizawa and Weisblum, 1981; Hotta et al., 1983a and b; Phillips et al. in press) 
and patterns of aminoglycoside or macrolide antibiotics have been shown to 
correlate with the production of an antibiotic of the same chemical class.
Detailed studies have been carried out on the biosynthesis and genetics of 
specific antibiotic producers and the regulatory, resistance and production genes of a 
range of species have been found to exist in clusters on their chromosomes (Chater 
and Bruton, 1985; Malpartida and Hop wood, 1986; Weber et a t., 1990). In 
addition, the biosynthesis pathways of many antibiotics have been elucidated 
(Stanzak et at., 1986; Binnie et at., 1989; Pratt, 1989) and certain resistance genes 
have been shown to play a role in antibiotic production (Murakami et a t., 1986). 
Some workers have related the occurrence of resistance genes to the presence of 
homologous sequences within producers of the same or related antibiotics; for 
example, homology to ermE has been found in tnacrolide-producing 
Saccharopolyspora strains, but is not present in macrolide producers from other 
genera (Stanzak et at., 1990). Similarly, homology to a streptomycin-resistance 
gene probe was specific to streptomycin-producing strains of S.griseus, whilst the 
kanamycin resistance determinant of S.griseus was found to be species specific 
(Hotta et a t., 1988). Virtually nothing is known about how such genes and 
antibiotic resistance mechanisms are distributed within natural populations in the 
soil.
Chapter 6 described the grouping of Streptomyces strains according to 
phenotypic antibiotic-resistance patterns. Two distinct populations were observed; 
one comprised strains with multiple and rare resistance phenotypes and many of 
these produced antibiotics, whilst the other contained strains with multiple antibiotic 
sensitivity and did not express antibiotic production. These data provided an 
opportunity to investigate the genetic basis of the resistance patterns and therefore
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was investigated for analysing these profiles further. Determining the distribution of 
sequences which hybridize to portions of cloned antibiotic resistance genes provides 
a first step for establishing the frequency with which specific genes occur in the 
natural environment and may assist in understanding the natural role o f secondary 
metabolism. The probes used are referred to as resistance gene probes, although it is 
understood that these determinants can also be involved in antibiotic biosynthesis.
7.1.1. Strain Choice.
Seventy-four Streptomyces type strains were used for this study and these are 
indicated in Table 2.2 and summarized in Table 7.1. They represented many species 
groups (Williams et al., 1983a and b) and produced a variety of antibiotics of 
different biochemical origin. Certain groups of strains were chosen from culture 
collections because there was evidence that they might light up a specific probe and 
these included a variety of cluster 1, 5 and 32 strains (Williams et al., 1983a). The 
latter were selected because this group has many bioactive members (Aral et al., 
1976), cluster Is were chosen to examine their relationship to the streptomycin 
resistance gene probe and the cluster 3 streptomycetes were chosen for probing with 
the bialaphos-resistance determinant because a strain of Kitasatosporia was known 
to produce phosalacine.
One hundred and two natural isolates were selected from strains studied in 
Chapter 6, including strains with multiple resistance and organisms with phenotypic 
resistances which might correlate with some of the gene probes used. A small 
selection of sensitive strains were also chosen. This study was aimed not only at 
finding more about the distribution of specific resistance determinants in 
phenotypically resistant strains, but also in antibiotic producers. All strains which 
produced potentially novel compounds were included as were strains which 
produced a selection of known antibiotics. Table 2.2. shows the products o f the type 
strains in the study, whilst Table 3.1. shows the bioactivity of the natural isolates.
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Table 7.1. Taxonomic identity (Williams et al. 1983a and b) of strains used in the 
Probing Study.
Number of Strains Number of Strains
Cluster Types Isolates Cluster Types Isolates
1 15 0 32 10 9
3 0 1 37 0 1
5 16 0 42 2 0
6 1 1 44 1 0
7 1 0 55 2 0
12 0 2 61 3 0
15 0 1 64 1 0
18 2 1 68 1 0
19 2 8 S.M.C. 1 0
21 6 0 S.spp 9 78
30 1 0
Key:
S.M.C. means single member cluster group.
Cluster refers to Streptomyces groups which were defined by Williams et al. 
(1983a)
7.1.2. Probes and Controls Used in this Work.
DNA probes used in this work are presented in Chapter 2 (Table 2.4). 
Internal fragments were excised from the appropriate plasmids (Table 2.3) using the 
restriction enzymes given in Table 2.4. Positive controls were chromosomal DNA 
from the Streptomyces strains from which the original genes were isolated (Table 
2.4), but additional positive controls were provided by loading 1 ng o f the plasmid
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containing the restriction fragment onto the filter. DNA from Streptomyces lividans 
66 (John Innes 1326), Erwinia carotovora (SCRI193) and salmon sperm 
(Boehringer) was selected as negative controls.
1.2. Interpretation of Data and Evaluation of Test Error.
One aim of the project was to give information on the likelihood that 
phenotypically resistant strains contained specific antibiotic-resistance genes (so they 
could be prioritized for future studies). This was assessed using highly stringent 
conditions and by choosing strains whose DNA samples gave a signal near to that of 
the positive control. A second aim of this research was to use results from DNA 
probing experiments as systematic information and for this work all signals which 
were stronger than the negative controls (usually no signal) were used. These 
constraints were also used when scoring positives at lower levels of stringency.
Random primed labelling (Feinberg and Vogelstein, 1983) was used to 
create radioactive DNA for probing and so the size of the hot DNA fragments 
varied in length. This meant that small highly conserved motifs could bind to 
labelled DNA at very high stringency, even though they did not indicate the 
presence of the entire probe sequence. This type of binding may account for some 
of the weaker signals observed at high stringency and may or may not indicate the 
presence of sequences which were related to the appropriate gene probe. The high 
G +C  content o f  Streptomyces DNA makes reiterations of small sequences more 
likely than in organisms which have a more even distribution of nucleotides in their 
DNA and it is therefore possible that some small homologous motifs which caused 
positive signals bore no relationship to the gene probes which were used.
The washing conditions were varied by using permissive and stringent salt 
concentrations so that gene sequences of varying levels of related ness might be 
indicated. The specific level of homology varied depending upon the G +C  content 
of the DNA sequence used for probing (Table 7.2).
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Table 7.2. The levels of  homology, which relate to hybridization to specific gene 
probes under various conditions of stringency.
Washing Conditions (0.1 % SDS + )
Gene G+C% of 
Probe
3xSSC lxSSC 0.2xSSC
aphD 68.55 66.86 74.82 87.43
bar 68.76 66.78 74.74 86.34
vph 76.0 63.81 71.77 83.37
aph 76.18 63.74 71.7 83.3
tsr 59.98 70.6 78.34 89.9
Mean 69.89 66.32 74.28 85.88
Average for Streptomyces DNA:
73 65.04 73
The above data were calculated from the following equation:
Tm -  81.5 +  16.6 (logM) +  0.41 (G+C%)
Tm was the melting temperature and M was the molarity of the salt solution 
A 1° change of temperature was assumed to be equivalent to a 1 % change in 
homology.
The sequence of the novobiocin-resistance determinant is not known, 
therefore a G +C  content of 73%, (Hopwood et a l., 1985) has been assumed.
84.6
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Positive signals declined as expected when stringency was increased from 
3xSSC and 0 .1 *  SDS to 0.2xSSC and 0.1% SDS (Table 7.3.). Fig. 7.1. gives an 
example of various stringent washes, after probing with aphD. A grid is provided 
showing the positions of each strain and the figure legend indicates which strains 
were scored positive for hybridization with the gene probe (replicate filters, in the 
same grid format, were used in the other experiments using different probes). The 
probability of non-specific binding within specific samples, which was due to 
protein contamination of DNA samples was another possible cause of weak signals, 
but was thought to be low because only 1.13% of strains hybridized with all six 
probes at high stringency.
It was possible to evaluate operator error for dot blots, which were probed 
with aphD at the lowest stringency and which were developed, both using the 
phosphorimager and by autoradiography. Autoradiography was the most common 
method and spots were read by eye, whilst the phosphorimager allowed the spot 
intensities to be quantified. An intensity, which was stronger than the count for the 
negative controls and which resulted in the same percentage positive strains as 
autoradiography was chosen from the phosphorimage (2000). Comparison of results 
from the two methods indicated that the P erroneous result (Sneath and Johnston, 
1973) was 11.02%. Unfortunately it was not possible to do a similar calculation for 
other filters or at other levels of stringency, therefore the P erroneous result for the 
whole of the data is not known.
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Fig. 7.1. (A and B); Dot blots, showing results from probing with apKD.
The photographs show one filter, which has been probed using aph at various levels 
of stringency.
A shows an autoradiograph of the filter after washing with 3 x SSC and 0.1% SDS. 
B shows an autoradiograph of the filter after washing with 1 x SSC and 0.1% SDS.
The following strains correspond to the dots and the figures in parenthesis illustrate
how each strain was scored for the purposes of cluster analysis:
A l, DSM4112 (0); A2, ISP5060 (11); A3, ISP5174 (11); A4, ISP5016 (11); A5, 
ISP5064 (0); A6 , ISP5022 (11); A7, ISP5278 (111); A8 , ISP5122 (111); Bl, 
ISPS 196 (11); B2, ISP5556 (11); B3, ISP5329 (0); B4, DSM40023 (11); B5, E35 
(0); B6 , DSM40077 (0); B7, ISP5069 (11); B8 , ISP4213 (111); C l, DSM40232 
(11); C2, ATCC12475 (111); C3, ISP5246 (111); C4, KCC S-0313 (11); C5, KCC 
S-0331 (0) C6 , DSM40323 (0); C7, KCC S-0783 (0); C8 , DSM40419 (0); D l, 419
(I I )  ; D2, DSM40438 (111); D3, DSM40455 (1); D4, KCC S-0446 (11); D5, KCC 
S-0459 (11); D6 , KCC S-0495 (0); D7, DSM40508 (111); D8 , KCC S-0519 (0); 
E l, ISP5550 (11); E2, DSM40598 (11); E3, KCC S-0731 (111); E4, KCC S-0772
( I I I )  ; E5, KCC S-0785 (111); E6 , KCC S-0850 (0); E7, C463 (111); E8, 
NRRL3664 (0); F I, JHCC1319 (111); F2, JHCC1236 (111); F3, JHCC1390 (11); 
F4, JHCC1234 (11); F5, 4-739 (11); F6 , 734 (1); F7, NRRL B-16130 (0); F8, 
NRRL B-16185 (111); G l, 734-A (1); G2, AM3672 (11); G3, A10 (111); G4, A19 
(111); G5, A26 (1); G6 , A39 (111); G7, A73 (0); G8, B4 (111); H I, C3 (0) H2, 
C5 (0); H3, C l l  (111); H4, C14 (111); H5, CIS (11); H6 , C20 (11); H7, C23
(I I )  ; H8 , C24 (1); II , C32 (0); 12, C38 (11); 13, C91 (111); 14, C92 (111); IS, 
C129 (0) ; 16, C151 (0) ; 17, C155, (11) ;I8 , C167 (11) ;J1, C158 (0) ; J2, C184
( I I I )  ; J3, C186 (111) ; J4, C189 (111) ; J5, C195 (11) ; J6 , C212 (111) ; J7, 
C159 (11) ; J8 , C222 (0) ; K l, C227 (0) ; K2, C229 (111); K3, C245 (111); K4, 
C284 (111); K5, C271 (11); K6 , C337 (11); K7, C402 (111); K8 , D5 (0); Ll, 
D104 (0); L2, D147 (111); L3, D1S3 (111); LA, E l (111); LS, Salmon Sperm 
DNA (1); L6 , JI1326 (0); L7, SCR119 (0); L8 , F53 (111).
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Fig. 7.I.C . Dot blot produced using the phosphorimager, where sample DNA was 
hybridized with a streptomycin resistance gene probe (aphD), overnight at 70°C in 
hybridization solution and washed twice with 3 x SSC and 0.1% SDS for 30 
minutes (equivalent to 63% homology, assuming G +C  =  73%). DNA from the 
following strains was probed and the phosphorimager signals (arbitrary units) are 
given in parenthesis.
A l, DSM4112 (2493); A2, ISP5060 (3093); A3, ISP5174 (2104); A4, ISP3016 
(1913); A5, ISP5064 (265); A6 , ISP5022 (2434); A7, ISP5278 (1712); A8, 
ISP5122 (8451); B l, ISP5196 (17338); B2, ISP5556 (4340); B3, ISP5329 (1401); 
B4, DSM40023 (2439); B5, E35 (1243); B6 , DSM40077 (1787); B7, ISP5069 
(3182); B8 , ISP4213 (3472); C l, DSM40232 (6793); C2, ATCC12475 (96865); 
C3, ISP5246 (5679); C4, KCC S-0313 (3662); C5, KCC S-0331 (1086) C6 , 
DSM40323 (1701); C7, KCC S-0783 (1508); C8, DSM40419 (140); D l, 419 
(3338); D2, DSM40438 (6576); D3, DSM40455 (2271); D4, KCC S-0446 (3276); 
D5, KCC S-0459 (5581); D6 , KCC S-0495 (2967); D7, DSM40508 (5305); D8, 
KCC S-0519 (256); E l, ISP5550 (3971); E2, DSM40598 (4170); E3, KCC S-0731 
(5636); E4, KCC S-0772 (16490); E5, KCC S-0785 95848); E6 , KCC S-0850 
(2060); E7, C463 (4790); E8 , NRRL3664 (545); F I, JHCC1319 (6469); F2, 
JHCC1236 (5534); F3, JHCC1390 (6469); F4, JHCC1234 (2499); F5, 4-739 
(2553); F6 , 724 (2134); F7, NRRL B-16130 (1986); F8 , NRRL B-16185 (6815); 
G l, 734-A (2393); G2, AM3672 (2906); G3, A10 (5406); G4, A19 (8362); G5, 
A26 (1171); G6 , A39 (5135); G7, A73 91548); G8 , B4 (5604); H I, C3 (1248) H2, 
C5 (2550); H3, C ll  (42567); H4, C14 (15060); H5, C15 (5023); H6 , C20 (3058); 
H7, C23 (3407); H8 , C24 (1475); II , C32 (1131); 12, C38 (2755); 13, C91 (3490); 
14, C92 (4070); 15, C129 (959.4) ; 16, C151 (1969) ; 17, C155, (6322) ;I8 , C167 
(3701) ¡11, C158 (1165) ; J2, C184 (4305) ; J3, C186 (14422) ; J4, C189 (2684) ; 
J5, C195 (3459) ; J6 , C212 (17048) ; J7, C159 (6000) ; J8, C222 (2715) ; Kl, 
C227 (1556) ; K2, C229 (5001); K3, C245 (13885); K4, C284 (4425); K5, C271 
(1749); K6 , C337 (3987); K7, C402 (6224); K8 , D5 (1406); L I, D104 (1638); L2, 
D147 (81129); L3, D153 (5335); L4, E l (3424); L5, Salmon Sperm DNA (735.1); 
L6 , JI1326 (1186); L7, SCR119 (251.5); L8 , F53 (2145).
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The use of replicate filters and replicate DNA samples could have helped 
with data interpretation and the estimation of test error. This was not done, since it 
was planned that positive results would be confirmed by carrying out Southern blot 
analysis (work in progress; Neil Cresswell and Leisa Huddleston, Department of 
Biological Sciences, University of Warwick). It is emphasised that positive results 
were used as an indication of homologous sequences to the gene probes, since only 
sequence analysis can provide information on their precise nature. It could also have 
been possible to prepare Southern blots from the outset, as in the study of Hotta et 
al. (1988), however this would not have been suitable for the screening of large 
numbers of strains and the study would have been more limited. The aim was to 
study a large population of strains, using several gene probes and to observe trends 
within that population. It was accepted that dot blots would contain more erroneous 
results than Southern blots. Information from this initial study can now be used to 
initiate more detailed studies concerning the nature specific positive signals and also 
of alternative resistance mechanisms.
7.3. The Distribution of Sequences, which Hybridized to Antibiotic Resistance 
Gene Probes.
7.3.1. The Distribution of Sequences, which Hybridized to Various Antibiotic
Resistance Gene Probes.
Table 7.3. shows that the most common hybridizations at high stringency 
were to the streptomycin and neomycin phosphotransferase gene probes and the 
least common was the bialaphos resistance fragment Fig 7.2. gives a graphical 
representation of this data where differences in the levels of homology, indicated by 
the stringency washes, have been taken into account.
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Fie. 7.2. The distribution of DNA from Streptomvces strains which hvhriHiwri tn 
antibiotic resistance gene probes.
The diagram is a graphical representation of Table 7.3. and shows the distribution 
of hybridizing sequences with respect to the stringency to which each probe was 
screened. (NB screening was only carried out at three stringencies for each probe).
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Table 7.3. The distribution of positive signals from dot blots within Streptomces 
Strains.
Probe Stringency (0.1 % SDS plus)
3 x SSC 1 x SSC 0.2 x SSC
aphD 69.32 (122) 56.25 (99) 31.82 (56)
aph 44.89 (79) 25.57 (45) 19.89 (35)
tsr 56.25 (99) 11.93 (21) 9.1 (16)
vph 59.66 (105) 27.27 (48) 7.39 (13)
nbr 27.84 (49) 14.21 (25) 8.52 (15)
bar 59.09 (104) 40.34 (71) 3.98(7)
The numbers given refer to the percentage of strains which hybridized, whilst the 
figures in parenthesis show the actual number of strains, which hybridized.
Different gene probes gave different homology profiles, possibly showing 
where there was an abundance or lack of related gene sequences, tsr, aph and nbr 
showed a sharp decline in the percentage of strains which hybridized to them 
between 3 x SSC and 1 x SSC and then the numbers of positive signals were more 
constant from 1 x SSC to 0.2 x SSC. This might suggest that highly related 
sequences to these genes were rare.
The probes for vph, aphD and bar gave more linear graphs and vph also 
showed a large decline in related sequences from 3 x SSC to 0.2 x SSC homology, 
but the percentage of hybridizing strains continued to fall, at a reduced slope, to 0.2  
x SSC. In contrast the mqjor loss of sequences binding to the bar and aphD gene 
probes was from 1 x SSC to 0.2 x SSC..
Table 7.3 describes positive signals which were stronger than the negative 
controls. However, different intensities were observed amongst the positive signals 
and Table 7.4 shows the strains for which the most intense signals were observed.
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Table 7,4. To show strains giving strong hybridization signals to antibiotic 
resistance pene probes.
Probe Strains Number
aphD •DSM40236, »ATCC25481 ATCC11062, 
C l l ,  D147, CAG23.
6(56)
aph CAG6 , *CAG7, Lu46, *C47, *C284 
•KCC S-0772, KCC S-0785, C402.
7(35)
tsr KCC S-0772, *KCC S-0785. 2(16)
vph •KCC S-0785, CAG7, 2(13)
nbr •KCC S-0772, *KCC S-0785. 2(15)
bar •1233, *8852. 2 ( 7 )
Positive controls are omitted from the table, but gave strong signals, whilst 
numbers in parentheses refer to the total number of positive signals.
Strains assigned * gave a signal which appeared as strong as the positive 
control; ie. the strain from which the relevant gene was isolated, except for Nbr  and 
aph where it was with reference to the spot from the plasmid containing the gene 
probe (this was because the relevant strains did not light up at 85% stringency).
The other strains on the table gave weaker signals (but these were stronger 
than the signals which were scored as positive for cluster analysis).
The number o f  highly related sequences was considerably reduced if only 
strong signals were scored. These strains were thought to be the most likely to 
contain similar genes to the actual probes used. The remaining weak signals could 
comprise strains with small homologous segments of DNA or strains with larger 
sequences which are not as closely related to the probes as the strong positives, 
although another consideration was the accuracy of spectrophotometric
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Four strong signals with the aphD probe occurred within the DNA of 
streptomycin producers (DSM40236, ATCC11062) and suspected producers (C ll, 
D147), whilst ATCC25481 (S.omatus) the omamycin producer also hybridized 
(none of the CAG or LU series have been screened for bioactivity). Strains, which 
hybridized to the aph probe included C402, which may produce herbimycins and 
C47, a strain suspected of producing a novel compound (recently found to be 
borrelidin). Interestingly, S.hygroscopicus (KCC S-0772) and S.lusitanus (KCC S- 
0785) hybridized strongly with several probes, including the nbr  probe, which is 
reported to be specific for the production of novobiocin (Mitchell et a t., 1990). The 
S.hygroscopicus strain is known to produce hygromycins and S.lusitanus produces 
tetracyclines. 1233 which hybridized to bar is an industrial strain of ATCC21705 
the positive control for the bar gene, whilst 8852 was S.vinaceus the viomycin 
producer. Most of the strains showing strong hybridization signals did not express 
resistance to the relevant antibiotic.
7.3.2. The Distribution of Patterns of Hybridization to Various Antibiotic 
Resistance Gene probes.
The diversity o f hybridization profiles, at high stringency is given in Table
7.5. Theoretically there are 720 (6 !) combinations of 6 gene probes; this contrasts 
with the 25 profiles which were observed within 176 different strains. Binding to 
either or both streptomycin and neomycin phosphotransferase was common, whilst 
multiple hybridizations were rare and each of these profiles was only ever present in 
1 or 2 strains. Examination of similar patterns at lower levels of stringency revealed 
greater diversity and there were 13 profiles repeated amongst 30 strains and 146 
which were unique (at 3 x SSC +  0.1% SDS).
quantifications. I f  1 /¿g o f DNA was not loaded for each sample then this might also
have contributed to differences in spot intensities.
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Four strong signals with the aphD probe occurred within the DNA of 
streptomycin producers (DSM40236, ATCC11062) and suspected producers (C ll, 
D147), whilst ATCC25481 (S.omatus) the omamycin producer also hybridized 
(none of the CAG or LU series have been screened for bioactivity). Strains, which 
hybridized to the aph probe included C402, which may produce herbimycins and 
C47, a strain suspected of producing a novel compound (recently found to be 
borrelidin). Interestingly, S.hygroscopicus (KCC S-0772) and S.lusitanus (KCC S- 
0785) hybridized strongly with several probes, including the nbr probe, which is 
reported to be specific for the production of novobiocin (Mitchell et al., 1990). The 
S.hygroscopicus strain is known to produce hygromycins and S.lusitanus produces 
tetracyclines. 1233 which hybridized to bar is an industrial strain of ATCC21705 
the positive control for the bar gene, whilst 8852 was S.vinaceus the viomycin 
producer. Most of the strains showing strong hybridization signals did not express 
resistance to the relevant antibiotic.
7.3.2. The Distribution of Patterns of Hybridization to Various Antibiotic
Resistance Gene probes.
The diversity of hybridization profiles, at high stringency is given in Table
7.5. Theoretically there are 720 (6!) combinations of 6  gene probes; this contrasts 
with the 25 profiles which were observed within 176 different strains. Binding to 
either or both streptomycin and neomycin phosphotransferase was common, whilst 
multiple hybridizations were rare and each of these profiles was only ever present in 
1 or 2 strains. Examination of similar patterns at lower levels of stringency revealed 
greater diversity and there were 13 profiles repeated amongst 30 strains and 146 
which were unique (at 3 x SSC +  0.1% SDS).
quantifications. If 1 ng o f  DNA was not loaded for each sample then this might also
have contributed to differences in spot intensities.
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Table 7.5. The distribution of patterns showing hybridization to antibiotic resistance 
gene probes.
The diagram shows how various strains hybridized to the gene probes at 85* 
stringency.
+  refers to a positive signal.
- refers to a negative signal.
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7.4. The Expression of Antibiotic Resistance and its Relationship to Homology with
Antibiotic Resistance Gene Probes.
Strains were classified into 4 groups based on resistance phenotype and 
hybridizations at 85% (Table 7.6.). Those strains which were resistant to a specific 
antibiotic and which hybridized to the relevant gene probe may provide evidence for 
the presence of that same gene in other streptomycetes and sensitive strains, 
showing hybridization to the gene probes may possess highly related sequences that 
are functionally unrelated, but are interesting in evolutionary terms, or else they 
could harbour silent antibiotic genes. Non-hybridizing resistant strains may exhibit 
resistance mechanisms other than those conferred by the probes (these are referred 
to in the text as alternative resistance mechanisms), whilst sensitive strains which 
did not hybridize did not contain the gene itself, highly related sequences or an 
alternative resistance mechanism (at least under the conditions tested in this study).
Sensitive non-hybridizing strains were most common for each probe, but the 
distributions amongst the other three categories varied. aphD and aph had many 
homologous sequences in sensitive strains and more strains with alternative 
resistance mechanisms than strains which were resistant and hybridized. There were 
high numbers of strains with alternative resistance mechanisms for the antibiotics 
viomycin, thiostrepton and novobiocin and very few strains with sensitive 
phenotypes hybridized with these gene probes. There were 16 strains which 
hybridized to three or more antibiotic-resistance gene probes, representing 48.5% of 
all positives observed at high stringency and two-fifths of these had resistant 
phenotypes.
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Table 7.6. T he distribution o f  antibiotic resistance and hybridization» (85%) to
antibiotic resistance gene probes.
Antibiotic
No. strains (total = 176) 
Resistant Resistant 
and and didn't 
Hybridized Hybridize
Sensitive
and
Hybridized
Sensitive 
and didn't 
Hybridize
Streptomycin 19 31 27 (12) 74 (13)
Neomycin 6 17 26(3) 105 (21)
Viomycin 9 33 3(1) 108(24)
Thiostrepton 13 53 2 (1) 86(23)
Novobiocin 8 38 7 100(25)
Numbers in parentheses refer to the number of strains which have not been 
tested for antibiotic resistance and could therefore be resistant. In the previous study 
(Chapter 6) strains were called sensitive below a cut-off value. Low level 
resistances affected three strains with high homology to novobiocin and these have 
been included in the above table as resistant.
7.5. The Relationship Between Antibiotic Production and Resistance.
Previous studies provided evidence for a dichotomy in the distribution of 
antibiotic-resistance phenotypes amongst natural isolates and type strains, where a 
high proportion of the population expressed multiple antibiotic resistances (3-4 or 
more) and many produced antibiotics, whilst the remainder showed only a limited 
resistance phenotype and did not express bioactivity. It was clear that the population 
of natural isolates and type strains which produced secondary metabolites contained 
higher numbers of strains, whose DNA hybridized with the gene probes (Table 
7.7.). This was compared to a lower number of strains with hybridizing DNA
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Table 7.7. The clustering of strains with sequences hybridizing with antibiotic 
resistance genes.
This table relates to work presented in Chapter 6 , where strains, which 
possessed multiple sensitive phenotypes did not produce antibiotics. Such strains are 
represented by the columns entitled 'no expression' and are those, which clustered 
to Area 2 (cluster 3) in the phenogram in Fig. 6 .6 . Conversely, the column entitled 
'expression' refers to strains which clustered to Areas 1, 3 and 4 (clusters 1, 2 and 
4 to 10) in the phenogram presented in Fig. 6 .6 . These strains were shown to 
express multiple antibiotic resistance and antibiotic production was observed in 
many of them.
The table indicates that a greater proportion of strains from the Areas 1, 2 
and 4 of the phenogram (Fig. 6 .6) had DNA, which hybridized with the gene 
probes, than did DNA from strains from Area 2 (group 3).
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sequences in the sensitive population, which did not express antibiotic production. 
Whilst this is not definitive evidence that such strains contain the same gene it does 
appear to correlate well with the distribution of resistance phenotypes.
7.5.1. Relationship Between Aminoglycoside Production and Antibiotic Resistance.
Eleven type strains, which produce aminoglycosides similar to streptomycin 
were examined for hybridization to aphD (Table 7.8). Six strains hybridized to 
aphD a t high stringency (87.43%) and one, a dihydroxystreptomycin producer, 
hybridized at low stringency (66.86%). Two aminoglycoside-producing 
s t r e p t o v e r t i c i l l i a  and two streptothricin producers hybridized at 74.82% 
homology and Table 7.9. shows how this compared to the average homologies of all 
strains in the study, although the set of aminoglycoside producers includes two 
natural isolates which were thought to produce streptomycin. The distribution of 
hybridization to aphD for aminoglycoside producers tended towards binding at high 
stringency, but there was not such a strong correlation between aminoglycoside 
production and hybridization with the other phosphotransferase genes, aph and vph 
(Table 7.9.), although the tendency was towards greater hybridization than the most 
common mean categories (ie no hybridization at any stringency studied). 
Aminoglycoside producers followed the average tsr trend, but hybridized more 
often than average to the novobiocin-resistance determinant.
It is interesting to note that Hotta et al. (1988) found that the 
streptomycin phosphotransferase gene from S.griseus (SS-1198) was species specific 
for streptomycin-producing S.griseus strains. This gene was reported to be identical, 
with respect to size and restriction sites, to genes cloned by Distler et al. (1985) and 
Tohyatna et al. (1984); Lim et al. (1989) consider that these latter two genes 
correspond to aphD (Vallins and Baumberg, 1985). The fragment, which was used 
for probing in the Hotta et al. (1988) study was an 0.4 Kb Sail fragment, compared 
to a 0.8 Kb (Pstl Stul) fragment, used in this study. The fragment used as probe 
for this study contained the B, C and D regions and a small part of the E region
237
Table 7.8. The distribution o f signals hybridizing to aph and aphD in aminoglycoside
producers
This table lists strains which were known aminoglycoside producers and shows 
whether their DNA hybridized to the aph and aphD gene probes.
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Table 7.9. T h e  distribution o f positive signals amongst specific antibiotic producers.
Antib­
iotic
Class
String­
ency
aphD aph tsr vph Nbr bar
Aminog- 0-65 0.0 38.5 38.5 15.4 46.2 38.5
lycos 65 7.7 30.8 38.5 46.2 7.7 0.0
ides 73 30.8 15.4 7.7 30.8 23.1 61.5
(13) 85 61.5 15.4 15.4 7.7 23.1 0.0
Macro- 0-65 60.0 80.0 40.0 80.0 100.0 60.0
lides 65 0.0 20.0 40.0 0.0 0.0 20.0
(5) 73 40.0 0.0 20.0 20.0 0.0 20.0
85 50.0 0.0 0.0 0.0 0.0 0.0
Amino 0-65 28.6 42.9 28.6 14.3 42.9 0.0
Acid 65 0.0 28.6 42.9 28.6 28.6 14.3
Deriva- 73 42.9 0.0 14.3 42.9 28.6 42.9
tives(7) 85 28.6 28.6 14.3 14.3 0.0 42.9
Cyclo 0-65
©©
33.3 66.7 66.7 66.7 33.3
alkane 65 0.0 66.7 33.3 0.0 33.3 33.3
Deriva- 73 33.3 0.0 0.0 33.3 0.0 0.0
tives (3) 85 66.7 0.0 0.0 0.0 0.0 0.0
Benzene 0-65 0.0 100.0 100.0 100.0 0.0 100.0
Deriva 65 100.0 0.0 0.0 0.0 100.0 0.0
tives 73 0.0 0.0 0.0 0.0 0.0 0.0
(1) 85 0.0 0.0 0.0 0.0 0.0 0.0
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Class
o f
Antib
iotic
String
ency
aphD aph tsr vph Nbr bar
Macro- 0-65 50.0 50.0 25.0 50.0 100.0 50.0
lactams 65 25.0 50.0 25.0 25.0 0.0 0.0
(4) 73 25.0 0.0 50.0 25.0 0.0 50.0
85 0.0 0.0 0.0 0.0 0.0 0.0
Quinon 0-6 50.0 0.0 25.0 25.0 50.0 0.0
-es and 65 25.0 50.0 50.0 25.0 0.0 50.0
Tetrac- 73 0.0 50.0 0.0 25.0 25.0 50.0
yclines (4) 85 75.0 0.0 25.0 25.0 25.0 0.0
Mean 0-65 30.7 55.1 43.8 40.3 72.3 40.9
(176) 65 13.1 19.3 44.3 32.4 13.6 18.8
73 24.4 5.7 2.8 19.9 5.7 36.4
85 32.8 29.9 9.1 7.4 8.5 4.0
This Table uses the stringency values associated with 73% G +C . The 
homology levels relating to individual genes are shown in Table 7.2. The mean 
values refer to the proportion of the entire population which hybridized and figures 
in parentheses refer to the number of strains in each group of antibiotic producers.
(Lim et al., 1989), whilst the fragment in the study of Hotta et al. (1988) 
comprised the B region and portions of the A and C region.
The only other group with a reasonable number of strains was the diverse 
group of peptide antibiotics. Three probes tsr, vph and bar were isolated from 
producers of peptide antibiotics. Even when the presence of positive control strains
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were taken into account, there was more than the average amount of hybridization 
shown to the vph and bar probes within this group.
None o f the macrolide or macrolactam producers showed binding at high 
stringency to any of the probes. This was also rare for cycloalkane and benzene 
derivatives. All producers o f macrolides and macrolactams showed less than 65% 
homology to the Nbr probe.
7.6. The Relationship Between Sequences Hybridizing to Antibiotic Resistance 
Gene Probes and Streptomvcete Taxonomy.
There were sufficient strains for four cluster groups (Williams et al., 1983a) 
to be examined in detail with respect to their average gene homology profiles.
Table 7.10. The distribution of sequences hybridizing to antibiotic resistance genes 
within Streptom vces clusters as defined bv Williams e.t a l. (1983a1.
Cluster
Group
%
Homol
% Strains with Homology to: 
aphD aph tsr vph Nbr bar
1 0-65 14.3 35.7 28.6 28.6 53.5 42.3
(15) 65 7.1 7.1 50.0 14.3 13.3 14.3
73 42.9 7.1 0.0 42.9 6.7 28.6
85 35.7 42.9 14.3 14.3 26.7 7.1
5 0-65 18.7 79.0 50.0 50.0 81.3 50.0
(16) 65 18.8 21.0 50.0 37.5 6.3 25.0
73 43.8 0.0 0.0 12.5 12.5 25.0
85 18.8 0.0 0.0 0.0 0.0 0.0
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Cluster
Group
%
Homol
% Strains with Homology 
aphD aph tsr vph Nbr bar
19 0-65 20.0 50.0 70.0 30.0 100.0 0.0
(10) 65 10.0 40.0 30.0 60.0 0.0 40.0
73 10.0 0.0 0.0 10.0 0.0 20.0
85 60.0 10.0 0.0 0.0 0.0 0.0
32 0-65 47.4 57.9 68.4 52.5 73.3 52.6
(19) 65 5.3 21.0 10.5 26.3 21.0 5.3
73 10.5 0.0 15.8 10.5 0.0 36.8
85 36.8 21.0 10.5 10.5 5.3 5.3
Mean 0-65 30.7 55.1 43.8 40.3 72.3 40.9
65 13.1 19.3 44.3 32.4 13.6 18.8
73 24.4 5.7 2.8 19.9 5.7 36.4
85 32.8 29.9 9.1 7.4 8.5 4.0
This Table uses the stringency values associated with 73% G +C. For 
homology levels relating to individual genes please see Table 7.2. The mean values 
refer to the proportion of strains from the whole population which hybridized to the 
antibiotic resistance gene probes. Figures in parentheses refer to the number of 
strains belonging to each taxonomic cluster group (Williams el a l., 1983a).
7.6.1. The Distribution of Sequences Hybridizing with Antibiotic Resistance Gene 
Probes in Streptomvces albidoflavus (Cluster 1),
The aphD gene probe was isolated from Streptomyces g rise us. This strain 
taxonomically identifies to S.albldoflavus cluster 1 and specifically to lb
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S. annul at us. Fifteen cluster 1 strep tomycetes were probed with aphD in order to 
ascertain any relationship between the gene and taxonomic identity. These strains 
contained more than the average amount of hybridization to aphD (Table 7.10.) and 
showed more than average resistance to streptomycin (section 6.4.7., Wellington 
and Cross, 1983; Williams et al., 1983a). In addition cluster 1 strep tomycetes 
showed greater hybridization than average with the other two phosphotransferases. 
The novobiocin resistance determinant was also isolated from a cluster 1 
streptomycete (specifically lc), S. niveus and there was some indication that more 
Cl ' s  than average showed bound to this probe at high stringency.
7.6.2. The Distribution of Sequences Hybridizing to Antibiotic Resistance Gene 
Probes in Streptomvce.s exfoliatus (Cluster 51.
None of the probes used in the study originated from a cluster 3 strain, 
although phosalacine, a compound which is related to bialaphos, is produced by 
Kitasatosporia. Cluster 3 strains tended to hybridize less than average with the bar 
gene probe and the aph probe, but hybridized more often to aphD at 73% than was 
expected.
7.6.3. The Distribution of Sequences Hybridizing with Antibiotic Resistance Gene 
Probes in Streptomvces diastaiochromofenes (Cluster 191.
This group also contained many sequences, which hybridized to the aphD 
probe, but they hybridized less than average to other phosphotransferases; 
interestingly Distler et al. (1987a) has shown that the streptomycin 
phosphotransferase genes from the taxonomically diverse strains, S.griseus and 
S.glaucescens, share 73% homology. The cluster 19 strains also showed less 
hybridization than average to the other resistance gene probes and this could reflect 
the fact that this group does not contain a huge proportion of antibiotic producers. 
None of the probes were isolated from a Cluster 19 streptomycete.
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7.6.4. The Distribution o f Sequences Hybridizing with Antibiotic Resistance Gene
Probes in Streptomvces violaceonifer fCluster 22).
The bar gene was isolated from a S.hygroscopicus strain which is a member 
of this cluster, however the group profile for hybridization to this probe was very 
close to the average profile. Lower than the mean hybridization frequencies were 
shown to aphD and vph and an average profile to aph was observed. The strains 
also showed less than average binding to the u r  probe, although more strains than 
average hybridized to this probe at 73%.
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7.7. Clustering Based on Hybridization Patterns to Antibiotic Gene Probes and its
Relationship to Antibiotic Production.
The data were clustered using both a binary form and a semi-quantitative 
form. For the latter the highest value at which a strain showed hybridization was 
entered into the matrix. For the former, the data were entered as in the following 
example:
probe number 1
OTU1
3xSSC
0
lxSSC
0
0.2xSSC
0 0-65% Homology
OTU2 1 0 0 = 65% Homology
OTU3 1 1 0 = 73% Homology
OTU4 1 1 1 - 85% Homology.
OTU5 1 0 0 = 65% Homology
Trees were created using both UPGMA and single linkage and a selection of 
available coefficients were examined for use with this data. Similarity values were 
calculated using Euclidean distance and the Manhatten metric for the semi- 
quantitative data, whilst the Dice and simple matching coefficients were used for the 
binary data fS^ i^  was chosen to show how weighting against negative matches, 
affected the clustering, compared to Ssm which gave negative and positive matches 
equal weight). Similarity was scored in the same way as phenotypic data (ie. scored 
with respect to the test used) which incorporate parallel and divergent evolution and 
which may therefore contain genetic dissimilarity. A possible alternative form of 
clustering could have been to weight against characters referring to binding at lower 
levels of stringency and to give higher regard to results which might be likely to 
reflect related sequences.
Figs. 7.3. and 7.4. show four relevant phenograms clustered using 
UPGMA;
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A shows a phenogram created from semi-quantitative data, using Euclidean distance 
and UPGMA. Eleven groups have been defined on this phenogram at a Euclidean 
distance of 92.
B shows a phenogram created from semi-quantitative data, using Manhatten distance 
and UPGMA. The positions of strains belonging to the groups which are indicated 
for phenogram A.
Fig. 7.3. Phenograms to show the clustering o f strains based on their hybridization
patterns to antibiotic resistance genes.
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close examination revealed reasonable agreement between all of the phenograms and 
very good reproduction of groups for phenograms clustered using the quantitative 
data. This was better than for those clustered using binary data. The reason could be 
that when all stringency levels were given an individual character status, the number 
of negative results increased, causing an overestimation of similarity when Ssm was 
used compared to S^ice- Cophenetic correlations showed that phenograms based on 
quantitative data gave higher Mantle statistics (eg. 0.84 compared to 0.78 for 
Euclidean with quantitative data versus Dice with binary data and both with 
UPGMA) and therefore were better representations of the similarity matrix. When 
new characters were added (erythromycin biosynthesis gene probes; results not 
discussed) tree topology was hardly altered and this also indicated that the 
classification was good.
The phenogram derived from Euclidean distances (Fig 7.5) has been chosen 
to illustrate trends seen within the data and eleven groups were defined at a 
Euclidean distance of 92. The distribution of 33 antibiotic-producing strains has 
been superimposed on the phenogram and preliminary observations indicated that 
the producers of certain classes of antibiotics grouped to specific clusters. All of the 
macrolide producers clustered to groups 1 or 5, and the macrolactam producers to 
groups 6 and 10, polyene producers were observed in groups 1, 5, 8 and 11 and 
those which produced aminoglycosides in 5 and 8 . Quinones and benzene and 
cycloalkane derivatives were found in the latter half of the phenogram (groups 6,8,9 
and 10), compared to macrolides and polyenes, which were in the first half. 
Interestingly producers of peptide antibiotics clustered to either side of the 
phenogram depending upon whether they were derived from aromatic or non­
aromatic amino acids. Two groups in the phenogram were rotated at positions SI 
and S2 and a diagram was drawn to illustrate the positions of antibiotic producers 
across the phenogram (Fig.7.6).
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A shows a phenogram created from binary data, using and UPGMA 
B shows a phenogram created from binary data, using Ssm and UPGMA 
The positions of strains belonging to the group,s which are indicated for phenognm 
A, Fig. 7.3. are indicated on both diagrams.
Fig. 7.4. Phenograms to show the clustering o f strains based on their hybridization
patterns to antibiotic resistance genes.
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The diagram shows the positions of strains belonging to specified classes of 
antibiotics.
P = Polyenes 
M = Macrolides 
AA = Amino acid derivatives 
C = Cycloalkane derivatives 
A = Aminoglycosides 
Q = Quinones and tetracyclines 
ML = Macrolactams 
B = Benzene derivatives.
Fig. 7.5. Phenogram to show the clustering o f strains based on their hybridization
patterns to antibiotic-resistance genes.
)
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Fig. 7.6. Schematic diagram to shows the clustering o f specific classes of antibiotics 
across a phenogram based on hybridization patterns to antibiotic resistance gene 
probes.
Two groups on the phenogram shown in Fig. 7.5. were rotated at position SI and 
S2 and this schematic diagram shows how the positions of antibiotic producers 
change when these changes in topology. The diagram also shows the trends which 
were observed with respect the producers of specific classes of antibiotics clustering 
to specific groups on the phenogram.
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7.8. Discussion,
At present only a small proportion of the antibiotic biosynthesis pathways 
and resistance mechanisms in nature are known and virtually nothing is understood 
about the distribution of production and resistance genes within natural 
streptomycete populations. The present study helped to prioritize a sizeable 
proportion (30%) of strains for further studies aimed at determining the nature of 
positive signals given by dot blot hybridizations. There was also good evidence for 
the existence of alternative resistance mechanisms and the majority of strains 
classified as resistant (Chapter 6) failed to hybridize with the gene probes used.
Streptomyces azureus and Streptomyces laurentii produce thiostrepton and 
can methylate rRNA for self-defense (Thompson and Cundliffe, 1980). These 
determinants also confer resistance to other peptide antibiotics with the same mode
of action, namely siomycin, sporangiomycin, nosiheptide and thiopeptin (Thompson 
and Cundliffe, 1980; Woodman et al., 1991). Producers of these compounds are 
resistant to thiostrepton and have closely related resistance determinants to tsr which 
could possibly account for some of the positive signals in this study. S.azureus 
actually has two rRNA methylases for thiostrepton resistance and these are not 
linked to the biosynthetic gene cluster, but are integrated on pUlOl-like plasmids 
elsewhere in the chromosome Woodman et ai. (1991). This has lead Woodman et 
al. (1991) to hypothesize that these genes are fortuitous acquisitions obtained later 
than an original resistance gene, which evolved alongside the biosynthetic 
apparatus. This supports findings presented in this thesis, which suggest that 
alternative resistance mechanisms to tsr do exist in nature, although further analysis 
of the resistant strains found in soil is needed to determine if there is more evidence
M  '' aa/
j L L
for the mobility of resistance genes within streptomycete populations.
A correlation was found between aminoglycoside production and 
hybridization with the aphD probe. Other workers have found that aminoglycoside 
phosphotransferases are appreciably homologous within streptomycetes (Distler et 
al., 1987b; Lim et a l., 1989) and may have a common evolutionary origin (Heinzel
250
et al., 1988; Lim et al., 1990) and some of the positive signals with the aphD and 
aph probes may be due to such genes. Neomycin is also known to be inactivated by 
an acetyltransferase (Thompson et al., 1982b) and so such enzymes may be 
responsible for some of the alternative resistance mechanisms observed for these 
aminoglycosides.
Walker (1990) suggested that there has been a selection pressure for the 
evolution of the streptomycin biosynthesis pathway. Guanidino inositol derivatives 
could serve as a nutrient reserve, which is readily utilized during starvation and 
differentiation and this might give organisms a selective advantage for developing 
this portion of the pathway (and might help the selection of the resistance gene). 
An alternative proposal for the function of streptomycin exploits its polycationic 
character, as an accelerator of cell lysis (Szabo et al., 1990). The high proportion of 
strains whose DNA hybridized to the aphD probe may indicate that there are related 
sequences within streptomycetes. Lim et al. (1989) found that aphD shared 
homology with other cloned antibiotic phosphotransferase genes and they also 
hypothesized that the B and D regions of the sequence encoded ATP binding or 
phosphate transfer domains, whilst regions A,C and E encoded antibiotic 
recognition sites. It may be that many of the weak signals were due to the binding 
of small motifs which encode similar functions to the B and D regions, but on 
different genes.
Only a small proportion of isolates hybridized to vph and Nbr, although the 
proportion of phenotypic resistance to sensitivity was similar to that observed for 
other antibiotics. The only known producer of viomycin is S.vinaceus, which has 
three resistance genes including vph, but the capreomycin-resistance determinant 
also confers resistance to this antibiotic (Skinner and Cundliffe, 1980). Although 
there is no evidence for an rRNA methylase in S.vinaceus, Mycobacterium 
smegmatis does possess such an enzyme, which makes it resistant to this antibiotic 
(Skinner and Cundliffe, 1980).
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The mechanism of the novobiovin-resistance determinant in this study is still 
unknown as is that of another resistance gene cloned from S.niveus (Mitchell t t  a/., 
1990). However, Cundliffe and co-workers have cloned a resistance determinant 
with DNA gyrase activity from another producer Streptomyces spheroides (Thiara 
and Cundliffe, 1989). It is possible that some of the strains with alternative 
novobiocin-resistance mechanisms in this study also contain such an enzyme.
Studying the diversity of streptomycete populations may help in 
understanding the evolution and ecological importance of antibiotic production and 
its relationship to antibiotic resistance. This study reported a novel approach to the 
analysis of resistance data and exploited taxonomic methodology for pattern 
recognition. It was shown that groups of strains producing similar antibiotics may 
be delimited by analysing their patterns of hybridization to antibiotic gene probes. 
These patterns appeared to be more related to antibiotic production than they were 
to the taxonomy of the relevant organisms.
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Chapter 8
General Discussion.
A variety of theories have described possible functions for secondary 
metabolite biosynthesis (Bu'loclc, 1965; Hutter, 1982; Z&hner, 1982; Williams et 
al., 1989a;), but the natural role of antibiotic production remains unclear. Few 
attempts have been made to investigate the distribution of bioactivity within natural 
populations of streptomycetes, although they comprise one of the major antibiotic 
producing groups. Most of the available data link taxonomic analysis with biased 
sampling of antibiotic producers (Arai et al., 1976). Whilst the current study did 
not involve an exhaustive investigation o f  secondary metabolite production and was 
still biased towards biologically active products, it attempted to link taxonomic data 
with phenotypic and genotypic analysis and superimposed biological activity on the 
clusters produced.
One of the main aims of this project was to take a new approach for 
analysing natural populations of streptomycetes. Methods from conventional 
bacterial taxonomy (Dice, 1945; Carmicheal and Sneath, 1969; Sokal and 
Michener, 1958; Florek et al., 1951; Lance and Williams, 1967) were used to carry 
out special purpose clustering. The data usually comprised single classes of 
characters (eg. fatty acid profiles, antibiotic resistance phenotypes and genotypes) 
which gave monothetic classifications. Groups of strains were delimited from these, 
allowing trends within the data and correlations with other characters to be 
discovered. This approach differs from conventional numerical taxonomy which 
uses large numbers of different tests to obtain polythetic classifications with the 
usual intention being to generate identification schemes based on general phenetic 
similarity (Williams et al., 1983 a and b; Langham et al., 1989; Kampfer et al., 
1991a and b). Variation and error are an integral part of systematic riata 
(Goodfellow and Dickenson, 1985) and must be rigourously tested as was done in
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other numerical studies (Williams et a l., 1983a, McCarthy and Cross, 1984 and 
Kampfer et al., 1991). If the error lies within acceptable limits (Sneath and 
Johnson, 1972) then cluster analysis can reveal stable relationships for given tests 
and OTUs.
Fatty acid profiles were observed from two different viewpoints, one which 
aimed to gain insight into the relationship between fatty acid metabolism and 
secondary metabolite biosynthesis and another which investigated their use as a 
taxonomic tool. The success of Saddler et al. (1987) in separating S.cyaneus from 
other streptomycetes had indicated that the delimitation of the S.violaceoniger group 
(Williams et al., 1983a and b) from less bioactive clusters was feasible. The attempt 
failed and reasons for this may lie in differences between the two studies. Like the 
study in Chapter 4, Saddler and co-workers (1987) used type strains, which 
represented a tight cluster and some markers from other groupings. However their 
natural isolates were pre-selected by spore morphology. This compared to an 
arbitrarily chosen selection, which comprised a variety of species (Williams et al., 
1983a and b) and unidentified strains. Work presented in Chapter 2 has shown that 
many o f the streptomycete natural isolates did not conform to described 
streptomycete taxa. If this was reflected by their fatty acid profiles they may have 
prevented the delimitation of tight groups for more typical strains, resulting in the 
relatively homogeneous groupings observed in Chapter 4.
Streptomyces species delimitation may require quantitative data, as opposed 
to the qualitative data used in Chapter 4. Saddler (1987) based his approach on an 
assumption that fatty acid profiles remaind constant during logarithmic growth and 
stationary phase following a study using one strain, grown in Sautons medium, with 
three day intervals between readings (Saddler, 1986). However, fluctuations in fatty 
acid levels occurred on a daily basis for D153 in ISP7 medium (section 4.3). 
Kroppenstedt (personal communication) suggested that changes in fluty acid 
composition at different growth phases were responsible for his failure to cluster 
S.violaceoniger amongst a tree comprising 12 different Streptomyces taxa. Success
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was achieved by removing three SMolaceoniger strains (Williams et al., 1983a), 
two of which were present in the study in Chapter 4. The study of Kroppenstedt 
contained only type strains, which may be biased towards strains which have been 
patented for antibiotic production and they would therefore differ from many of the 
antibiotic producers included in Chapter 4. Industrial strains are selected for the 
production of either one or a group of related antibiotics. Antibiotic-producing 
isolates often produce several different compounds (Chapter 3), which may or may 
not relate to fatty acid profiles. Work carried out with D133, a producer of 
nigericin and geldanamycin, suggested that this was possible. The levels of fatty 
acids in this strain fluctuated in line with changes in secondary metabolism. 
However, this study was carried out in a production medium (ISP7), compared to 
Sautons medium, which aims to optimize biomass for taxonomic studies. D153 did 
not produce antibiotics in Sautons medium.
Information about the bioactivity of isolates (Chapter 3) was of central 
importance to the project because it was used to find correlations with all of the 
other data sets. Data used for these comparisons were generated using a wide range 
of culture conditions, extraction procedures and screening methods to increase the 
chances that antibiotic production would be expressed. This also yielded information 
about the distribution of antibiotic production in natural Streptomyces isolates 
(within the experimental limits of the study). Twenty percent of the strains studied 
produced a bioactive compound. The most common antibiotics were nigericin 
(13.3%) and geldanamycin (10%). It was hypothesized that the presence of these 
metabolites in such large numbers of streptomycetes could indicate that they play a 
useful role in their producers. For example, a suggested function for nigericin was 
as an ion scavenging agent. The preferential binding of nigericin to K+  as opposed 
to Na+  could suggest a function in maintaining intracellular K +  concentrations. A 
similar role was put forward and a survival advantage indicated for the 
siderophores, which act as iron scavengers (Hutter, 1982). A role in the inhibition 
of germination has been suggested for other polyethers, which have been shown to
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bind to spore surfaces in a similar manner to the germination inhibitor of 
SMridochromogenes (Ensign, 1976; Grafe et al., 1986). It is not known whether 
nigericin binds to spores in this way. The proposed function of nigericin is further 
supported by the work of Williams et al. (1989a) and Grably et al. (1990), who 
have shown that a highly sophisticated receptor-antibiotic complementation exists 
between this antibiotic and chemically-related compounds and the ions to which they 
bind.
An additional discovery made was that geldanamycin production was always 
associated with nigericin biosynthesis. A portion of the geldanamycin molecule is 
derived from polyketide biosynthesis (Ghisalba, 1985) and it was suggested, 
therefore, that the two compounds might share early biosynthesis steps or else have 
evolved separately in the same progenitor strain (and possibly from the same 
progenitor pathway). In the latter case, nigericin producers which did not express 
geldanamycin production might contain silent biosynthesis genes or represent a line 
of descent in which the ability to make this compound has been lost. The producers 
of many polyketide antibiotics show hybridization to the early genes in actinorhodin 
biosynthesis (Malpartida et al., 1987) and the consensus of scientific opinion is that 
the majority of polyketide biosynthesis pathways share a common evolutionary 
origin (O'Hagan, 1988; Professor D.A. Hopwood, personal communication).
Most strains which produced compounds, thought to be good candidates for 
novel agrochemicals (comprising various different activities) also produced 
nigericin. Because both nigericin and geldanamycin are broad spectrum antibiotics it 
was hypothesized that novel compounds, which were produced concomitantly with 
them, might not be detected (ie their activity spectrum could be hidden within that 
of the broad spectrum antibiotic). Antibiotic expression in the producers of these 
compounds was examined more closely.
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Expression studies revealed a greater diversity of responses to different 
nutrient concentrations and oxygen tensions. Reducing oxygen tension, in cultures 
of strain D1S3, lead to differential expression, between nigericin production, which 
was repressed and geldanamycin biosynthesis, which remained unchanged. This 
effect may have been responsible for the expression of nigericin production on solid 
media, rather than in liquid media in certain strains where shear factors may have 
given rise to small mycelial fragments, which were inefficient at oxygen transfer. 
Polyethers are biosynthesized from a polyene precursor via a triepoxide 
intermediate. In monensin biosynthesis, the formation of this intermediate is the 
only point in the pathway which requires molecular oxygen (Cane et al., 1983). A 
similar pathway is likely for related polyethers, such as nigericin, and it is possible 
that denying sufficient molecular oxygen to D153 prior to nigericin biosynthesis 
would block the pathway at the point prior to the formation of this tri-epoxide 
intermediate.
Growth on nutrient gradients showed that a group of streptomycetes (similar 
in the sense that they all produced nigericin and that some produced geldanamycin) 
did not show the same response to possible stimuli for differentiation (Chapter 3). It 
was thought that this might reflect differences in rates of substrate utilization, 
thresholds for responses to nutrient limitation and pH or the presence of special 
mechanisms for the uptake of limited nutrients, which helped to delay the onset of 
starvation responses. Grafe (1989) has suggested that the characteristic 
cytodifferentiation and polymorphic behaviour of streptomycetes is a form of 
adaptation to a constantly changing natural environment. Grafe (1989) states that 
this could be done either by choosing between an array of pre-set developmental 
programs throughout the growth cycle or via rearrangements of chromosomal or 
extrachromosomal genetic elements. These were also thought to be possible 
explanations for the behaviour of some strains, which frequently exhibited variable 
expression in this work (Chapters 3 and 6).
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The expression of antibacterial and antifungal activity was also strain 
specific with respect to the nutrient environment and altering nutrient conditions led 
to a changed product spectrum for most strains. This is in line with observations 
made for the different responses of rifamycin-producing strains to nitrate 
concentrations (Ghisalba, 1984). There was evidence that some of the strains could 
produce compounds which had not been previously observed. Exposure to certain 
nutrient conditions caused some strains to repress antibiotic production, whilst under 
others they behaved as would be expected from the preceding work (Chapter 3). 
Differential expression at varying nutrient concentrations has also been reported by 
Hall and Has sal (1970) who found that S.jamaciensis produced a different antibiotic 
at 0. ImM Pi than it did at 0.4mM Pi. In addition, Grabley et al. (1990) have shown 
that the antibiotic spectrum of DSM 3816 (a nigericin producer, which also 
produces several other antibiotics) was also dependent on the culture medium and 
conditions. The switch on of antibiotic production within the group of strains 
presented in Chapter 3 required a diversity of nutrient conditions and nutrient 
gradient plates offered a novel approach to investigate this in some detail. Gradients 
were also used to investigate antibiotic resistance (Chapter 6).
Several facts emerged when antibiotic-resistance profiles were examined for 
correlations with bioactivity. Resistance was not always present in producers of the 
relevant compound and was found in strains which showed no evidence of antibiotic 
production; an observation also made by Fujisawa and Weisblum (1982). There 
was, however, a general correlation between resistance and secondary metabolite 
biosynthesis. A strain was more likely to be bioactive the more resistances it 
possessed, and also if these resistances were rare within the population examined. 
Strains which did not express antibiotic production during the current study showed 
mainly sensitive phenotypes apart from common resistances such as penicillin 
resistance. Interestingly, Hotta et al. (1983a, 1983b, 1983), Yamashita et al. (1983) 
and Bibikova et al. (1990) have shown that resistance profiles using specific classes
258
of antibiotics correlate with the production of antibiotics belonging to the same 
chemical group.
Where sensitivity correlated with no antibiotic production, strains may not 
have been exposed to the conditions required to express the relevant genes. 
However, if there are streptomycetes which neither produce antibiotics nor possess 
antbiotic resistance genes then this has ecological implications. Perhaps these strains 
have other advantages for survival in the environment and might be suited to growth 
in more extreme conditions, such as high salt microenvironments. Alternatively they 
could have specializations for utilizing recalcitrant substances.
Resistances which were not associated with antibiotic production have been 
described by Fujisawa and Weisblum, 1981, Jenkins el al. , 1989 and Mosher et al., 
1990.). Antibiotic resistance (Chapter 6) was defined in the context of a population 
study and may not always reflect the levels of resistance required by an antibiotic 
producer. However, some strains which possessed antibiotic resistance but did not 
produce an antibiotic could have a survival advantage against external attack from 
the bioactive products of foreign microorganisms and might also benefit from the 
reduction of other competetive species without having to expend energy on 
antibiotic production. This assumes that antibiotic production occurs in the soil and 
some evidence for this was given by Rothrock and Gottleib (1984), who described 
the production of geldanamycin in soil by Streptomyces hygroscopicus var geldanus. 
The concept also is supported by Martin and Demain, (1980), Demain (1981) and 
(1984), Williams and Vickers (1986) and Weller and Thomashow (1990).
All the above types of strains (with respect to the expression of antibiotic 
resistance and production) were isolated from the same soil samples, but could 
inhabit different microniches. For instance, antibiotic producers may inhabit more 
competitive micro-environments, such as the rhizosphere, It would be interesting to 
know whether populations from different types of locations have higher or lower 
diversity with respect to antibiotic production and resistance. Most strains studied in 
Chapter 6 came from grassland or agricultural soil samples.
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The majority of phenotypic resistances did not appear to be correlate with 
the production of the relevant antibiotic by the resistant strain. Resistance directed 
against the compounds studied (Chapter 6) might be due to a variety of factors. 
Some determinants may have evolved to confer resistance against a different 
compound, which may be structurally related to the test antibiotic. For example, 
aminoglycoside self-resistance determinants can confer resistance to other antibiotics 
of the same class (Skeggs et al., 1987). Alternatively a different compound might 
have a similar mode of action as seen in the MLS resistance phenotype (Fujizawa 
and Weisblum, 1981; Jenkins et al., 1989; Zalacain and Cundliffe, 1989). Other 
resistances may be present to confer protection against the products of competitors. 
This type of resistance would not necessarily correlate with bioactivity, but by 
measuring how often a resistance occurs in a natural population could give a 
measure of the selection pressures, due to antibiotic production, present within that 
environment. Neither penicillin resistance nor a proportion of the nigericin 
resistances correlated with bioactivity and beta-lactams and polyethers are common 
products of soil isolates (J. Benner, personal communication). Assuming antibiotic 
production in the natural environment (Weller and Thomashow, 1990), the high 
occurrence of these resistances could be related to defence against external attack. 
Multiple resistances might indicate an array of different mechanisms or a general 
mechanism. C.J.Thompson (personal communication) has isolated a promoter, 
which can be switched on by many different antibiotics, irrespective of mode of 
action or structure. It was associated with a pristinamycin-resistance gene, which 
was thought to be involved in drug export. Apart from rRNA methylases 
(Cundliffe, 1989), drug export is implicated in multiple resistance (MLS) in many 
macrolide producers (C. Hershberger, personal communication).
The fact that specific phenetic resistance could be due to many underlying 
mechanisms {eg. resistance to kanamycin can be conferred by acetyltransferase 
(Cundliffe, 1986) and rRNA methylase (Skeggs et a l., 1987)} means that resistance 
profiles are very useful for preselecting strains for screening. A resistance expressed
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to a certain antibiotic could be due to a resistance determinant for a novel antibiotic. 
This hypothesis was strengthened by probing data (Chapter 7), which suggested that 
resistances exhibited by most strains in the study were due to mechanisms other than 
those which were related to the gene probes used. The data is also supported by the 
results from an antibiotic resistance pre-screen set up at ICI Agrochemicals Pic., 
which has shown that strains chosen because they have multiple antibiotic resistance 
patterns give many more positive activities on in vivo screens than do sensitive 
strains and the number of strains being further investigated is also greater.
In an attempt to understand the nature of antibiotic resistance at the genetic 
level, strains were probed with a relevant selection of antibiotic-resistance genes. 
Out of 9 strains with only penicillin resistance and 8 strains with only penicillin and 
nigericin resistance 2 showed positive hybridizations to one gene probe. Of the 
strains, which had three or more resistances, 45% hybridized to between 1 and 6 
probes. The probing data was of a preliminary nature, but if the homologies were to 
represent the presence of resistance genes then the phenetic trend would be 
supported by a similar genetic trend.
Tentative observations suggested that there could be a relationship between 
the production of specific antibiotic classes and the presence of sequences that 
hybridized to antibiotic resistance gene probes. Special purpose clustering 
uncovered two populations. Strains which showed a close relationship to the gene 
probes (ie hybridized to them) included aminoglycoside and macrolide producers. 
Producers of other antibiotics, derived from fatty acid metabolism, showed a lower 
relationship to the gene sequences used.
Potentially highly related sequences which gave strong signals were present 
in streptomycetes other than those from which the genes were isolated. Weaker 
signals were present at high stringency for many other streptomycetes and may have 
indicated the presence of less related sequences or highly related sequences of a 
shorter length. In order to assess how successful using dot blots as a primary screen 
for finding genes in large populations of streptomycetes confirmation using southern
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hybridization and sequencing studies will be required. The findings o f these future 
studies may have a bearing on the evolution of secondary metabolism, antibiotic 
resistance and gene transfer. The approach appears to have been useful in 
determining strains, which could have novel or different resistance mechanisms.
A recurring theme throughout this work was that the raw data were not 
definitive and referred to phenotype rather than genotype. For instance, the growth 
conditions were important for the expression of both antibiotic production (Chapter 
3) and antibiotic resistance (Chapter 6). Different nutrient concentrations and 
oxygen tensions affected whether or not antibiotics were produced and could change 
the product spectrum and which particular strains expressed antibiotic resistance was 
influenced by the growth medium. A consequence of this was that although a strain 
was negative under test conditions, it was not known whether that strain was 
capable of expressing a relevant set of genes if the environmental conditions were 
made favourable. Similarly, conditions could be found to repress gene expression 
by strains, which gave a positive score under the test conditions (Chapter 3). 
Strains, which express the same character under identical conditions, could be 
assumed to be more like one another than strains which express this character under 
different conditions. However, the latter is more like the former type of strain than 
a strain which cannot express the character at all.
Detection limits may also have influenced the scoring of negative results and 
low level expression might not always have been detected by the instrumentation or 
assay procedures used. Examples of where this may have occurred included, Gas 
Chromatography Mass Spectrometry (Chapter 4), thin layer chromatography 
(Chapters 3 and 3), and bioautography (Chapter 6). Likewise positive results could 
be due to different things. For example, phenetic antibiotic resistance was scored in 
Chapter 6 and a resistant phenotype could be due to one or several of a range of 
underlying mechanisms (a fact which was exploited). Even when a strain has the 
same mechanism the enzymes and genes responsible may be different. Similarly, in 
Chapter 3 different compounds may have identical Rf values. These problems are
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common to other taxonomic studies, which use the systematic approach for phenetic 
data. For example, carbon source utilization tests could show positive as a result of 
different enzymes, pigmentation can be due to different compounds and negative 
results might show positive under slightly different conditions. All these factors can 
lead to strains grouping against general trends during cluster analysis. In order to 
minimise the influence of 'mis-scored' negative results coefficients were chosen 
which weighted against negative matches.
Positive results using the dot blot approach gave a range of intensities and 
therefore a certain type of interpretation was necessary. Weak hybridizations were 
scored positive, although they could be due to non-specific binding resulting from 
protein contamination in DNA samples or, since random primed labelling was used, 
they might be due to short homologous motifs. Weak positive results may also have 
been due to related sequences, which might or might not comprise portions of 
resistance genes. In view of this equal weight was given to positive and negative 
signals, for cluster analysis.
8.2. Future Work.
This project has provided a variety o f opportunities for future research and 
the knowledge gained, whilst carrying out the work has led to the development of 
several interesting hypotheses. The theory that common occurrence of certain 
antibiotics might indicate that they are useful to their producers could be developed 
further by carrying out experiments aimed at discovering what their natural 
functions might be. For example, if nigericin was involved in maintaining ionic 
balance or if  it functioned as an ion scavenging agent then its producers might 
survive better in excessively high or low ionic (Na+ , K + ) environments than 
would non-producers.
Another fact which emerged was that geldanamycin appeared to only be 
produced by strains, which also produced nigericin. This is interesting from an 
evolutionary point of view and more insight might be gained into this relationship
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by carefully examining their chemical structures and pathways of biosynthesis. 
Professor Don Ritchie (personnal communication) has cloned the geldanamycin 
production genes and if relevant probes and sequence information became available 
then these could be used to examine nigericin and geldanamycin producing strains in 
detail. Experiments using strain D1S3 indicated that changes in the levels of fatty 
acids might be related to production of geldanamycin and nigericin and this 
relationship could be investigated in more detail. For example radioactively-labelled 
precursors might establish whether the decline in fatty acid levels relates directly to 
antibiotic production.
It is still not clear as to whether antibiotic production is a feature of all 
streptomycetes or if there are some strains, which do not express this aspect of 
secondary metabolism. Strains which did not express antibiotic production and 
resistance were identified during this research and a more detailed look at the effect 
of environmental factors on these strains might help to assess how the strains might 
behave in the natural environment. Questions to be addressed include whether they 
are incapable o f expressing bioactivity and resistance, and if not whether they might 
inhabit a different type of micro-niche to the strains which expressed antibiotic 
production and resistance. If evidence suggested that the latter case was correct then 
it would be o f ecological interest to determine if relevant strains were specialized 
for survival in the natural environment in other ways (eg. extreme concentrations of 
ions, salt, heavy metals or the ability to utillize recalcitrant compounds).
Little is known about secondary resistances (those not connected with 
antibiotic production), although this work has identified a series of strains which 
expressed antibiotic resistance, but did not produce an antibiotic under the 
experimental conditions used. It would be useful to use other methods for 
determining bioactivity in these strains. If this further supported the existence of 
secondary resistance in these strains then it would be challenging to pursue the 
ecological and evolutionary relationship between determinants, which confer 
secondary resistance and those which confer primary resistance.
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The study also indicated strains, which might contain specific antibiotic 
resistance genes or related genes and has allowed a smaller number of strains to 
enter a secondary screen, involving southern analysis, which will permit further 
selections to take place. The chosen strains will then undergo detailed analyses 
aimed at determining evolutionary relationships within their secondary metabolisms. 
For example, sequence specific and consensus primers from known genes (eg. 
aphD) might be used and sequence analysis of interesting genes might then be 
carried out.
Although a variety of antibiotic resistance mechanisms are known it is likely 
that more exist in nature. It might therefore be enlightening to examine the nature of 
resistance mechanisms in resistant nonhomologous strains. This could be achieved 
by using assays for specific enzymes that could be involved in antibiotic resistance 
or by using additional probes if they became available
The study also allowed the development of several new methodologies. For 
example nutrient and antibiotic gradient plates were useful tools for population and 
expression studies; both of these methods could undergo further development. 
Streptomycetes could be grown on two dimensional nutrient gradients and then 
overlayed with test organisms to provide useful information on conditions required 
for bioactivity in individual strains. Antibiotic gradients could also provide a means 
of stimulating antibiotic production. Diffusion effects on gradient plates could also 
be studied using dyes of varying solubilities, or by direct assay in the form of plug 
assays for the antibiotic plates; perhaps colorimetric and flourimetric enzyme assays 
could be adapted for use with nutrient gradients.
Another application of the work was that a pre-screen based on antibiotic 
resistance profiles was incorporated into the screening system at ICI Agrochemicals 
P.l.c. and proved useful in prioritizing strains for screening. This system could be 
developed to include a much wider range of antibiotic resistances, which might 
allow prediction of the producers of known compounds as in the work of Kunimoto 
Hotta.
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Although TLC profiles were not a useful taxonomic tool, it might be 
interesting to analyse the rare compounds which were observed in Chapter 5, both 
chemically and for biological activity. In addition chemical analysis of the variable 
spots might help to understand why the results were not consistent and timecourse 
experiments might show how important standardized conditions were to scoring 
profiles. Image analysis could be useful for reducing operator error.
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